Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature
Office of the Revisor of Statutes

SF 4782

4th Engrossment - 93rd Legislature (2023 - 2024) Posted on 04/23/2024 01:20pm

KEY: stricken = removed, old language.
underscored = added, new language.
Version List Authors and Status
Pdf Rtf

Current Version - 4th Engrossment

Line numbers 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 1.23 1.24 1.25 1.26 1.27 1.28
1.29 1.30 1.31 1.32 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 2.30 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25 3.26 3.27 3.28 3.29 3.30 3.31 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18 4.19 4.20 4.21 4.22 4.23 4.24 4.25 4.26 4.27 4.28 4.29 4.30 4.31 4.32 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 5.9 5.10 5.11 5.12 5.13 5.14 5.15 5.16 5.17 5.18 5.19 5.20 5.21 5.22 5.23 5.24 5.25 5.26 5.27 5.28 5.29 5.30 5.31 5.32 5.33 5.34 6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 6.9 6.10 6.11 6.12 6.13 6.14 6.15 6.16 6.17 6.18 6.19 6.20 6.21
6.22
6.23 6.24 6.25 6.26 6.27 6.28 6.29
7.1 7.2 7.3 7.4 7.5 7.6 7.7 7.8 7.9 7.10 7.11 7.12 7.13 7.14 7.15 7.16 7.17 7.18 7.19 7.20 7.21 7.22 7.23 7.24 7.25 7.26 7.27 7.28 7.29 7.30 7.31 8.1 8.2 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.11 8.12 8.13 8.14 8.15 8.16 8.17 8.18
8.19 8.20 8.21 8.22 8.23 8.24 8.25 8.26 8.27 8.28
9.1 9.2 9.3 9.4 9.5 9.6 9.7 9.8 9.9 9.10 9.11 9.12 9.13 9.14 9.15 9.16 9.17 9.18 9.19 9.20 9.21 9.22 9.23 9.24 9.25 9.26 9.27 9.28 9.29 9.30 9.31
10.1 10.2 10.3 10.4 10.5 10.6 10.7 10.8 10.9 10.10 10.11 10.12 10.13 10.14 10.15 10.16 10.17 10.18 10.19 10.20 10.21 10.22 10.23 10.24 10.25 10.26 10.27 10.28 10.29 10.30 10.31 10.32 11.1 11.2 11.3 11.4 11.5 11.6 11.7 11.8 11.9 11.10 11.11 11.12 11.13 11.14 11.15 11.16 11.17 11.18 11.19 11.20 11.21 11.22
11.23 11.24 11.25 11.26 11.27 11.28 11.29 11.30 11.31 11.32 12.1 12.2 12.3 12.4 12.5 12.6 12.7
12.8 12.9 12.10 12.11 12.12 12.13 12.14 12.15 12.16 12.17 12.18 12.19 12.20 12.21 12.22 12.23 12.24 12.25 12.26 12.27 12.28 12.29 12.30 12.31 12.32 13.1 13.2 13.3 13.4 13.5 13.6 13.7 13.8 13.9 13.10 13.11 13.12 13.13
13.14 13.15 13.16 13.17 13.18 13.19 13.20 13.21 13.22 13.23 13.24 13.25 13.26 13.27 13.28 13.29 13.30 13.31 14.1 14.2 14.3 14.4
14.5 14.6 14.7 14.8 14.9 14.10 14.11 14.12 14.13 14.14
14.15
14.16 14.17 14.18 14.19 14.20 14.21 14.22 14.23 14.24 14.25 14.26 14.27 14.28 14.29 15.1 15.2 15.3 15.4 15.5 15.6 15.7 15.8 15.9 15.10 15.11 15.12 15.13 15.14 15.15 15.16 15.17 15.18 15.19 15.20 15.21
15.22
15.23 15.24 15.25 15.26
15.27
16.1 16.2 16.3 16.4 16.5 16.6 16.7 16.8 16.9 16.10 16.11 16.12 16.13 16.14 16.15
16.16
16.17 16.18 16.19 16.20 16.21 16.22 16.23 16.24
16.25
16.26 16.27 16.28 16.29 16.30 17.1 17.2 17.3 17.4 17.5 17.6 17.7 17.8 17.9 17.10 17.11 17.12 17.13 17.14 17.15 17.16 17.17 17.18 17.19 17.20 17.21 17.22 17.23 17.24 17.25 17.26 17.27 17.28 17.29 17.30 17.31 17.32 17.33 17.34 18.1 18.2 18.3 18.4 18.5 18.6 18.7 18.8 18.9
18.10
18.11 18.12 18.13 18.14 18.15 18.16 18.17 18.18 18.19 18.20 18.21 18.22 18.23 18.24 18.25 18.26 18.27 18.28 18.29 18.30 18.31 18.32 19.1 19.2 19.3 19.4 19.5 19.6 19.7
19.8
19.9 19.10 19.11 19.12 19.13 19.14 19.15 19.16 19.17
19.18
19.19 19.20 19.21 19.22 19.23 19.24 19.25 19.26 19.27 19.28 19.29 19.30 20.1 20.2 20.3 20.4 20.5 20.6 20.7 20.8
20.9
20.10 20.11 20.12 20.13 20.14 20.15 20.16 20.17 20.18 20.19 20.20 20.21 20.22 20.23 20.24 20.25 20.26 20.27 20.28 20.29 20.30 20.31 21.1 21.2 21.3 21.4 21.5 21.6 21.7 21.8 21.9 21.10 21.11 21.12 21.13
21.14
21.15 21.16 21.17 21.18 21.19 21.20 21.21 21.22 21.23 21.24 21.25 21.26 21.27 21.28 21.29 21.30 21.31 22.1 22.2 22.3 22.4 22.5 22.6 22.7 22.8 22.9 22.10 22.11 22.12 22.13 22.14 22.15
22.16
22.17 22.18 22.19 22.20 22.21 22.22 22.23 22.24
22.25
22.26 22.27 22.28 22.29 22.30 23.1 23.2 23.3 23.4 23.5 23.6 23.7 23.8 23.9 23.10 23.11 23.12 23.13 23.14 23.15 23.16 23.17 23.18 23.19 23.20 23.21 23.22 23.23 23.24 23.25 23.26 23.27 23.28 23.29 23.30 23.31 23.32 24.1 24.2 24.3 24.4 24.5 24.6 24.7 24.8 24.9 24.10 24.11 24.12 24.13 24.14 24.15 24.16 24.17
24.18
24.19 24.20 24.21 24.22 24.23 24.24 24.25 24.26 24.27 24.28 24.29 24.30
25.1
25.2 25.3 25.4 25.5 25.6 25.7 25.8 25.9 25.10 25.11 25.12 25.13 25.14 25.15 25.16 25.17 25.18 25.19 25.20 25.21 25.22 25.23 25.24 25.25 25.26 25.27
25.28
26.1 26.2 26.3 26.4 26.5 26.6 26.7 26.8
26.9 26.10 26.11 26.12 26.13 26.14 26.15 26.16
26.17 26.18 26.19 26.20 26.21 26.22 26.23 26.24 26.25 26.26 26.27 26.28 26.29 26.30 26.31 26.32 27.1 27.2 27.3 27.4 27.5 27.6 27.7 27.8 27.9 27.10 27.11 27.12 27.13 27.14 27.15 27.16 27.17 27.18 27.19 27.20 27.21 27.22 27.23 27.24 27.25 27.26 27.27 27.28 27.29 27.30 28.1 28.2 28.3 28.4 28.5 28.6 28.7 28.8
28.9 28.10 28.11 28.12 28.13 28.14 28.15 28.16 28.17 28.18 28.19 28.20 28.21 28.22 28.23 28.24 28.25 28.26 28.27 28.28 28.29
29.1 29.2 29.3 29.4 29.5 29.6 29.7 29.8 29.9 29.10 29.11 29.12 29.13 29.14 29.15 29.16 29.17 29.18 29.19 29.20 29.21 29.22 29.23 29.24 29.25 29.26 29.27 29.28 29.29 29.30 29.31 30.1 30.2 30.3
30.4 30.5 30.6 30.7 30.8 30.9 30.10 30.11 30.12 30.13 30.14 30.15 30.16 30.17 30.18 30.19 30.20 30.21 30.22 30.23 30.24 30.25 30.26 30.27 30.28 30.29 30.30 30.31 31.1 31.2 31.3 31.4 31.5 31.6 31.7 31.8 31.9 31.10 31.11 31.12 31.13 31.14 31.15 31.16 31.17 31.18 31.19 31.20 31.21
31.22 31.23 31.24 31.25 31.26 31.27
31.28
31.29 31.30 31.31 31.32 32.1 32.2
32.3
32.4 32.5 32.6 32.7 32.8 32.9 32.10 32.11 32.12 32.13 32.14 32.15 32.16
32.17 32.18 32.19 32.20 32.21 32.22 32.23 32.24 32.25 32.26 32.27 32.28 33.1 33.2 33.3 33.4 33.5 33.6
33.7
33.8 33.9 33.10 33.11 33.12 33.13
33.14
33.15 33.16 33.17 33.18 33.19
33.20
33.21 33.22 33.23 33.24 33.25 33.26 33.27 33.28
33.29
34.1 34.2 34.3 34.4 34.5 34.6 34.7 34.8 34.9 34.10 34.11
34.12
34.13 34.14 34.15 34.16
34.17
34.18 34.19 34.20 34.21 34.22 34.23 34.24 34.25 34.26 34.27 34.28 34.29 35.1 35.2 35.3 35.4 35.5 35.6 35.7 35.8
35.9
35.10 35.11 35.12 35.13 35.14 35.15 35.16 35.17 35.18 35.19 35.20 35.21 35.22 35.23
35.24
35.25 35.26 35.27 35.28 35.29 36.1 36.2 36.3 36.4
36.5
36.6 36.7 36.8 36.9 36.10 36.11 36.12
36.13
36.14 36.15 36.16 36.17 36.18 36.19 36.20 36.21 36.22 36.23 36.24 36.25 36.26 36.27 36.28 36.29 36.30 37.1 37.2 37.3 37.4 37.5 37.6 37.7 37.8 37.9 37.10 37.11 37.12 37.13 37.14 37.15 37.16 37.17 37.18 37.19 37.20 37.21 37.22 37.23 37.24 37.25 37.26 37.27 37.28 37.29 37.30 37.31 37.32 38.1 38.2 38.3 38.4 38.5 38.6 38.7 38.8 38.9 38.10 38.11 38.12 38.13 38.14 38.15 38.16 38.17 38.18 38.19
38.20
38.21 38.22 38.23 38.24 38.25 38.26 38.27 38.28 38.29 38.30 39.1 39.2 39.3 39.4 39.5 39.6 39.7 39.8 39.9 39.10 39.11 39.12 39.13 39.14 39.15 39.16 39.17 39.18
39.19
39.20 39.21 39.22 39.23 39.24 39.25 39.26 39.27
39.28
40.1 40.2 40.3 40.4 40.5 40.6 40.7 40.8 40.9 40.10 40.11 40.12 40.13 40.14 40.15 40.16 40.17 40.18
40.19 40.20 40.21 40.22 40.23 40.24 40.25 40.26 40.27 40.28 40.29 40.30 40.31 41.1 41.2 41.3 41.4 41.5 41.6 41.7 41.8 41.9 41.10 41.11 41.12 41.13 41.14 41.15 41.16 41.17
41.18 41.19 41.20 41.21 41.22 41.23 41.24 41.25 41.26 41.27 41.28 41.29 41.30 41.31 42.1 42.2 42.3 42.4 42.5 42.6 42.7 42.8 42.9 42.10 42.11 42.12 42.13 42.14 42.15 42.16 42.17 42.18 42.19 42.20 42.21 42.22 42.23 42.24 42.25 42.26 42.27 42.28 42.29 42.30 42.31 43.1 43.2 43.3 43.4 43.5 43.6 43.7 43.8 43.9 43.10 43.11 43.12 43.13 43.14 43.15 43.16 43.17 43.18
43.19
43.20 43.21 43.22 43.23 43.24 43.25 43.26
43.27
43.28 43.29 43.30 43.31 44.1 44.2 44.3 44.4 44.5 44.6 44.7 44.8 44.9 44.10 44.11 44.12 44.13 44.14 44.15
44.16
44.17 44.18 44.19 44.20 44.21 44.22 44.23 44.24 44.25 44.26 44.27 44.28 45.1 45.2 45.3 45.4 45.5 45.6 45.7 45.8 45.9 45.10 45.11 45.12 45.13 45.14 45.15 45.16 45.17 45.18 45.19 45.20 45.21 45.22 45.23 45.24 45.25 45.26 45.27 46.1 46.2 46.3 46.4 46.5 46.6 46.7 46.8 46.9 46.10 46.11 46.12 46.13 46.14 46.15 46.16 46.17 46.18 46.19 46.20 46.21 46.22 46.23 46.24 46.25 46.26 46.27 47.1 47.2 47.3 47.4 47.5 47.6 47.7
47.8 47.9 47.10 47.11 47.12 47.13 47.14 47.15 47.16 47.17 47.18 47.19 47.20 47.21 47.22 47.23 47.24 47.25 47.26 47.27 47.28 47.29 47.30 47.31 48.1 48.2 48.3
48.4 48.5 48.6 48.7 48.8 48.9 48.10 48.11 48.12 48.13 48.14 48.15 48.16 48.17 48.18 48.19 48.20 48.21 48.22 48.23 48.24 48.25 48.26 48.27 48.28 49.1 49.2 49.3 49.4 49.5 49.6 49.7 49.8 49.9 49.10 49.11 49.12 49.13 49.14 49.15 49.16 49.17 49.18 49.19 49.20 49.21 49.22 49.23 49.24 49.25 49.26 49.27 49.28 49.29 49.30 50.1 50.2 50.3 50.4 50.5 50.6 50.7 50.8 50.9 50.10 50.11 50.12 50.13 50.14 50.15 50.16 50.17 50.18 50.19 50.20 50.21 50.22 50.23 50.24 50.25 50.26 50.27 50.28 50.29 50.30 50.31 51.1 51.2 51.3 51.4 51.5 51.6 51.7 51.8 51.9 51.10 51.11 51.12 51.13 51.14 51.15 51.16 51.17 51.18 51.19 51.20 51.21 51.22 51.23 51.24 51.25 51.26 51.27 51.28 51.29 51.30 51.31 52.1 52.2 52.3 52.4 52.5 52.6 52.7 52.8 52.9 52.10 52.11 52.12 52.13 52.14 52.15 52.16 52.17 52.18 52.19 52.20 52.21 52.22
52.23
52.24 52.25 52.26 52.27 52.28 52.29 52.30 53.1 53.2 53.3 53.4 53.5 53.6 53.7 53.8 53.9 53.10 53.11 53.12 53.13 53.14 53.15 53.16 53.17 53.18 53.19 53.20 53.21 53.22 53.23 53.24 53.25 53.26 53.27 53.28 53.29 53.30 53.31 53.32 53.33 54.1 54.2 54.3 54.4 54.5 54.6 54.7 54.8 54.9 54.10 54.11 54.12 54.13 54.14 54.15 54.16 54.17 54.18 54.19 54.20 54.21 54.22 54.23 54.24 54.25 54.26
54.27 54.28 54.29 54.30 54.31 54.32 54.33 55.1 55.2 55.3 55.4 55.5 55.6 55.7 55.8 55.9 55.10 55.11 55.12 55.13 55.14 55.15 55.16 55.17 55.18 55.19 55.20 55.21 55.22 55.23 55.24 55.25 55.26 55.27 55.28 55.29 55.30 55.31 56.1 56.2 56.3 56.4 56.5 56.6 56.7 56.8 56.9 56.10 56.11 56.12 56.13 56.14 56.15 56.16 56.17 56.18 56.19 56.20 56.21 56.22 56.23 56.24 56.25 56.26 56.27 56.28 56.29 56.30 56.31 57.1 57.2 57.3 57.4 57.5 57.6 57.7 57.8 57.9 57.10 57.11 57.12 57.13 57.14 57.15 57.16 57.17 57.18
57.19 57.20 57.21 57.22 57.23 57.24 57.25 57.26 57.27 57.28 57.29 57.30 57.31 57.32 57.33 58.1 58.2 58.3 58.4 58.5 58.6 58.7 58.8 58.9
58.10 58.11 58.12 58.13 58.14 58.15 58.16 58.17 58.18
58.19 58.20 58.21 58.22 58.23 58.24 58.25 58.26 58.27 58.28 58.29
58.30 58.31 58.32 59.1 59.2 59.3 59.4 59.5 59.6 59.7 59.8 59.9 59.10 59.11 59.12 59.13 59.14 59.15 59.16 59.17 59.18 59.19 59.20 59.21 59.22 59.23 59.24
59.25 59.26 59.27 59.28 59.29 60.1 60.2 60.3 60.4 60.5 60.6 60.7 60.8 60.9 60.10 60.11 60.12 60.13 60.14 60.15 60.16 60.17 60.18 60.19 60.20 60.21 60.22 60.23 60.24 60.25 60.26
60.27 60.28 60.29 60.30 60.31 61.1 61.2 61.3
61.4 61.5 61.6 61.7 61.8 61.9 61.10 61.11 61.12 61.13 61.14 61.15 61.16 61.17 61.18 61.19 61.20 61.21 61.22 61.23 61.24 61.25 61.26 61.27 61.28 61.29 61.30 61.31 62.1 62.2 62.3 62.4 62.5 62.6 62.7 62.8 62.9
62.10 62.11 62.12 62.13 62.14 62.15 62.16 62.17 62.18 62.19 62.20 62.21 62.22 62.23 62.24 62.25 62.26 62.27 62.28 62.29 62.30 62.31 62.32 62.33 63.1 63.2 63.3 63.4 63.5 63.6 63.7 63.8
63.9 63.10 63.11 63.12 63.13 63.14 63.15 63.16 63.17 63.18 63.19 63.20 63.21 63.22 63.23 63.24 63.25 63.26 63.27 63.28
64.1 64.2 64.3 64.4 64.5 64.6 64.7 64.8 64.9 64.10 64.11 64.12 64.13 64.14 64.15 64.16 64.17 64.18
64.19 64.20 64.21 64.22 64.23 64.24 64.25
64.26 64.27 64.28 64.29 64.30 64.31 64.32 65.1 65.2 65.3 65.4 65.5 65.6 65.7 65.8 65.9 65.10 65.11 65.12
65.13 65.14 65.15 65.16 65.17 65.18 65.19 65.20 65.21 65.22 65.23 65.24 65.25 65.26 65.27 65.28 65.29 65.30 65.31 65.32 65.33 66.1 66.2 66.3 66.4 66.5
66.6 66.7 66.8 66.9 66.10 66.11 66.12 66.13 66.14 66.15 66.16 66.17 66.18 66.19 66.20 66.21 66.22 66.23 66.24 66.25 66.26 66.27 66.28 66.29 66.30 66.31 66.32 67.1 67.2 67.3 67.4 67.5 67.6 67.7 67.8 67.9 67.10 67.11 67.12 67.13 67.14 67.15 67.16 67.17 67.18 67.19 67.20 67.21 67.22 67.23 67.24 67.25 67.26 67.27 67.28 67.29 67.30 67.31 67.32 67.33 68.1 68.2 68.3 68.4 68.5 68.6 68.7 68.8 68.9 68.10 68.11 68.12 68.13 68.14 68.15 68.16 68.17 68.18 68.19 68.20 68.21 68.22
68.23 68.24 68.25 68.26 68.27 68.28 68.29 68.30 68.31 68.32 68.33 69.1 69.2 69.3
69.4 69.5 69.6 69.7 69.8 69.9 69.10 69.11 69.12 69.13 69.14 69.15 69.16 69.17 69.18 69.19 69.20 69.21 69.22
69.23 69.24 69.25 69.26 69.27 69.28 69.29 69.30
70.1 70.2 70.3 70.4 70.5 70.6 70.7 70.8 70.9 70.10 70.11 70.12 70.13 70.14 70.15 70.16 70.17 70.18 70.19
70.20 70.21 70.22 70.23 70.24 70.25 70.26 70.27 70.28 70.29 70.30 70.31 71.1 71.2 71.3 71.4 71.5 71.6 71.7 71.8 71.9 71.10 71.11 71.12 71.13 71.14 71.15 71.16 71.17 71.18 71.19 71.20 71.21 71.22 71.23
71.24 71.25 71.26 71.27 71.28 71.29 71.30 71.31 72.1 72.2 72.3
72.4 72.5 72.6 72.7 72.8 72.9 72.10 72.11 72.12 72.13 72.14 72.15 72.16 72.17 72.18 72.19
72.20 72.21 72.22 72.23 72.24 72.25 72.26 72.27 72.28 72.29 72.30 72.31 72.32 73.1 73.2 73.3
73.4 73.5 73.6 73.7 73.8 73.9 73.10 73.11 73.12 73.13 73.14 73.15 73.16 73.17
73.18 73.19 73.20 73.21 73.22 73.23 73.24 73.25 73.26 73.27 73.28 73.29 73.30
74.1 74.2 74.3 74.4 74.5 74.6 74.7 74.8 74.9 74.10
74.11 74.12 74.13 74.14 74.15 74.16 74.17 74.18 74.19 74.20 74.21 74.22 74.23 74.24 74.25 74.26 74.27 74.28 74.29 74.30 74.31 74.32 74.33 75.1 75.2 75.3 75.4 75.5 75.6 75.7 75.8 75.9 75.10 75.11 75.12 75.13 75.14 75.15 75.16 75.17 75.18 75.19 75.20 75.21 75.22 75.23 75.24 75.25 75.26 75.27 75.28 75.29
76.1 76.2 76.3 76.4 76.5 76.6 76.7 76.8 76.9
76.10 76.11 76.12 76.13 76.14 76.15 76.16 76.17 76.18 76.19 76.20 76.21 76.22 76.23 76.24
76.25 76.26 76.27
76.28 76.29 76.30 76.31 77.1 77.2 77.3 77.4 77.5 77.6 77.7 77.8 77.9 77.10 77.11 77.12 77.13 77.14 77.15 77.16 77.17 77.18 77.19 77.20 77.21 77.22 77.23 77.24 77.25 77.26 77.27 77.28 77.29 77.30 77.31 77.32 78.1 78.2 78.3 78.4 78.5 78.6 78.7 78.8 78.9 78.10 78.11 78.12 78.13 78.14 78.15 78.16 78.17 78.18 78.19 78.20 78.21 78.22 78.23 78.24 78.25 78.26 78.27 78.28 78.29 78.30 78.31 78.32 79.1 79.2 79.3 79.4 79.5 79.6 79.7 79.8 79.9 79.10 79.11 79.12 79.13 79.14 79.15 79.16 79.17 79.18 79.19 79.20 79.21 79.22 79.23 79.24 79.25 79.26 79.27 79.28 79.29 79.30 79.31 79.32 79.33 80.1 80.2 80.3 80.4 80.5 80.6 80.7 80.8 80.9 80.10 80.11 80.12 80.13 80.14 80.15 80.16 80.17 80.18
80.19 80.20 80.21
80.22 80.23 80.24 80.25 80.26 80.27 80.28 80.29 80.30 80.31 81.1 81.2 81.3 81.4 81.5 81.6 81.7 81.8 81.9 81.10 81.11 81.12 81.13 81.14 81.15 81.16 81.17 81.18 81.19 81.20 81.21 81.22 81.23 81.24 81.25 81.26 81.27 81.28 81.29 81.30 81.31 81.32 82.1 82.2 82.3 82.4 82.5 82.6 82.7 82.8 82.9 82.10 82.11 82.12 82.13 82.14 82.15 82.16 82.17 82.18 82.19 82.20 82.21 82.22 82.23 82.24 82.25 82.26 82.27 82.28 82.29 82.30 82.31 82.32 82.33 83.1 83.2
83.3
83.4 83.5 83.6 83.7
83.8 83.9 83.10
83.11 83.12 83.13 83.14 83.15 83.16 83.17 83.18 83.19 83.20 83.21 83.22 83.23 83.24 83.25 83.26 83.27 83.28 83.29 83.30 84.1 84.2 84.3 84.4 84.5 84.6 84.7 84.8 84.9 84.10 84.11 84.12 84.13 84.14 84.15 84.16 84.17 84.18 84.19
84.20 84.21 84.22
84.23 84.24 84.25 84.26 84.27 84.28 84.29 84.30 84.31 84.32 84.33 85.1 85.2
85.3
85.4 85.5 85.6 85.7 85.8 85.9 85.10 85.11 85.12 85.13 85.14 85.15 85.16 85.17 85.18 85.19 85.20 85.21 85.22 85.23 85.24 85.25 85.26 85.27 85.28 85.29 85.30 86.1 86.2 86.3 86.4 86.5 86.6 86.7 86.8 86.9 86.10
86.11 86.12 86.13
86.14 86.15 86.16 86.17 86.18 86.19 86.20 86.21 86.22 86.23 86.24 86.25 86.26
86.27 86.28 86.29
87.1 87.2 87.3 87.4 87.5 87.6 87.7 87.8 87.9 87.10 87.11 87.12 87.13 87.14 87.15 87.16 87.17 87.18 87.19 87.20 87.21 87.22 87.23
87.24 87.25 87.26
87.27 87.28 87.29 87.30 87.31 87.32
88.1 88.2 88.3
88.4 88.5 88.6 88.7 88.8 88.9 88.10 88.11 88.12 88.13 88.14 88.15 88.16 88.17 88.18 88.19 88.20
88.21 88.22 88.23
88.24 88.25 88.26 88.27 88.28 88.29 88.30 88.31 88.32 89.1 89.2 89.3 89.4 89.5 89.6 89.7 89.8 89.9 89.10 89.11 89.12 89.13 89.14 89.15 89.16 89.17 89.18 89.19 89.20 89.21 89.22 89.23 89.24 89.25 89.26 89.27 89.28 89.29 89.30 89.31 89.32 90.1 90.2 90.3 90.4 90.5 90.6 90.7 90.8 90.9 90.10 90.11 90.12 90.13 90.14 90.15 90.16 90.17
90.18
90.19 90.20 90.21 90.22 90.23 90.24 90.25 90.26 90.27 90.28 90.29 90.30 90.31 90.32 90.33 91.1 91.2
91.3 91.4 91.5
91.6 91.7 91.8 91.9 91.10 91.11 91.12 91.13 91.14 91.15 91.16 91.17 91.18 91.19 91.20 91.21
91.22
91.23 91.24 91.25 91.26 91.27 91.28 91.29 91.30 91.31 92.1 92.2 92.3 92.4 92.5 92.6 92.7 92.8 92.9 92.10 92.11 92.12 92.13 92.14 92.15 92.16 92.17 92.18 92.19
92.20 92.21 92.22
92.23 92.24 92.25 92.26 92.27 92.28 92.29 92.30 92.31 92.32 93.1 93.2 93.3 93.4 93.5 93.6 93.7 93.8 93.9 93.10 93.11 93.12 93.13 93.14 93.15 93.16 93.17 93.18 93.19 93.20 93.21 93.22 93.23 93.24 93.25 93.26 93.27 93.28 93.29 93.30 93.31 93.32 93.33 93.34 93.35
94.1 94.2 94.3
94.4 94.5 94.6 94.7 94.8 94.9 94.10 94.11 94.12 94.13
94.14 94.15 94.16
94.17 94.18 94.19 94.20 94.21 94.22 94.23 94.24 94.25 94.26 94.27 94.28 94.29 94.30 94.31 95.1 95.2 95.3 95.4 95.5 95.6 95.7 95.8 95.9 95.10 95.11 95.12 95.13 95.14 95.15 95.16 95.17 95.18 95.19 95.20 95.21 95.22 95.23 95.24 95.25 95.26 95.27 95.28 95.29 95.30 95.31 95.32 96.1 96.2 96.3 96.4
96.5 96.6 96.7
96.8 96.9 96.10 96.11 96.12 96.13 96.14 96.15 96.16 96.17 96.18 96.19
96.20 96.21 96.22
96.23 96.24 96.25 96.26 96.27 96.28 96.29
96.30 96.31 96.32
97.1 97.2 97.3 97.4 97.5 97.6 97.7 97.8 97.9 97.10 97.11 97.12 97.13 97.14 97.15
97.16 97.17 97.18
97.19 97.20 97.21 97.22 97.23 97.24 97.25 97.26
97.27 97.28 97.29
98.1 98.2 98.3 98.4 98.5 98.6 98.7 98.8
98.9 98.10 98.11
98.12 98.13 98.14 98.15 98.16 98.17 98.18 98.19 98.20
98.21 98.22 98.23
98.24 98.25 98.26 98.27 98.28 98.29 98.30 98.31 99.1 99.2
99.3 99.4 99.5
99.6 99.7 99.8 99.9 99.10 99.11 99.12 99.13 99.14 99.15 99.16 99.17 99.18 99.19 99.20 99.21 99.22 99.23 99.24 99.25 99.26 99.27 99.28 99.29 99.30 99.31 99.32 99.33 99.34
100.1
100.2 100.3 100.4 100.5 100.6 100.7 100.8 100.9 100.10 100.11 100.12 100.13 100.14 100.15 100.16 100.17 100.18 100.19 100.20 100.21 100.22 100.23 100.24 100.25 100.26 100.27 100.28 100.29 100.30
100.31
101.1 101.2 101.3 101.4 101.5 101.6 101.7 101.8 101.9 101.10 101.11 101.12 101.13 101.14 101.15 101.16 101.17 101.18 101.19 101.20 101.21 101.22 101.23 101.24
101.25
101.26 101.27 101.28 101.29 101.30 102.1 102.2 102.3 102.4 102.5 102.6 102.7 102.8 102.9 102.10 102.11 102.12 102.13 102.14 102.15 102.16 102.17 102.18 102.19 102.20 102.21 102.22 102.23 102.24 102.25 102.26 102.27 102.28 102.29 102.30 102.31 103.1 103.2 103.3 103.4 103.5 103.6 103.7 103.8 103.9 103.10 103.11 103.12 103.13 103.14
103.15
103.16 103.17 103.18 103.19 103.20 103.21 103.22 103.23 103.24 103.25 103.26 103.27
103.28
104.1 104.2 104.3 104.4 104.5 104.6 104.7 104.8 104.9 104.10 104.11 104.12 104.13 104.14 104.15 104.16 104.17 104.18 104.19 104.20 104.21 104.22 104.23 104.24 104.25 104.26 104.27 104.28 104.29 104.30
104.31
105.1 105.2
105.3 105.4
105.5 105.6
105.7 105.8 105.9
105.10 105.11
105.12 105.13
105.14 105.15
105.16 105.17 105.18
105.19 105.20
105.21 105.22 105.23
105.24 105.25
105.26 105.27 105.28
106.1 106.2
106.3 106.4 106.5
106.6 106.7
106.8 106.9 106.10
106.11 106.12
106.13 106.14 106.15
106.16 106.17
106.18 106.19 106.20
106.21 106.22
106.23 106.24 106.25
106.26 106.27
106.28
107.1 107.2
107.3 107.4
107.5 107.6 107.7 107.8 107.9 107.10 107.11 107.12 107.13 107.14 107.15 107.16 107.17 107.18 107.19 107.20 107.21 107.22 107.23 107.24 107.25 107.26 107.27 107.28 107.29 107.30
108.1 108.2 108.3 108.4 108.5 108.6 108.7 108.8
108.9 108.10 108.11 108.12 108.13 108.14 108.15 108.16 108.17 108.18 108.19 108.20 108.21 108.22 108.23 108.24 108.25 108.26 108.27 108.28 108.29 108.30 108.31 108.32 108.33 109.1 109.2 109.3 109.4 109.5
109.6 109.7 109.8 109.9 109.10 109.11 109.12 109.13
109.14 109.15 109.16 109.17

A bill for an act
 relating to state government; modifying cannabis provisions; appropriating money;
amending Minnesota Statutes 2022, sections 18K.03, by adding a subdivision;
152.22, subdivisions 11, 14, by adding a subdivision; 152.25, subdivision 2; 152.27,
subdivisions 1, 2, 3, 4, 6, by adding a subdivision; 152.28, subdivision 2; 152.29,
subdivision 3; Minnesota Statutes 2023 Supplement, sections 3.9224; 151.72,
subdivisions 1, 2, 4, 5a, 5b, 6, 7; 152.28, subdivision 1; 152.30; 256B.0625,
subdivision 13d; 290.0132, subdivision 29; 290.0134, subdivision 19; 295.81,
subdivisions 1, 4; 297A.67, subdivision 2; 297A.70, subdivision 2; 342.01,
subdivisions 3, 4, 12, 14, 16, 17, 19, 20, 48, 64, 65, 66, by adding a subdivision;
342.02, subdivisions 2, 3, 5, 6; 342.07, subdivision 3; 342.09, subdivisions 1, 3;
342.10; 342.11; 342.12; 342.13; 342.14; 342.15, subdivisions 1, 2, by adding a
subdivision; 342.17; 342.18, subdivision 3, by adding subdivisions; 342.19,
subdivisions 1, 3, 4, 5; 342.22; 342.24, subdivisions 1, 2; 342.28, subdivision 2,
by adding a subdivision; 342.29, subdivisions 1, 4; 342.30, subdivision 4; 342.31,
subdivision 4; 342.32, subdivision 4; 342.35, subdivision 1; 342.37, subdivision
1; 342.40, subdivision 7; 342.41, subdivisions 1, 3; 342.51; 342.515; 342.52,
subdivisions 1, 2, 3, 4, 5, 9, 11; 342.53; 342.54; 342.55, subdivisions 1, 2; 342.56,
subdivisions 1, 2; 342.57, subdivisions 1, 2, 3, 4, 5, 6, 7; 342.58; 342.60; 342.61,
subdivisions 4, 5; 342.63, subdivisions 2, 3, 4, 6; Laws 2023, chapter 63, article
1, sections 2; 51; 52; 53; 54; 55; 56; 57; 58; 59; 61; article 6, sections 10; 73;
proposing coding for new law in Minnesota Statutes, chapter 342; repealing
Minnesota Statutes 2022, sections 152.22, subdivision 3; 152.36; Minnesota Statutes
2023 Supplement, sections 342.01, subdivisions 28, 52, 53, 54, 55; 342.18,
subdivision 1; 342.27, subdivision 13; 342.29, subdivision 9; 342.47; 342.48;
342.49; 342.50; 342.52, subdivision 8; Laws 2023, chapter 63, article 7, sections
4; 6.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2023 Supplement, section 3.9224, is amended to read:


3.9224 MEDICAL CANNABIS; COMPACTS TO BE NEGOTIATED.

Subdivision 1.

Definitions.

(a) As used in this section, the following terms have the
meanings given.

(b) "Medical cannabis law" or "medical cannabis program" means the regulatory
framework for cultivation, production, distribution, and sale of cannabis to qualifying
patients for therapeutic use in the treatment of a qualifying condition.

(c) "deleted text begin Medicaldeleted text end Cannabis flower" means cannabis flower approved for sale under the
medical cannabis law of a Minnesota Tribal government or under a compact entered into
under this section.

(d) "Medical cannabis product" means a cannabis product approved for sale under the
medical cannabis law of a Minnesota Tribal government or under a compact entered into
under this section.

(e) "Medical cannabis business" means a deleted text begin medicaldeleted text end cannabis deleted text begin cultivator, processor, or
retailerdeleted text end new text begin business with a medical cannabis retail endorsementnew text end .

(f) "Medical cannabis industry" means every item, product, person, process, action,
business, or other thing or activity related to deleted text begin medicaldeleted text end cannabis flower or medical cannabis
products and subject to regulation under the law of a Minnesota Tribal government or under
a compact entered into under this section.

(g) "Cannabis product" means any of the following:

(1) cannabis concentrate;

(2) a product infused with cannabinoids, whether artificially derived, or extracted or
derived from cannabis plants or cannabis flower, including but not limited to
tetrahydrocannabinol; or

(3) any other product that contains cannabis concentrate.

(h) "Minnesota Tribal governments" means the following federally recognized Indian
Tribes located in Minnesota:

(1) Bois Forte Band;

(2) Fond Du Lac Band;

(3) Grand Portage Band;

(4) Leech Lake Band;

(5) Mille Lacs Band;

(6) White Earth Band;

(7) Red Lake Nation;

(8) Lower Sioux Indian Community;

(9) Prairie Island Indian Community;

(10) Shakopee Mdewakanton Sioux Community; and

(11) Upper Sioux Indian Community.

(i) "Tribal medical cannabis business" means a medical cannabis business licensed by
a Minnesota Tribal government, including the business categories identified in paragraph
(e), as well as any others that may be provided under the law of a Minnesota Tribal
government.

(j) "Tribally regulated land" means:

(1) all land held in trust by the United States for the benefit of a Minnesota Tribal
government ("trust land");

(2) all land held by a Minnesota Tribal government in restricted fee status; and

(3) all land within the exterior boundaries of the reservation of a Minnesota Tribal
government that is subject to the civil regulatory jurisdiction of the Tribal government. For
the purposes of this section, land that is subject to the civil regulatory jurisdiction of the
Tribal government includes:

(i) trust land, or fee land held, including leased land, by the Tribe, entities organized
under Tribal law, or individual Indians; and

(ii) land held, including leased land, by non-Indian entities or individuals who consent
to the civil regulation of the Tribal government or are otherwise subject to such regulation
under federal law.

Subd. 2.

Acknowledgment and purpose; negotiations authorized.

(a) The state of
Minnesota acknowledges the sovereign right of Minnesota Tribal governments to regulate
the medical cannabis industry and address other matters of cannabis regulation related to
the internal affairs of Minnesota Tribal governments or otherwise within their jurisdiction,
without regard to whether such Tribal government has entered a compact authorized by this
section. The purpose of this section is to provide for the negotiation of compacts to
proactively address jurisdictional issues related to the regulation of the medical cannabis
industry. The legislature finds that these agreements will facilitate and promote a cooperative
and mutually beneficial relationship between the state and the Tribes regarding the
legalization of cannabis. Such cooperative agreements will enhance public health and safety,
ensure a lawful and well-regulated medical cannabis market, encourage economic
development, and provide fiscal benefits to both Indian Tribes and the state.

(b) The governor or the governor's designee shall negotiate in good faith, and has the
authority to execute and bind the state to, a compact with any Minnesota Tribal government
wishing to enter into such a compact regulating deleted text begin medicaldeleted text end cannabis flower and medical
cannabis products.

Subd. 3.

Terms of compact; rights of parties.

(a) A compact agreed to under this
section may address any issues related to the medical cannabis industry, including deleted text begin medicaldeleted text end
cannabis flower, medical cannabis products, extracts, concentrates, and artificially derived
cannabinoids that affect the interest of both the state and Minnesota Tribal government or
otherwise have an impact on Tribal-state relations. Indian Tribes are not required to enter
into compacts pursuant to this section in order to regulate the medical cannabis industry,
or engage in medical cannabis businesses or activities on Tribally regulated land or participate
as a licensee in the state's legal medical cannabis market.

(b) The state shall not, as a condition for entering into a compact under this section:

(1) require any Minnesota Tribal government to waive any right, privilege, or immunity
based on their status as independent sovereigns;

(2) require that any revenue generated by a medical cannabis business licensed by a
Minnesota Tribal government be subject to any state cannabis gross receipt taxes or state
and local sales or use taxes on sales of cannabis;

(3) require any taxes collected by Minnesota Tribal governments to be shared in any
manner with the state or any subdivisions thereof;

(4) require a Minnesota Tribal government to consent to state licensing of a medical
cannabis business on the Tribally regulated land of the Minnesota Tribal government;

(5) require any Minnesota Tribal government or any medical cannabis business licensed
by a Minnesota Tribal government pursuant to a compact agreed to under this section to
comply with specific state law or regulations on Tribally regulated land; or

(6) impose, or attempt to impose, and shall not require or attempt to require any Indian
Tribe to impose, any taxes, fees, assessments, and other charges related to the production,
processing, sale, purchase, distribution, or possession of deleted text begin medicaldeleted text end cannabis flower and medical
cannabis products on Minnesota Tribal governments, or their members, on a reservation or
Tribally regulated land.

(c) Compacts agreed to under this section may allow an exemption from any otherwise
applicable tax for: (i) sales to a Minnesota Tribal government, a Tribal medical cannabis
business, or Tribal members, of deleted text begin medicaldeleted text end cannabis flower and cannabis products grown,
produced, or processed as provided for in said compacts; or (ii) for activities of Tribal
medical cannabis businesses.

Subd. 4.

Civil and criminal immunities.

(a) Without limiting any immunity or exemption
that may apply under federal law, the following acts, when performed by a Tribal medical
cannabis business or an employee in the course of their employment for a Tribal medical
cannabis business, pursuant to a compact entered into under this section, do not constitute
a criminal or civil offense under state law:

(1) the cultivation of deleted text begin medicaldeleted text end cannabis flower, and the extraction, processing, or
manufacture of medical cannabis and artificially derived cannabinoid products, extracts, or
concentrates;

(2) the possession, purchase, and receipt of deleted text begin medicaldeleted text end cannabis seed, new text begin cannabis new text end flower, and
medical cannabis products that are properly packaged and labeled as authorized under a
compact entered into pursuant to this section, and the sale, delivery, transport, or distribution
of such products to a licensed cannabis business; and

(3) the delivery, distribution, and sale of deleted text begin medicaldeleted text end cannabis seed, new text begin cannabis new text end flower, and
medical cannabis products as authorized under a compact entered into pursuant to this
section and that takes place on, or originates from, the premises of a Tribal medical cannabis
business on Tribally regulated land, to any person eligible to participate in a medical cannabis
program.

(b) The following acts, when performed by a patron of a Tribal medical cannabis business
do not constitute a criminal or civil offense under state law: the purchase, possession, or
receipt of deleted text begin medicaldeleted text end cannabis seed, new text begin cannabis new text end flower, and medical cannabis products as
authorized under a compact entered into pursuant to this section.

(c) Without limiting any immunity or exemption that may apply under federal law,
actions by a Tribal medical cannabis business, a Tribal member, employee, or agent of a
Minnesota Tribal government or Tribal medical cannabis business on Tribally regulated
land pursuant to Tribal laws governing cannabis, or a compact entered into under this section,
do not constitute a criminal or civil offense under state law.

(d) The following acts, when performed by a state-licensed medical cannabis business,
or an employee of such business, and which would be permitted under the terms of the
applicable medical cannabis business license if undertaken with another state-licensed
medical cannabis business, are permitted under the state license conditions when undertaken
with a Tribal medical cannabis business and do not constitute a criminal or civil offense
under state law: the possession, purchase, wholesale and retail sale, delivery, transport,
distribution, and receipt of deleted text begin medicaldeleted text end cannabisdeleted text begin ,deleted text end seed, new text begin cannabis new text end flower, and medical cannabis
products that are properly packaged and labeled as authorized under a compact entered into
pursuant to this section.

(e) Without limiting any immunity or exemption that may apply under federal law, the
following acts, when performed by a Minnesota Tribal government, a Tribal medical cannabis
business licensed by such Tribal government, or an employee of such Tribal government
or Tribal medical cannabis business, regardless of whether the Minnesota Tribal government
issuing such license has compacted with the state under this section, do not constitute a
criminal or civil offense under state law: purchase, sale, receipt, or delivery (including
delivery that involves transit through the state, outside a reservation), of deleted text begin medicaldeleted text end cannabis
flowerdeleted text begin ,deleted text end new text begin cannabisnew text end seeddeleted text begin ,deleted text end and medical cannabis products from or to another Minnesota Tribal
government or cannabis business licensed by such government.

(f) Notwithstanding any other provision of law, a state-licensed cannabis testing facility
may provide cannabis testing services to a Tribal medical cannabis business, and the
possession or transport of cannabis flower or cannabis products for such purpose by a Tribal
cannabis business shall not constitute a criminal or civil offense under state law.

Subd. 5.

Publication.

The governor shall post any compact entered into under this section
on a publicly accessible website.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 2.

Minnesota Statutes 2022, section 18K.03, is amended by adding a subdivision to
read:


new text begin Subd. 3. new text end

new text begin Sale to cannabis and hemp businesses. new text end

new text begin (a) An industrial hemp grower licensed
under this chapter may sell hemp plant parts and propagules to a cannabis business or hemp
business licensed under chapter 342.
 new text end

new text begin (b) An industrial hemp processor licensed under this chapter may sell hemp concentrate
to a cannabis business or hemp business licensed under chapter 342.
 new text end

Sec. 3.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 1, is amended
to read:


Subdivision 1.

Definitions.

For the purposes of this section, the following terms have
the meanings given.

(a) "Artificially derived cannabinoid" means a cannabinoid extracted from a hemp plant
or hemp plant parts with a chemical makeup that is changed after extraction to create a
different cannabinoid or other chemical compound by applying a catalyst other than heat
or light. Artificially derived cannabinoid includes but is not limited to any
tetrahydrocannabinol created from cannabidiol.

(b) "Batch" means a specific quantity of a specific product containing cannabinoids
derived from hemp, including an edible cannabinoid product, that is manufactured at the
same time and using the same methods, equipment, and ingredients that is uniform and
intended to meet specifications for identity, strength, purity, and composition, and that is
manufactured, packaged, and labeled according to a single batch production record executed
and documented.

(c) "Certified hemp" means hemp plants that have been tested and found to meet the
requirements of chapter 18K and the rules adopted thereunder.

deleted text begin (d) "Commissioner" means the commissioner of health.
 deleted text end

deleted text begin (e)deleted text end new text begin (d)new text end "Distributor" means a person who sells, arranges a sale, or delivers a product
containing cannabinoids derived from hemp, including an edible cannabinoid product, that
the person did not manufacture to a retail establishment for sale to consumers. Distributor
does not include a common carrier used only to complete delivery to a retailer.

deleted text begin (f)deleted text end new text begin (e)new text end "Edible cannabinoid product" means any product that is intended to be eaten or
consumed as a beverage by humans, contains a cannabinoid in combination with food
ingredients, and is not a drug.

deleted text begin (g)deleted text end new text begin (f)new text end "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision
3.

deleted text begin (h)deleted text end new text begin (g)new text end "Label" has the meaning given in section 151.01, subdivision 18.

deleted text begin (i)deleted text end new text begin (h)new text end "Labeling" means all labels and other written, printed, or graphic matter that are:

(1) affixed to the immediate container in which a product regulated under this section
is sold;

(2) provided, in any manner, with the immediate container, including but not limited to
outer containers, wrappers, package inserts, brochures, or pamphlets; or

(3) provided on that portion of a manufacturer's website that is linked by a scannable
barcode or matrix barcode.

deleted text begin (j)deleted text end new text begin (i)new text end "Matrix barcode" means a code that stores data in a two-dimensional array of
geometrically shaped dark and light cells capable of being read by the camera on a
smartphone or other mobile device.

deleted text begin (k)deleted text end new text begin (j)new text end "Nonintoxicating cannabinoid" means substances extracted from certified hemp
plants that do not produce intoxicating effects when consumed by any route of administration.

new text begin (k) "Office" means the Office of Cannabis Management.
 new text end

(l) "Synthetic cannabinoid" means a substance with a similar chemical structure and
pharmacological activity to a cannabinoid, but which is not extracted or derived from hemp
plants, or hemp plant parts and is instead created or produced by chemical or biochemical
synthesis.

new text begin (m) "Tincture" means a solution of hemp extract, derived either directly from a hemp
plant or from a manufactured hemp extract, dissolved in glycerin, food-grade oils, or other
food-grade solvents and is intended to be eaten as an edible cannabinoid product under
section 151.72, paragraph (f).
 new text end

Sec. 4.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 2, is amended
to read:


Subd. 2.

Scope.

(a) This section applies to the sale of any product that contains
cannabinoids extracted from hemp and that is an edible cannabinoid product or is intended
for human or animal consumption by any route of administration.

(b) This section does not apply to any product dispensed by a registered medical cannabis
manufacturer pursuant to sections 152.22 to 152.37.

(c) The deleted text begin commissionerdeleted text end new text begin officenew text end must have no authority over food products, as defined in
section 34A.01, subdivision 4, that do not contain cannabinoids extracted or derived from
hemp.

Sec. 5.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 4, is amended
to read:


Subd. 4.

Testing requirements.

(a) A manufacturer of a product regulated under this
section must submit representative samples of each batch of the product to an independent,
accredited laboratory in order to certify that the product complies with the standards deleted text begin adopted
by the board on or before July 1, 2023, or the standardsdeleted text end adopted by the deleted text begin commissionerdeleted text end new text begin officenew text end .
Testing must be consistent with generally accepted industry standards for herbal and botanical
substances, and, at a minimum, the testing must confirm that the product:

(1) contains the amount or percentage of cannabinoids that is stated on the label of the
product;

(2) does not contain more than trace amounts of any mold, residual solvents or other
catalysts, pesticides, fertilizers, or heavy metals; and

(3) does not contain more than 0.3 percent of any tetrahydrocannabinol.

(b) A manufacturer of a product regulated under this section must disclose all known
information regarding pesticides, fertilizers, solvents, or other foreign materials applied to
industrial hemp or added to industrial hemp during any production or processing stages of
any batch from which a representative sample has been sent for testing, including any
catalysts used to create artificially derived cannabinoids. The disclosure must be made to
the laboratory performing testing or sampling and, upon request, to the deleted text begin commissionerdeleted text end new text begin officenew text end .
The disclosure must include all information known to the deleted text begin licenseedeleted text end new text begin manufacturernew text end regardless
of whether the application or addition was made intentionally or accidentally, or by the
manufacturer or any other person.

(c) Upon the request of the deleted text begin commissionerdeleted text end new text begin officenew text end , the manufacturer of the product must
provide the deleted text begin commissionerdeleted text end new text begin officenew text end with the results of the testing required in this section.

(d) The deleted text begin commissionerdeleted text end new text begin officenew text end may determine that any testing laboratory that does not
operate formal management systems under the International Organization for Standardization
is not an accredited laboratory and require that a representative sample of a batch of the
product be retested by a testing laboratory that meets this requirement.

(e) Testing of the hemp from which the nonintoxicating cannabinoid was derived, or
possession of a certificate of analysis for such hemp, does not meet the testing requirements
of this section.

Sec. 6.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5a, is amended
to read:


Subd. 5a.

Additional requirements for edible cannabinoid products.

(a) In addition
to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid
must meet the requirements of this subdivision.

(b) An edible cannabinoid product must not:

(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person,
animal, or fruit that appeals to children;

(2) be modeled after a brand of products primarily consumed by or marketed to children;

(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a
commercially available candy or snack food item;

(4) be substantively similar to a meat food product; poultry food product as defined in
section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision
7;

(5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved
by the United States Food and Drug Administration for use in food;

(6) be packaged in a way that resembles the trademarked, characteristic, or
product-specialized packaging of any commercially available food product; or

(7) be packaged in a container that includes a statement, artwork, or design that could
reasonably mislead any person to believe that the package contains anything other than an
edible cannabinoid product.

(c) An edible cannabinoid product must be prepackaged in packaging or a container that
is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is
child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The
requirement that packaging be child-resistant does not apply to an edible cannabinoid product
that is intended to be consumed as a beverage.

(d) If an edible cannabinoid product, other than a product that is intended to be consumed
as a beverage, is intended for more than a single use or contains multiple servings, each
serving must be indicated by scoring, wrapping, or other indicators designating the individual
serving size that appear on the edible cannabinoid product.

(e) A label containing at least the following information must be affixed to the packaging
or container of all edible cannabinoid products sold to consumers:

(1) the serving size;

(2) the cannabinoid profile per serving and in total;

(3) a list of ingredients, including identification of any major food allergens declared
by name; and

(4) the following statement: "Keep this product out of reach of children."

(f) An edible cannabinoid product must not contain more than five milligrams of any
tetrahydrocannabinol in a single serving. An edible cannabinoid product, other than a product
that is intended to be consumed as a beverage, may not contain more than a total of 50
milligrams of any tetrahydrocannabinol per package. An edible cannabinoid product that
is intended to be consumed as a beverage may not contain more than two servings per
container.

(g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9
tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an
artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing
any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and
HHC, unless the deleted text begin commissionerdeleted text end new text begin officenew text end authorizes use of the artificially derived cannabinoid
in edible cannabinoid products. Edible cannabinoid products are prohibited from containing
synthetic cannabinoids.

(h) Every person selling edible cannabinoid products to consumers, other than products
that are intended to be consumed as a beverage, must ensure that all edible cannabinoid
products are displayed behind a checkout counter where the public is not permitted or in a
locked case.

Sec. 7.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5b, is amended
to read:


Subd. 5b.

Registration; prohibitions.

deleted text begin (a) On or before October 1, 2023, every person
selling edible cannabinoid products to consumers must register with the commissioner in
a form and manner established by the commissioner. After October 1, 2023, the sale of
edible cannabinoid products by a person that is not registered is prohibited.
 deleted text end

new text begin (a) Every person selling an edible cannabinoid product to a consumer must be registered
with the office. All existing registrations with the Department of Health, Office of Medical
Cannabis, as of June 30, 2024, will automatically transfer to the office on July 1, 2024. All
other persons required to register must register in a form and manner established by the
office. The sale of edible cannabinoid products by a person who is not registered with the
office is prohibited.
 new text end

(b) The registration form must contain an attestation of compliance and each registrant
must affirm that it is operating and will continue to operate in compliance with the
requirements of this section and all other applicable state and local laws and ordinances.

(c) The deleted text begin commissioner shalldeleted text end new text begin office mustnew text end not charge a fee for registration under this
subdivision.

Sec. 8.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 6, is amended
to read:


Subd. 6.

Noncompliant products; enforcement.

(a) A product regulated under this
section, including an edible cannabinoid product, shall be considered a noncompliant product
if the product is offered for sale in this state or if the product is manufactured, imported,
distributed, or stored with the intent to be offered for sale in this state in violation of any
provision of this section, including but not limited to if:

(1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance;

(2) it has been produced, prepared, packed, or held under unsanitary conditions where
it may have been rendered injurious to health, or where it may have been contaminated with
filth;

(3) its container is composed, in whole or in part, of any poisonous or deleterious
substance that may render the contents injurious to health;

(4) it contains any food additives, color additives, or excipients that have been found by
the FDA to be unsafe for human or animal consumption;

(5) it contains an amount or percentage of nonintoxicating cannabinoids that is different
than the amount or percentage stated on the label;

(6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is
an edible cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits
established in subdivision 5a, paragraph (f); or

(7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers,
or heavy metals.

(b) A product regulated under this section shall be considered a noncompliant product
if the product's labeling is false or misleading in any manner or in violation of the
requirements of this section.

(c) The deleted text begin commissionerdeleted text end new text begin officenew text end may assume that any product regulated under this section
that is present in the state, other than a product lawfully possessed for personal use, has
been manufactured, imported, distributed, or stored with the intent to be offered for sale in
this state if a product of the same type and brand was sold in the state on or after July 1,
2023, or if the product is in the possession of a person who has sold any product in violation
of this section.

(d) The deleted text begin commissionerdeleted text end new text begin officenew text end may enforce this section, including enforcement against a
manufacturer or distributor of a product regulated under this section, under deleted text begin sections 144.989
to 144.993deleted text end new text begin section 342.19new text end .

(e) deleted text begin The commissioner may enter into an interagency agreement withdeleted text end The office deleted text begin of
Cannabis Management anddeleted text end new text begin may enter into an interagency agreement withnew text end the commissioner
of agriculture to perform inspections and take other enforcement actions on behalf of the
deleted text begin commissionerdeleted text end new text begin officenew text end .

Sec. 9.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 7, is amended
to read:


Subd. 7.

Violations; criminal penalties.

(a) deleted text begin Notwithstanding section 144.99, subdivision
11,deleted text end A person who does any of the following regarding a product regulated under this section
is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than
364 days or to payment of a fine of not more than $3,000, or both:

(1) knowingly alters or otherwise falsifies testing results;

(2) intentionally alters or falsifies any information required to be included on the label
of an edible cannabinoid product; or

(3) intentionally makes a false material statement to the deleted text begin commissionerdeleted text end new text begin officenew text end .

(b) deleted text begin Notwithstanding section 144.99, subdivision 11,deleted text end A person who does any of the
following on the premises of a registered retailer or another business that sells retail goods
to customers is guilty of a gross misdemeanor and may be sentenced to imprisonment for
not more than 364 days or to payment of a fine of not more than $3,000, or both:

(1) sells an edible cannabinoid product knowing that the product does not comply with
the limits on the amount or types of cannabinoids that a product may contain;

(2) sells an edible cannabinoid product knowing that the product does not comply with
the applicable testing, packaging, or labeling requirements; or

(3) sells an edible cannabinoid product to a person under the age of 21, except that it is
an affirmative defense to a charge under this clause if the defendant proves by a
preponderance of the evidence that the defendant reasonably and in good faith relied on
proof of age as described in subdivision 5c.

Sec. 10.

Minnesota Statutes 2022, section 152.22, subdivision 11, is amended to read:


Subd. 11.

Registered designated caregiver.

"Registered designated caregiver" means
a person who:

(1) is at least 18 years old;

deleted text begin (2) does not have a conviction for a disqualifying felony offense;
 deleted text end

deleted text begin (3)deleted text end new text begin (2)new text end has been approved by the deleted text begin commissionerdeleted text end new text begin officenew text end to assist a patient who requires
assistance in administering medical cannabis or obtaining medical cannabis from a
distribution facility; and

deleted text begin (4)deleted text end new text begin (3)new text end is authorized by the deleted text begin commissionerdeleted text end new text begin officenew text end to assist the patient with the use of
medical cannabis.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 11.

Minnesota Statutes 2022, section 152.22, subdivision 14, is amended to read:


Subd. 14.

Qualifying medical condition.

"Qualifying medical condition" means a
diagnosis of any of the following conditions:

new text begin (1) Alzheimer's disease;
 new text end

new text begin (2) autism spectrum disorder that meets the requirements of the fifth edition of the
Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric
Association;
 new text end

deleted text begin (1)deleted text end new text begin (3)new text end cancer, if the underlying condition or treatment produces one or more of the
following:

(i) severe or chronic pain;

(ii) nausea or severe vomiting; or

(iii) cachexia or severe wasting;

new text begin (4) chronic motor or vocal tic disorder;
 new text end

new text begin (5) chronic pain;
 new text end

deleted text begin (2)deleted text end new text begin (6)new text end glaucoma;

deleted text begin (3)deleted text end new text begin (7)new text end human immunodeficiency virus or acquired immune deficiency syndrome;

new text begin (8) intractable pain as defined in section 152.125, subdivision 1, paragraph (c);
 new text end

new text begin (9) obstructive sleep apnea;
 new text end

new text begin (10) post-traumatic stress disorder;
 new text end

deleted text begin (4)deleted text end new text begin (11)new text end Tourette's syndrome;

deleted text begin (5)deleted text end new text begin (12)new text end amyotrophic lateral sclerosis;

deleted text begin (6)deleted text end new text begin (13)new text end seizures, including those characteristic of epilepsy;

deleted text begin (7)deleted text end new text begin (14)new text end severe and persistent muscle spasms, including those characteristic of multiple
sclerosis;

deleted text begin (8)deleted text end new text begin (15)new text end inflammatory bowel disease, including Crohn's disease;

new text begin (16) irritable bowel syndrome;
 new text end

new text begin (17) obsessive-compulsive disorder;
 new text end

new text begin (18) sickle cell disease;
 new text end

deleted text begin (9)deleted text end new text begin (19)new text end terminal illness, with a probable life expectancy of under one year, if the illness
or its treatment produces one or more of the following:

(i) severe or chronic pain;

(ii) nausea or severe vomiting; or

(iii) cachexia or severe wasting; or

deleted text begin (10)deleted text end new text begin (20)new text end any other medical condition or its treatment approved by the deleted text begin commissionerdeleted text end new text begin
officenew text end .

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 12.

Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to
read:


new text begin Subd. 19. new text end

new text begin Veteran. new text end

new text begin "Veteran" means an individual who satisfies the requirements in
section 197.447 and is receiving care from the United States Department of Veterans Affairs.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 13.

Minnesota Statutes 2022, section 152.25, subdivision 2, is amended to read:


Subd. 2.

Range of compounds and dosages; report.

The deleted text begin commissionerdeleted text end new text begin officenew text end shall
review and publicly report the existing medical and scientific literature regarding the range
of recommended dosages for each qualifying condition and the range of chemical
compositions of any plant of the genus cannabis that will likely be medically beneficial for
each of the qualifying medical conditions. The deleted text begin commissionerdeleted text end new text begin officenew text end shall make this
information available to patients with qualifying medical conditions beginning December
1, 2014, and update the information deleted text begin annuallydeleted text end new text begin every three yearsnew text end . The deleted text begin commissionerdeleted text end new text begin officenew text end
may consult with the independent laboratory under contract with the manufacturer or other
experts in reporting the range of recommended dosages for each qualifying medical condition,
the range of chemical compositions that will likely be medically beneficial, and any risks
of noncannabis drug interactions. The deleted text begin commissionerdeleted text end new text begin officenew text end shall consult with each
manufacturer on an annual basis on medical cannabis offered by the manufacturer. The list
of medical cannabis offered by a manufacturer shall be published on the deleted text begin Department of
Healthdeleted text end new text begin Office of Cannabis Managementnew text end website.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 14.

Minnesota Statutes 2022, section 152.27, subdivision 1, is amended to read:


Subdivision 1.

Patient registry program; establishment.

deleted text begin (a)deleted text end The deleted text begin commissionerdeleted text end new text begin officenew text end
shall establish a patient registry program to evaluate data on patient demographics, effective
treatment options, clinical outcomes, and quality-of-life outcomes for the purpose of reporting
on the benefits, risks, and outcomes regarding patients with a qualifying medical condition
engaged in the therapeutic use of medical cannabis.

deleted text begin (b) The establishment of the registry program shall not be construed or interpreted to
condone or promote the illicit recreational use of marijuana.
 deleted text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 15.

Minnesota Statutes 2022, section 152.27, subdivision 2, is amended to read:


Subd. 2.

deleted text begin Commissionerdeleted text end new text begin Officenew text end duties.

(a) The deleted text begin commissionerdeleted text end new text begin officenew text end shall:

(1) give notice of the program to health care practitioners in the state who are eligible
to serve as health care practitioners and explain the purposes and requirements of the
program;

(2) allow each health care practitioner who meets or agrees to meet the program's
requirements and who requests to participate, to be included in the registry program to
collect data for the patient registry;

(3) provide explanatory information and assistance to each health care practitioner in
understanding the nature of therapeutic use of medical cannabis within program requirements;

(4) create and provide a certification to be used by a health care practitioner for the
practitioner to certify whether a patient has been diagnosed with a qualifying medical
condition deleted text begin and include in the certification an option for the practitioner to certify whether
the patient, in the health care practitioner's medical opinion, is developmentally or physically
disabled and, as a result of that disability, the patient requires assistance in administering
medical cannabis or obtaining medical cannabis from a distribution facilitydeleted text end ;

(5) supervise the participation of the health care practitioner in conducting patient
treatment and health records reporting in a manner that ensures stringent security and
record-keeping requirements and that prevents the unauthorized release of private data on
individuals as defined by section 13.02;

(6) develop safety criteria for patients with a qualifying medical condition as a
requirement of the patient's participation in the program, to prevent the patient from
undertaking any task under the influence of medical cannabis that would constitute negligence
or professional malpractice on the part of the patient; and

(7) conduct research and studies based on data from health records submitted to the
registry program and submit reports on intermediate or final research results to the legislature
and major scientific journals. The deleted text begin commissionerdeleted text end new text begin officenew text end may contract with a third party to
complete the requirements of this clause. Any reports submitted must comply with section
152.28, subdivision 2.

(b) The deleted text begin commissionerdeleted text end new text begin officenew text end may add deleted text begin a delivery method under section 152.22, subdivision
6, or add, remove,deleted text end or modify a qualifying medical condition under section 152.22, subdivision
14, upon a petition from a member of the public or the deleted text begin task force on medical cannabis
therapeutic researchdeleted text end new text begin Cannabis Advisory Council under section 342.03,new text end or as directed by
law. The deleted text begin commissionerdeleted text end new text begin officenew text end shall evaluate all petitions to add a qualifying medical condition
deleted text begin or to removedeleted text end or modify an existing qualifying medical condition submitted by the deleted text begin task force
on medical cannabis therapeutic researchdeleted text end new text begin Cannabis Advisory Council under section 342.03,new text end
or as directed by law and may make the additiondeleted text begin , removal,deleted text end or modification if the
deleted text begin commissionerdeleted text end new text begin officenew text end determines the additiondeleted text begin , removal,deleted text end or modification is warranted based
on the best available evidence and research. If the deleted text begin commissionerdeleted text end new text begin officenew text end wishes to deleted text begin add a
delivery method under section 152.22, subdivision 6, ordeleted text end add or deleted text begin removedeleted text end new text begin modifynew text end a qualifying
medical condition under section 152.22, subdivision 14, the deleted text begin commissionerdeleted text end new text begin officenew text end must notify
the chairs and ranking minority members of the legislative policy committees having
jurisdiction over health and public safety of the addition or deleted text begin removaldeleted text end new text begin modificationnew text end and the
reasons for its addition or deleted text begin removaldeleted text end new text begin modificationnew text end , including any written comments received
by the deleted text begin commissionerdeleted text end new text begin officenew text end from the public and any guidance received from the deleted text begin task force
on medical cannabis researchdeleted text end new text begin Cannabis Advisory Council under section 342.03new text end , by January
15 of the year in which the deleted text begin commissionerdeleted text end new text begin officenew text end wishes to make the change. The change
shall be effective on August 1 of that year, unless the legislature by law provides otherwise.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 16.

Minnesota Statutes 2022, section 152.27, subdivision 3, is amended to read:


Subd. 3.

Patient application.

(a) The deleted text begin commissionerdeleted text end new text begin officenew text end shall develop a patient
application for enrollment into the registry program. The application shall be available to
the patient and given to health care practitioners in the state who are eligible to serve as
health care practitioners. The application must include:

(1) the name, mailing address, and date of birth of the patient;

(2) the name, mailing address, and telephone number of the patient's health care
practitioner;

(3) the name, mailing address, and date of birth of the patient's designated caregiver, if
any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian, or spouse
will be acting as a caregiver;

(4) a copy of the certification from the patient's health care practitioner that is dated
within 90 days prior to submitting the application that certifies that the patient has been
diagnosed with a qualifying medical condition; and

(5) all other signed affidavits and enrollment forms required by the deleted text begin commissionerdeleted text end new text begin officenew text end
under sections 152.22 to 152.37, including, but not limited to, the disclosure form required
under paragraph deleted text begin (c)deleted text end new text begin (b)new text end .

deleted text begin (b) The commissioner shall require a patient to resubmit a copy of the certification from
the patient's health care practitioner on a yearly basis and shall require that the recertification
be dated within 90 days of submission.
 deleted text end

deleted text begin (c)deleted text end new text begin (b)new text end The deleted text begin commissionerdeleted text end new text begin officenew text end shall develop a disclosure form and require, as a condition
of enrollment, all patients to sign a copy of the disclosure. The disclosure must include:

(1) a statement that, notwithstanding any law to the contrary, the deleted text begin commissionerdeleted text end new text begin officenew text end ,
or an employee of any state agency, may not be held civilly or criminally liable for any
injury, loss of property, personal injury, or death caused by any act or omission while acting
within the scope of office or employment under sections 152.22 to 152.37; and

(2) the patient's acknowledgment that enrollment in the patient registry program is
conditional on the patient's agreement to meet all of the requirements of sections 152.22 to
152.37.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 17.

Minnesota Statutes 2022, section 152.27, is amended by adding a subdivision to
read:


new text begin Subd. 3a. new text end

new text begin Application procedure for veterans. new text end

new text begin (a) Beginning July 1, 2024, the
commissioner shall establish an alternative certification procedure for veterans to confirm
that the veteran has been diagnosed with a qualifying medical condition.
 new text end

new text begin (b) A patient who is also a veteran and is seeking to enroll in the registry program must
submit a copy of the patient's veteran health identification card issued by the United States
Department of Veterans Affairs and an application established by the commissioner to
certify that the patient has been diagnosed with a qualifying medical condition.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 18.

Minnesota Statutes 2022, section 152.27, subdivision 4, is amended to read:


Subd. 4.

Registered designated caregiver.

(a) The deleted text begin commissionerdeleted text end new text begin officenew text end shall register
a designated caregiver for a patient if the patient requires assistance in administering medical
cannabis or obtaining medical cannabis from a distribution facility and the caregiver has
agreed, in writing, to be the patient's designated caregiver. As a condition of registration as
a designated caregiver, the commissioner shall require the person to:

(1) be at least 18 years of age;

(2) agree to only possess the patient's medical cannabis for purposes of assisting the
patient; and

(3) agree that if the application is approved, the person will not be a registered designated
caregiver for more than six registered patients at one time. Patients who reside in the same
residence shall count as one patient.

deleted text begin (b) The commissioner shall conduct a criminal background check on the designated
caregiver prior to registration to ensure that the person does not have a conviction for a
disqualifying felony offense. Any cost of the background check shall be paid by the person
seeking registration as a designated caregiver. A designated caregiver must have the criminal
background check renewed every two years.
 deleted text end

deleted text begin (c)deleted text end new text begin (b)new text end Nothing in sections 152.22 to 152.37 shall be construed to prevent a person
registered as a designated caregiver from also being enrolled in the registry program as a
patient and possessing and using medical cannabis as a patient.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 19.

Minnesota Statutes 2022, section 152.27, subdivision 6, is amended to read:


Subd. 6.

Patient enrollment.

(a) After receipt of a patient's applicationdeleted text begin , application fees,deleted text end
and signed disclosure, the deleted text begin commissionerdeleted text end new text begin officenew text end shall enroll the patient in the registry program
and issue the patient and patient's registered designated caregiver or parent, legal guardian,
or spouse, if applicable, a registry verification. The deleted text begin commissionerdeleted text end new text begin officenew text end shall approve or
deny a patient's application for participation in the registry program within 30 days after
the deleted text begin commissionerdeleted text end new text begin officenew text end receives the patient's application deleted text begin and application feedeleted text end . deleted text begin The
commissioner may approve applications up to 60 days after the receipt of a patient's
application and application fees until January 1, 2016.deleted text end A patient's enrollment in the registry
program shall only be denied if the patient:

(1) does not have certification from a health care practitionernew text begin , or if the patient is a veteran
receiving care from the United States Department of Veterans Affairs, who does not have
the documentation required under subdivision 3anew text end that the patient has been diagnosed with
a qualifying medical condition;

(2) has not signed and returned the disclosure form required under subdivision 3,
paragraph (c), to the deleted text begin commissionerdeleted text end new text begin officenew text end ;

(3) does not provide the information required;

(4) has previously been removed from the registry program for violations of section
152.30 or 152.33; or

(5) provides false information.

(b) The deleted text begin commissionerdeleted text end new text begin officenew text end shall give written notice to a patient of the reason for
denying enrollment in the registry program.

(c) Denial of enrollment into the registry program is considered a final decision of the
deleted text begin commissionerdeleted text end new text begin officenew text end and is subject to judicial review under the Administrative Procedure
Act pursuant to chapter 14.

(d) A patient's enrollment in the registry program may only be revoked upon the death
of the patient or if a patient violates a requirement under section 152.30 or 152.33.

(e) The deleted text begin commissionerdeleted text end new text begin officenew text end shall develop a registry verification to provide to the patient,
the health care practitioner identified in the patient's application, and to the manufacturer.
The registry verification shall include:

(1) the patient's name and date of birth;

(2) the patient registry number assigned to the patient; and

(3) the name and date of birth of the patient's registered designated caregiver, if any, or
the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or
spouse will be acting as a caregiver.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 20.

Minnesota Statutes 2023 Supplement, section 152.28, subdivision 1, is amended
to read:


Subdivision 1.

Health care practitioner duties.

(a) Prior to a patient's enrollment in
the registry program, a health care practitioner shall:

(1) determine, in the health care practitioner's medical judgment, whether a patient suffers
from a qualifying medical condition, and, if so determined, provide the patient with a
certification of that diagnosis;

(2) advise patients, registered designated caregivers, and parents, legal guardians, or
spouses who are acting as caregivers of the existence of any nonprofit patient support groups
or organizations;

(3) provide explanatory information from the commissioner to patients with qualifying
medical conditions, including disclosure to all patients about the experimental nature of
therapeutic use of medical cannabis; the possible risks, benefits, and side effects of the
proposed treatment; the application and other materials from the commissioner; and provide
patients with the Tennessen warning as required by section 13.04, subdivision 2; and

(4) agree to continue treatment of the patient's qualifying medical condition and report
medical findings to the commissioner.

(b) Upon notification from the commissioner of the patient's enrollment in the registry
program, the health care practitioner shall:

(1) participate in the patient registry reporting system under the guidance and supervision
of the commissioner;

(2) report health records of the patient throughout the ongoing treatment of the patient
to the commissioner in a manner determined by the commissioner and in accordance with
subdivision 2;

(3) determine, deleted text begin on a yearly basisdeleted text end new text begin every three yearsnew text end , if the patient continues to suffer from
a qualifying medical condition and, if so, issue the patient a new certification of that
diagnosis; and

(4) otherwise comply with all requirements developed by the commissioner.

(c) A health care practitioner may utilize telehealth, as defined in section 62A.673,
subdivision 2, for certifications and recertifications.

(d) Nothing in this section requires a health care practitioner to participate in the registry
program.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 21.

Minnesota Statutes 2022, section 152.28, subdivision 2, is amended to read:


Subd. 2.

Data.

Data collected on patients by a health care practitioner and reported to
the patient registrynew text begin , including data on patients who are veterans who receive care from the
United States Department of Veterans Affairs,new text end are health records under section 144.291,
and are private data on individuals under section 13.02, but may be used or reported in an
aggregated, nonidentifiable form as part of a scientific, peer-reviewed publication of research
conducted under section 152.25 or in the creation of summary data, as defined in section
13.02, subdivision 19.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 22.

Minnesota Statutes 2022, section 152.29, subdivision 3, is amended to read:


Subd. 3.

Manufacturer; distribution.

(a) A manufacturer shall require that employees
licensed as pharmacists pursuant to chapter 151 be the only employees to give final approval
for the distribution of medical cannabis to a patient. A manufacturer may transport medical
cannabis or medical cannabis products that have been cultivated, harvested, manufactured,
packaged, and processed by that manufacturer to another registered manufacturer for the
other manufacturer to distribute.

(b) A manufacturer may distribute medical cannabis products, whether or not the products
have been manufactured by that manufacturer.

(c) Prior to distribution of any medical cannabis, the manufacturer shall:

(1) verify that the manufacturer has received the registry verification from the
deleted text begin commissionerdeleted text end new text begin officenew text end for that individual patient;

(2) verify that the person requesting the distribution of medical cannabis is the patient,
the patient's registered designated caregiver, or the patient's parent, legal guardian, or spouse
listed in the registry verification using the procedures described in section 152.11, subdivision
2d;

(3) assign a tracking number to any medical cannabis distributed from the manufacturer;

(4) ensure that any employee of the manufacturer licensed as a pharmacist pursuant to
chapter 151 has consulted with the patient to determine the proper dosage for the individual
patient after reviewing the ranges of chemical compositions of the medical cannabis and
the ranges of proper dosages reported by the deleted text begin commissionerdeleted text end new text begin officenew text end . For purposes of this
clause, a consultation may be conducted remotely by secure videoconference, telephone,
or other remote means, so long as the employee providing the consultation is able to confirm
the identity of the patient and the consultation adheres to patient privacy requirements that
apply to health care services delivered through telehealth. A pharmacist consultation under
this clause is deleted text begin not required when a manufacturer is distributing medical cannabis to a patient
according to a patient-specific dosage plan established with that manufacturer and is not
modifying the dosage or product being distributed under that plan and the medical cannabis
is distributed by a pharmacy techniciandeleted text end new text begin only required:
new text end

new text begin (i) if the patient is purchasing the product not previously purchased;
 new text end

new text begin (ii) if the patient purchases a product that the patient must administer using a different
method than the patient's previous method of administration;
 new text end

new text begin (iii) if the patient purchases a product with a cannabinoid concentration of at least double
the patient's prior dosage; and
 new text end

new text begin (iv) upon request of the patientnew text end ;new text begin and
new text end

(5) properly package medical cannabis in compliance with the United States Poison
Prevention Packing Act regarding child-resistant packaging and exemptions for packaging
for elderly patients, and label distributed medical cannabis with a list of all active ingredients
and individually identifying information, including:

(i) the patient's name and date of birth;

(ii) the name and date of birth of the patient's registered designated caregiver or, if listed
on the registry verification, the name of the patient's parent or legal guardian, if applicable;

(iii) the patient's registry identification number;

(iv) the chemical composition of the medical cannabis; and

(v) the dosagedeleted text begin ; anddeleted text end new text begin .
new text end

deleted text begin (6) ensure that the medical cannabis distributed contains a maximum of a 90-day supply
of the dosage determined for that patient.
 deleted text end

(d) A manufacturer shall require any employee of the manufacturer who is transporting
medical cannabis or medical cannabis products to a distribution facility or to another
registered manufacturer to carry identification showing that the person is an employee of
the manufacturer.

(e) A manufacturer shall distribute medical cannabis in dried raw cannabis form only
to a patient age 21 or older, or to the registered designated caregiver, parent, legal guardian,
or spouse of a patient age 21 or older.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 23.

Minnesota Statutes 2023 Supplement, section 152.30, is amended to read:


152.30 PATIENT DUTIES.

(a) A patient shall apply to the commissioner for enrollment in the registry program by
submitting an application as required in section 152.27 deleted text begin and an annual registration fee as
determined under section 152.35deleted text end .

(b) As a condition of continued enrollment, patients shall agree to:

(1) continue to receive regularly scheduled treatment for their qualifying medical
condition from their health care practitioner; and

(2) report changes in their qualifying medical condition to their health care practitioner.

(c) A patient shall only receive medical cannabis from a registered manufacturer or
Tribal medical cannabis program but is not required to receive medical cannabis products
from only a registered manufacturer or Tribal medical cannabis program.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 24.

Minnesota Statutes 2023 Supplement, section 256B.0625, subdivision 13d, is
amended to read:


Subd. 13d.

Drug formulary.

(a) The commissioner shall establish a drug formulary. Its
establishment and publication shall not be subject to the requirements of the Administrative
Procedure Act, but the Formulary Committee shall review and comment on the formulary
contents.

(b) The formulary shall not include:

(1) drugs, active pharmaceutical ingredients, or products for which there is no federal
funding;

(2) over-the-counter drugs, except as provided in subdivision 13;

(3) drugs or active pharmaceutical ingredients when used for the treatment of impotence
or erectile dysfunction;

(4) drugs or active pharmaceutical ingredients for which medical value has not been
established;

(5) drugs from manufacturers who have not signed a rebate agreement with the
Department of Health and Human Services pursuant to section 1927 of title XIX of the
Social Security Act; and

(6) deleted text begin medicaldeleted text end cannabis flower as defined in section 342.01, subdivision deleted text begin 54deleted text end new text begin 16new text end , deleted text begin or medicaldeleted text end
cannabinoid products as defined in section 342.01, subdivision deleted text begin 52deleted text end new text begin 12, or cannabis products
as defined in section 342.01, subdivision 20new text end .

(c) If a single-source drug used by at least two percent of the fee-for-service medical
assistance recipients is removed from the formulary due to the failure of the manufacturer
to sign a rebate agreement with the Department of Health and Human Services, the
commissioner shall notify prescribing practitioners within 30 days of receiving notification
from the Centers for Medicare and Medicaid Services (CMS) that a rebate agreement was
not signed.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 25.

Minnesota Statutes 2023 Supplement, section 290.0132, subdivision 29, is amended
to read:


Subd. 29.

Disallowed section 280E expenses; cannabis licensees.

The amount of
expenses of a deleted text begin medical cannabis businessdeleted text end new text begin license holdernew text end , as defined under section 342.01,
subdivision deleted text begin 53deleted text end new text begin 48new text end , related to the business of deleted text begin medical cannabis under sections 342.47 to
342.59, or a license holder under chapter deleted text end deleted text begin 342deleted text end deleted text begin , related to the business of nonmedical cannabis
under that chapter,deleted text end new text begin cannabis or hemp new text end and not allowed for federal income tax purposes under
section 280E of the Internal Revenue Code is a subtraction.

Sec. 26.

Minnesota Statutes 2023 Supplement, section 290.0134, subdivision 19, is amended
to read:


Subd. 19.

Disallowed section 280E expenses; cannabis licensees.

The amount of
expenses of a deleted text begin medical cannabis businessdeleted text end new text begin license holdernew text end , as defined under section 342.01,
subdivision deleted text begin 53deleted text end new text begin 48new text end , related to the business of deleted text begin medical cannabis under sections 342.47 to
342.59, or a license holder under chapter deleted text end deleted text begin 342deleted text end deleted text begin , related to the business of nonmedical cannabis
under that chapter,deleted text end new text begin cannabis or hemp new text end and not allowed for federal income tax purposes under
section 280E of the Internal Revenue Code is a subtraction.

Sec. 27.

Minnesota Statutes 2023 Supplement, section 295.81, subdivision 1, is amended
to read:


Subdivision 1.

Definitions.

(a) For purposes of this section, the following terms have
the meanings given.

(b) "Bundled transaction" means the retail sale of two or more products when the products
are otherwise distinct and identifiable and the products are sold for one nonitemized price.

(c) "Cannabis flower" has the meaning given in section 342.01, subdivision 16.

(d) "Cannabis product" has the meaning given in section 342.01, subdivision 20.

(e) "Cannabis solution product" means any cartridge, bottle, or other package that contains
a taxable cannabis product in a solution that is consumed or meant to be consumed through
the use of a heating element, power source, electronic circuit, or other electronic, chemical,
or mechanical means that produces vapor or aerosol. A cannabis solution product includes
any electronic delivery system, electronic vaping device, electronic vape pen, electronic
oral device, electronic delivery device, or similar product or device, and any batteries,
heating elements, or other components, parts, or accessories sold with and meant to be used
in the consumption of a solution containing a taxable cannabis product.

(f) "Cannabis mezzobusiness" means a cannabis business licensed under section 342.29.

(g) "Cannabis microbusiness" means a cannabis business licensed under section 342.28.

(h) "Cannabis retailer" means a cannabis business licensed under section 342.32.

(i) "Commissioner" means the commissioner of revenue.

(j) "Gross receipts" means the total amount received in money or by barter or exchange
for all taxable cannabis product sales at retail as measured by the sales price. Gross receipts
include but are not limited to delivery charges and packaging costs. Gross receipts do not
include:

(1) any taxes imposed directly on the customer that are separately stated on the invoice,
bill of sale, or similar document given to the purchaser; and

(2) discounts, including cash, terms, or coupons, that are not reimbursed by a third party
and that are allowed by the seller and taken by a purchaser on a sale.

(k) "Hemp-derived consumer product" has the meaning given in section 342.01,
subdivision 37.

(l) "Lower-potency hemp edible" has the meaning given in section 342.01, subdivision
50.

(m) "Lower-potency hemp edible retailer" means a cannabis business licensed under
section 342.43, subdivision 1, clause (2).

deleted text begin (n) "Medical cannabis flower" has the meaning given in section 342.01, subdivision 54.
 deleted text end

deleted text begin (o) "Medical cannabinoid product" has the meaning given in section 342.01, subdivision
52.
 deleted text end

deleted text begin (p) "Medical cannabis paraphernalia" has the meaning given in section 342.01,
subdivision 55.
 deleted text end

deleted text begin (q)deleted text end new text begin (n)new text end "Retail sale" has the meaning given in section 297A.61, subdivision 4.

deleted text begin (r)deleted text end new text begin (o)new text end "Taxable cannabis product" means cannabis flower, cannabis product, cannabis
solution product, hemp-derived consumer product, lower-potency hemp edible, and any
substantially similar itemnew text begin , and does not include items exempt from tax under subdivision
4, paragraph (b)new text end .

deleted text begin (s)deleted text end new text begin (p)new text end "Taxable cannabis product retailer" means a retailer that sells any taxable cannabis
product, and includes a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness,
medical cannabis combination business, and lower-potency hemp edible retailer. Taxable
cannabis product retailer includes but is not limited to a:

(1) retailer maintaining a place of business in this state;

(2) marketplace provider maintaining a place of business in this state, as defined in
section 297A.66, subdivision 1, paragraph (a);

(3) retailer not maintaining a place of business in this state; and

(4) marketplace provider not maintaining a place of business in this state, as defined in
section 297A.66, subdivision 1, paragraph (b).

Sec. 28.

Minnesota Statutes 2023 Supplement, section 295.81, subdivision 4, is amended
to read:


Subd. 4.

Exemptions.

(a) The use tax imposed under subdivision 3, paragraph (a), does
not apply to the possession, use, or storage of taxable cannabis products if (1) the taxable
cannabis products have an aggregate cost in any calendar month to the customer of $100
or less, and (2) the taxable cannabis products were carried into this state by the customer.

(b) The tax imposed under this section does not apply to sales new text begin by a cannabis business
with a medical cannabis retail endorsement or by a medical cannabis combination business
new text end of deleted text begin medicaldeleted text end new text begin the followingnew text end items deleted text begin purchased by or for a patientdeleted text end new text begin : cannabis flower, cannabinoid
products, or cannabis paraphernalia. Items sold under this paragraph must be sold to a personnew text end
enrolled in the registry programdeleted text begin , including medical cannabis flower, medical cannabinoid
products, or medical cannabis paraphernaliadeleted text end .

(c) Unless otherwise specified in this section, the exemptions applicable to taxes imposed
under chapter 297A are not applicable to the taxes imposed under this section.

(d) The tax imposed under this section does not apply to:

(1) sales made in Indian country as defined in United States Code, title 18, section 1151,
by a cannabis business licensed by a Minnesota Tribal government, as defined in section
3.9228, subdivision 1, paragraph (f); or

(2) use tax owed on taxable cannabis products purchased on Tribally regulated land as
defined in section 3.9228, subdivision 1, from a cannabis business licensed by a Minnesota
Tribal government as defined in section 3.9228, subdivision 1, paragraph (f).

Sec. 29.

Minnesota Statutes 2023 Supplement, section 297A.67, subdivision 2, is amended
to read:


Subd. 2.

Food and food ingredients.

Except as otherwise provided in this subdivision,
food and food ingredients are exempt. For purposes of this subdivision, "food" and "food
ingredients" mean substances, whether in liquid, concentrated, solid, frozen, dried, or
dehydrated form, that are sold for ingestion or chewing by humans and are consumed for
their taste or nutritional value. Food and food ingredients exempt under this subdivision do
not include candy, soft drinks, dietary supplements, and prepared foods. Food and food
ingredients do not include alcoholic beverages, tobacco, taxable cannabis products, deleted text begin medical
cannabis flower, and medical cannabinoid productsdeleted text end new text begin and any item exempt from tax under
section 295.81, subdivision 4, paragraph (b)new text end . For purposes of this subdivision, "alcoholic
beverages" means beverages that are suitable for human consumption and contain one-half
of one percent or more of alcohol by volume. For purposes of this subdivision, "tobacco"
means cigarettes, cigars, chewing or pipe tobacco, or any other item that contains tobacco.
For purposes of this subdivision, "taxable cannabis product" has the meaning given in section
295.81, subdivision 1, paragraph deleted text begin (r), "medical cannabis flower" has the meaning given in
section 342.01, subdivision 54, and "medical cannabinoid product" has the meaning given
in section 342.01, subdivision 52deleted text end new text begin (o)new text end . For purposes of this subdivision, "dietary supplements"
means any product, other than tobacco, intended to supplement the diet that:

(1) contains one or more of the following dietary ingredients:

(i) a vitamin;

(ii) a mineral;

(iii) an herb or other botanical;

(iv) an amino acid;

(v) a dietary substance for use by humans to supplement the diet by increasing the total
dietary intake; and

(vi) a concentrate, metabolite, constituent, extract, or combination of any ingredient
described in items (i) to (v);

(2) is intended for ingestion in tablet, capsule, powder, softgel, gelcap, or liquid form,
or if not intended for ingestion in such form, is not represented as conventional food and is
not represented for use as a sole item of a meal or of the diet; and

(3) is required to be labeled as a dietary supplement, identifiable by the supplement facts
box found on the label and as required pursuant to Code of Federal Regulations, title 21,
section 101.36.

Sec. 30.

Minnesota Statutes 2023 Supplement, section 297A.70, subdivision 2, is amended
to read:


Subd. 2.

Sales to government.

(a) All sales, except those listed in paragraph (b), to the
following governments and political subdivisions, or to the listed agencies or instrumentalities
of governments and political subdivisions, are exempt:

(1) the United States and its agencies and instrumentalities;

(2) school districts, local governments, the University of Minnesota, state universities,
community colleges, technical colleges, state academies, the Perpich Minnesota Center for
Arts Education, and an instrumentality of a political subdivision that is accredited as an
optional/special function school by the North Central Association of Colleges and Schools;

(3) hospitals and nursing homes owned and operated by political subdivisions of the
state of tangible personal property and taxable services used at or by hospitals and nursing
homes;

(4) other states or political subdivisions of other states, if the sale would be exempt from
taxation if it occurred in that state; and

(5) public libraries, public library systems, multicounty, multitype library systems as
defined in section 134.001, county law libraries under chapter 134A, state agency libraries,
the state library under section 480.09, and the Legislative Reference Library.

(b) This exemption does not apply to the sales of the following products and services:

(1) building, construction, or reconstruction materials purchased by a contractor or a
subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed
maximum price covering both labor and materials for use in the construction, alteration, or
repair of a building or facility;

(2) construction materials purchased by tax exempt entities or their contractors to be
used in constructing buildings or facilities which will not be used principally by the tax
exempt entities;

(3) the leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except
for leases entered into by the United States or its agencies or instrumentalities;

(4) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2),
prepared food, candy, soft drinks, alcoholic beverages as defined in section 297A.67,
subdivision 2, and taxable cannabis products as defined under section 295.81, subdivision
1, paragraph (r), except for lodging, prepared food, candy, soft drinks, alcoholic beverages,
and taxable cannabis products purchased directly by the United States or its agencies or
instrumentalities; or

(5) goods or services purchased by a local government as inputs to a liquor store, new text begin taxable
cannabis product retailer as defined under section 295.81, subdivision 1, paragraph (p), new text end gas
or electric utility, solid waste hauling service, solid waste recycling service, landfill, golf
course, marina, campground, cafe, or laundromat.

(c) As used in this subdivision, "school districts" means public school entities and districts
of every kind and nature organized under the laws of the state of Minnesota, and any
instrumentality of a school district, as defined in section 471.59.

(d) For purposes of the exemption granted under this subdivision, "local governments"
has the following meaning:

(1) for the period prior to January 1, 2017, local governments means statutory or home
rule charter cities, counties, and townships; and

(2) beginning January 1, 2017, local governments means statutory or home rule charter
cities, counties, and townships; special districts as defined under section 6.465; any
instrumentality of a statutory or home rule charter city, county, or township as defined in
section 471.59; and any joint powers board or organization created under section 471.59.

Sec. 31.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 3, is amended
to read:


Subd. 3.

Adult-use cannabis flower.

"Adult-use cannabis flower" means cannabis
flower that is approved for sale by the office or is substantially similar to a product approved
by the office. Adult-use cannabis flower does not include deleted text begin medical cannabis flower,deleted text end hemp
plant partsdeleted text begin ,deleted text end or hemp-derived consumer products.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 32.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 4, is amended
to read:


Subd. 4.

Adult-use cannabis product.

"Adult-use cannabis product" means a cannabis
product that is approved for sale by the office or is substantially similar to a product approved
by the office. Adult-use cannabis product includes edible cannabis products but does not
include deleted text begin medical cannabinoid products ordeleted text end lower-potency hemp edibles.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 33.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 12, is amended
to read:


Subd. 12.

Cannabinoid product.

"Cannabinoid product" means new text begin any of the following:
new text end

new text begin (1) new text end a cannabis productdeleted text begin ,deleted text end new text begin ;
new text end

new text begin (2)new text end a hemp-derived consumer productdeleted text begin , ordeleted text end new text begin ;
new text end

new text begin (3)new text end a lower-potency hemp ediblenew text begin ; or
new text end

new text begin (4) a product that consists of or contains cannabis concentrate or hemp concentrate or
is infused with cannabinoids, and is provided to:
 new text end

new text begin (i) a patient enrolled in the registry program;
 new text end

new text begin (ii) a registered designated caregiver; or
 new text end

new text begin (iii) a parent, legal guardian, or spouse of an enrolled patient, if provided by a cannabis
retailer or medical cannabis retailer to treat or alleviate the symptoms of a qualifying medical
conditionnew text end .

Sec. 34.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 14, is amended
to read:


Subd. 14.

Cannabis business.

"Cannabis business" means any of the following licensed
under this chapter:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service;new text begin and
new text end

deleted text begin (11) medical cannabis cultivator;
 deleted text end

deleted text begin (12) medical cannabis processor;
 deleted text end

deleted text begin (13) medical cannabis retailer; and
 deleted text end

deleted text begin (14)deleted text end new text begin (11)new text end medical cannabis combination business.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 35.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 16, is amended
to read:


Subd. 16.

Cannabis flower.

"Cannabis flower" means the harvested flower, bud, leaves,
deleted text begin anddeleted text end new text begin ornew text end stems of a cannabis plant. Cannabis flower includes adult-use cannabis flower deleted text begin and
medical cannabis flowerdeleted text end . Cannabis flower does not include cannabis seed, hemp plant parts,
or hemp-derived consumer products.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 36.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 17, is amended
to read:


Subd. 17.

Cannabis industry.

"Cannabis industry" means every item, product, person,
process, action, business, or other thing related to new text begin cannabis plants, new text end cannabis flowernew text begin ,new text end and
cannabis products deleted text begin and subject to regulation under this chapterdeleted text end .

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 37.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 19, is amended
to read:


Subd. 19.

Cannabis plant.

"Cannabis plant" means all parts of the plant of the genus
Cannabis that deleted text begin isdeleted text end new text begin arenew text end growing or deleted text begin hasdeleted text end new text begin havenew text end not been harvested deleted text begin and has a delta-9
tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basisdeleted text end new text begin , including
but not limited to a mother plant; a mature, flowering plant; an immature plant; or a seedling.
Cannabis plant does not include industrial hemp as defined in section 18K.02, subdivision
3new text end .

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 38.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 20, is amended
to read:


Subd. 20.

Cannabis product.

(a) "Cannabis product" means any of the following:

(1) cannabis concentrate;

(2) a product infused with cannabinoids, including but not limited to tetrahydrocannabinol,
extracted or derived from cannabis plants or cannabis flower; or

(3) any other product that contains cannabis concentrate.

(b) Cannabis product includes adult-use cannabis products, including but not limited to
edible cannabis products and deleted text begin medicaldeleted text end cannabinoid products. Cannabis product does not
include cannabis flower, artificially derived cannabinoid, lower-potency hemp edibles,
hemp-derived consumer products, or hemp-derived topical products.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 39.

Minnesota Statutes 2023 Supplement, section 342.01, is amended by adding a
subdivision to read:


new text begin Subd. 31a. new text end

new text begin Endorsement. new text end

new text begin "Endorsement" means an authorization from the Office of
Cannabis Management to conduct a specified operation activity.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 40.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 48, is amended
to read:


Subd. 48.

License holder.

"License holder" means a person, cooperative, or business
that holds any of the following licenses:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service;

(11) lower-potency hemp edible manufacturer;

(12) lower-potency hemp edible retailer;new text begin or
new text end

deleted text begin (13) medical cannabis cultivator;
 deleted text end

deleted text begin (14) medical cannabis processor;
 deleted text end

deleted text begin (15) medical cannabis retailer; or
 deleted text end

deleted text begin (16)deleted text end new text begin (13)new text end medical cannabis combination business.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 41.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 64, is amended
to read:


Subd. 64.

Registered designated caregiver.

"Registered designated caregiver" means
an individual who:

(1) is at least 18 years old;

deleted text begin (2) is not disqualified for a criminal offense according to rules adopted pursuant to
section 342.15, subdivision 2;
 deleted text end

deleted text begin (3)deleted text end new text begin (2)new text end has been approved by the deleted text begin Division of Medical Cannabisdeleted text end new text begin Office of Cannabis
Managementnew text end to assist a patient with obtaining deleted text begin medicaldeleted text end cannabis flower and deleted text begin medicaldeleted text end
cannabinoid products from a cannabis deleted text begin retailer or medical cannabis retailerdeleted text end new text begin business with a
medical cannabis retail endorsementnew text end and with administering deleted text begin medicaldeleted text end cannabis flower and
deleted text begin medicaldeleted text end cannabinoid products; and

deleted text begin (4)deleted text end new text begin (3)new text end is authorized by the deleted text begin Division of Medical Cannabisdeleted text end new text begin Office of Cannabis Managementnew text end
to assist a patient with the use of deleted text begin medicaldeleted text end cannabis flower and deleted text begin medicaldeleted text end cannabinoid products.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 42.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 65, is amended
to read:


Subd. 65.

Registry or registry program.

"Registry" or "registry program" means the
new text begin medical cannabis new text end patient registry established under this chapter listing deleted text begin patientsdeleted text end new text begin each personnew text end
authorized tonew text begin :
new text end

new text begin (1)new text end obtain deleted text begin medicaldeleted text end cannabis flower, deleted text begin medicaldeleted text end cannabinoid products, and deleted text begin medicaldeleted text end cannabis
paraphernalia from new text begin a new text end cannabis deleted text begin retailers and medical cannabis retailersdeleted text end new text begin business with a
medical cannabis retail endorsement;new text end and

new text begin (2)new text end administer deleted text begin medicaldeleted text end cannabis flower and deleted text begin medicaldeleted text end cannabinoid products.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 43.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 66, is amended
to read:


Subd. 66.

Registry verification.

"Registry verification" means the verification provided
by the deleted text begin Division of Medical Cannabisdeleted text end new text begin Office of Cannabis Managementnew text end that a patient is
enrolled in the registry program and that includes the patient's name, patient registry number,
and, if applicable, the name of the patient's registered designated caregiver or parent, legal
guardian, or spouse.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 44.

Minnesota Statutes 2023 Supplement, section 342.02, subdivision 2, is amended
to read:


Subd. 2.

Powers and duties.

(a) The office has the following powers and duties:

(1) to develop, maintain, and enforce an organized system of regulation for the cannabis
industry and hemp consumer industry;

(2) to establish programming, services, and notification to protect, maintain, and improve
the health of citizens;

(3) to prevent unauthorized access to cannabis flower, cannabis products, lower-potency
hemp edibles, and hemp-derived consumer products by individuals under 21 years of age;

(4) to establish and regularly update standards for product manufacturing, testing,
packaging, and labeling, including requirements for an expiration, sell-by, or best-used-by
date;

(5) to promote economic growth with an emphasis on growth in areas that experienced
a disproportionate, negative impact from cannabis prohibition;

(6) to issue and renew licenses;

(7) to require fingerprints from individuals determined to be subject to fingerprinting,
including the submission of fingerprints to the Federal Bureau of Investigation where
required by law and to obtain criminal conviction data for individuals seeking a license
from the office on the individual's behalf or as a cooperative member or director, manager,
or general partner of a business entity;

(8) to receive reports required by this chapter and inspect the premises, records, books,
and other documents of license holders to ensure compliance with all applicable laws and
rules;

(9) to authorize the use of unmarked motor vehicles to conduct seizures or investigations
pursuant to the office's authority;

(10) to impose and collect civil and administrative penalties as provided in this chapter;

(11) to publish such information as may be deemed necessary for the welfare of cannabis
businesses, cannabis workers, hemp businesses, and hemp workers and the health and safety
of citizens;

(12) to make loans and grants in aid to the extent that appropriations are made available
for that purpose;

(13) to authorize research and studies on cannabis flower, cannabis products, artificially
derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, the
cannabis industry, and the hemp consumer industry;

(14) to provide reports as required by law;

(15) to develop a warning label regarding the effects of the use of cannabis flower and
cannabis products by persons 25 years of age or younger;

(16) to determine, based on a review of medical and scientific literature, whether it is
appropriate to require additional health and safety warnings containing information that is
both supported by credible science and helpful to consumers in considering potential health
risks from the use of cannabis flower, cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products, including but not limited to warnings regarding any risks
associated with use by pregnant or breastfeeding individuals, or by individuals planning to
become pregnant, and the effects that use has on brain development for individuals under
the age of 25;

(17) to establish limits on the potency of cannabis flower and cannabis products that can
be sold to customers by licensed cannabis retailers, licensed cannabis microbusinesses, and
licensed cannabis mezzobusinesses with an endorsement to sell cannabis flower and cannabis
products to customers;

(18) to establish rules authorizing an increase in plant canopy limits and outdoor
cultivation limits to meet market demand and limiting cannabis manufacturing consistent
with the goals identified in subdivision 1; deleted text begin and
deleted text end

new text begin (19) to order a person or business that manufactures or produces cannabis flower, cannabis
products, artificially derived cannabinoids, lower-potency hemp edibles, hemp-derived
consumer products, or hemp-derived topical products to recall a product if the office
determines that the product represents a risk of causing a serious adverse incident; and
 new text end

deleted text begin (19)deleted text end new text begin (20)new text end to exercise other powers and authority and perform other duties required by
law.

(b) In addition to the powers and duties in paragraph (a), the office has the following
powers and duties until January 1, 2027:

(1) to establish limits on the potency of adult-use cannabis flower and adult-use cannabis
products that can be sold to customers by licensed cannabis retailers, licensed cannabis
microbusinesses, and licensed cannabis mezzobusinesses with an endorsement to sell
adult-use cannabis flower and adult-use cannabis products to customers; and

(2) to permit, upon application to the office in the form prescribed by the director of the
office, a licensee under this chapter to perform any activity if such permission is substantially
necessary for the licensee to perform any other activity permitted by the applicant's license
and is not otherwise prohibited by law.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 45.

Minnesota Statutes 2023 Supplement, section 342.02, subdivision 3, is amended
to read:


Subd. 3.

Medical cannabis program.

(a) The powers and duties of the Department of
Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections
152.22 to 152.37, are transferred to the Office of Cannabis Management under section
15.039.

(b) The following protections shall apply to employees who are transferred from the
Department of Health to the Office of Cannabis Management:

(1) the employment status and job classification of a transferred employee shall not be
altered as a result of the transfer;

(2) transferred employees who were represented by an exclusive representative prior to
the transfer shall continue to be represented by the same exclusive representative after the
transfer;

(3) the applicable collective bargaining agreements with exclusive representatives shall
continue in full force and effect for such transferred employees after the transfer;

(4) the state must meet and negotiate with the exclusive representatives of the transferred
employees about any proposed changes affecting or relating to the transferred employees'
terms and conditions of employment to the extent such changes are not addressed in the
applicable collective bargaining agreement; and

(5) for an employee in a temporary unclassified position transferred to the Office of
Cannabis Management, the total length of time that the employee has served in the
appointment shall include all time served in the appointment and the transferring agency
and the time served in the appointment at the Office of Cannabis Management. An employee
in a temporary unclassified position who was hired by a transferring agency through an
open competitive selection process in accordance with a policy enacted by Minnesota
Management and Budget shall be considered to have been hired through such process after
the transfer.

new text begin (c) This subdivision is effective July 1, 2024.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 46.

Minnesota Statutes 2023 Supplement, section 342.02, subdivision 5, is amended
to read:


Subd. 5.

Rulemaking.

new text begin (a) new text end The office may adopt rules to implement any provisions in
this chapter.

new text begin (b)new text end Rules for which new text begin a new text end notice new text begin of intent to adopt rules new text end is published in the State Register
before July 1, 2025, may be adopted using the expedited rulemaking process in section
14.389.new text begin The 18-month time limit imposed by section 14.125 does not apply to rules adopted
under this paragraph.
new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 47.

Minnesota Statutes 2023 Supplement, section 342.02, subdivision 6, is amended
to read:


Subd. 6.

Director.

(a) The governor shall appoint a director of the office with the advice
and consent of the senate. The director must be in the unclassified service and must serve
at the pleasure of the governor.

deleted text begin (b) The salary of the director must not exceed the salary limit established under section
15A.0815, subdivision 3.
 deleted text end

new text begin (b) The director may appoint and employ no more than two deputy directors.
 new text end

new text begin (c) The director has administrative control of the office. The director has the powers
described in section 15.06, subdivision 6.
 new text end

new text begin (d) The director may apply for and accept on behalf of the state any grants, bequests,
gifts, or contributions for the purpose of carrying out the duties and responsibilities of the
director.
 new text end

new text begin (e) Pursuant to state law, the director may apply for and receive money made available
from federal sources for the purpose of carrying out the duties and responsibilities of the
director.
 new text end

new text begin (f) The director may make contracts with and grants to Tribal Nations, public and private
agencies, for-profit and nonprofit organizations, and individuals using appropriated money.
 new text end

Sec. 48.

Minnesota Statutes 2023 Supplement, section 342.07, subdivision 3, is amended
to read:


Subd. 3.

Edible cannabinoid product handler endorsement.

(a) Any person seeking
to manufacture, process, sell, handle, or store an edible cannabis product or lower-potency
hemp edible, other than an edible cannabis product or lower-potency hemp edible that has
been placed in its final packaging, must first obtain an edible cannabinoid product handler
endorsement.

(b) In consultation with the commissioner of agriculture, the office shall establish an
edible cannabinoid product handler endorsement.

(c) The office must regulate edible cannabinoid product handlers deleted text begin and assess penalties
in the samedeleted text end new text begin in anew text end manner deleted text begin provided fordeleted text end new text begin consistent with Department of Agriculture regulation
ofnew text end food handlers under chapters 28A, 31, and 34A and associated rules, with the following
exceptions:

(1) the office must issue an edible cannabinoid product handler endorsement, rather than
a license;

(2) eligibility for an edible cannabinoid product handler endorsement is limited to persons
who possess a valid license issued by the office;

(3) the office may not charge a fee for issuing or renewing the endorsement;

(4) the office must align the term and renewal period for edible cannabinoid product
handler endorsements with the term and renewal period of the license issued by the office;
and

(5) an edible cannabis product or lower-potency hemp edible must not be considered
adulterated solely because the product or edible contains tetrahydrocannabinol, cannabis
concentrate, hemp concentrate, artificially derived cannabinoids, or any other material
extracted or derived from a cannabis plant, cannabis flower, hemp plant, or hemp plant
parts.

(d) The edible cannabinoid product handler endorsement must prohibit the manufacture
of edible cannabis products at the same premises where food is manufactured, except for
the limited production of edible products produced solely for product development, sampling,
or testing. This limitation does not apply to the manufacture of lower-potency hemp edibles.

Sec. 49.

Minnesota Statutes 2023 Supplement, section 342.09, subdivision 1, is amended
to read:


Subdivision 1.

Personal adult use, possession, and transportation of cannabis flower
and cannabinoid products.

(a) An individual 21 years of age or older may:

(1) use, possess, or transport cannabis paraphernalia;

(2) possess or transport two ounces or less of adult-use cannabis flower in a public place;

(3) possess two pounds or less of adult-use cannabis flower in the individual's private
residence;

(4) possess or transport eight grams or less of adult-use cannabis concentrate;

(5) possess or transport edible cannabis products or lower-potency hemp edibles infused
with a combined total of 800 milligrams or less of tetrahydrocannabinol;

(6) give for no remuneration to an individual who is at least 21 years of age:

(i) two ounces or less of adult-use cannabis flower;

(ii) eight grams or less of adult-use cannabis concentrate; or

(iii) an edible cannabis product or lower-potency hemp edible infused with 800 milligrams
or less of tetrahydrocannabinol; and

(7) use adult-use cannabis flower and adult-use cannabis products in the following
locations:

(i) a private residence, including the individual's curtilage or yard;

(ii) on private property, not generally accessible by the public, unless the individual is
explicitly prohibited from consuming cannabis flower, cannabis products, lower-potency
hemp edibles, or hemp-derived consumer products on the property by the owner of the
property; or

(iii) on the premises of an establishment or event licensed to permit on-site consumption.

(b) Except as provided in paragraph (c), an individual may not:

(1) use, possess, or transport cannabis flower, cannabis products, lower-potency hemp
edibles, or hemp-derived consumer products if the individual is under 21 years of age;

(2) use cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived
consumer products in a motor vehicle as defined in section 169A.03, subdivision 15;

(3) use cannabis flower, cannabis products, or hemp-derived consumer products in a
manner that involves the inhalation of smoke, aerosol, or vapor at any location where
smoking is prohibited under section 144.414;

(4) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or
hemp-derived consumer products in a public school, as defined in section 120A.05,
subdivisions 9, 11, and 13, or in a charter school governed by chapter 124E, including all
facilities, whether owned, rented, or leased, and all vehicles that a school district owns,
leases, rents, contracts for, or controls;

(5) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or
hemp-derived consumer products in a state correctional facility;

(6) operate a motor vehicle while under the influence of cannabis flower, cannabis
products, lower-potency hemp edibles, or hemp-derived consumer products;

(7) give for no remuneration cannabis flower, cannabis products, lower-potency hemp
edibles, or hemp-derived consumer products to an individual under 21 years of age;

(8) give for no remuneration cannabis flower or cannabis products as a sample or
promotional gift if the giver is in the business of selling goods or services; or

(9) vaporize or smoke cannabis flower, cannabis products, artificially derived
cannabinoids, or hemp-derived consumer products in any location where the smoke, aerosol,
or vapor would be inhaled by a minor.

(c) The prohibitions under paragraph (b), clauses (1) to (4), do not apply to use other
than by smoking or by a vaporized delivery method, possession, or transportation of deleted text begin medicaldeleted text end
cannabis flower or deleted text begin medicaldeleted text end cannabinoid products by a patient; a registered designated
caregiver; or a parent, legal guardian, or spouse of a patient.

new text begin (d) The possession limits in paragraph (a), clauses (2) to (5), do not apply to a person
enrolled in the medical cannabis patient registry program under section 342.52 if the person
possesses cannabis flower or cannabinoid products that include patient-specific labeling
according to sections 342.51, subdivision 2, and 342.63, subdivision 4.
 new text end

deleted text begin (d)deleted text end new text begin (e)new text end A proprietor of a family or group family day care program must disclose to parents
or guardians of children cared for on the premises of the family or group family day care
program, if the proprietor permits the smoking or use of cannabis flower, cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products on the premises outside
of its hours of operation. Disclosure must include posting on the premises a conspicuous
written notice and orally informing parents or guardians. Cannabis flower or cannabis
products must be inaccessible to children and stored away from food products.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 50.

Minnesota Statutes 2023 Supplement, section 342.09, subdivision 3, is amended
to read:


Subd. 3.

Home extraction of cannabis concentrate by use of volatile solvent
prohibited.

No person may use a volatile solvent to separate or extract cannabis concentrate
or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, cannabis
manufacturer, deleted text begin medical cannabis processor,deleted text end or lower-potency hemp edible manufacturer
license issued under this chapter.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 51.

Minnesota Statutes 2023 Supplement, section 342.10, is amended to read:


342.10 LICENSES; TYPES.

The office shall issue the following types of license:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service;

(11) lower-potency hemp edible manufacturer;

(12) lower-potency hemp edible retailer;new text begin or
new text end

deleted text begin (13) medical cannabis cultivator;
 deleted text end

deleted text begin (14) medical cannabis processor;
 deleted text end

deleted text begin (15) medical cannabis retailer; or
 deleted text end

deleted text begin (16)deleted text end new text begin (13)new text end medical cannabis combination business.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 52.

Minnesota Statutes 2023 Supplement, section 342.11, is amended to read:


342.11 LICENSES; FEES.

(a) The office shall require the payment of application fees, initial licensing fees, and
renewal licensing fees as provided in this section. The initial license fee shall include the
fee for initial issuance of the license and the first annual renewal. The renewal fee shall be
charged at the time of the second renewal and each subsequent annual renewal thereafter.
Nothing in this section prohibits a local unit of government from charging the retailer
registration fee established in section 342.22. Application fees, initial licensing fees, and
renewal licensing fees are nonrefundable.

(b) Application and licensing fees shall be as follows:

(1) for a cannabis microbusiness:

(i) an application fee of $500;

(ii) an initial license fee of $0; and

(iii) a renewal license fee of $2,000;

(2) for a cannabis mezzobusiness:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(3) for a cannabis cultivator:

(i) an application fee of $10,000;

(ii) an initial license fee of $20,000; and

(iii) a renewal license fee of $30,000;

(4) for a cannabis manufacturer:

(i) an application fee of $10,000;

(ii) an initial license fee of $10,000; and

(iii) a renewal license fee of $20,000;

(5) for a cannabis retailer:

(i) an application fee of $2,500;

(ii) an initial license fee of $2,500; and

(iii) a renewal license fee of $5,000;

(6) for a cannabis wholesaler:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(7) for a cannabis transporter:

(i) an application fee of $250;

(ii) an initial license fee of $500; and

(iii) a renewal license fee of $1,000;

(8) for a cannabis testing facility:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(9) for a cannabis delivery service:

(i) an application fee of $250;

(ii) an initial license fee of $500; and

(iii) a renewal license fee of $1,000;

(10) for a cannabis event organizer:

(i) an application fee of $750; and

(ii) an initial license fee of $750;

(11) for a lower-potency hemp edible manufacturer:

(i) an application fee of $250;

(ii) an initial license fee of $1,000; and

(iii) a renewal license fee of $1,000;

(12) for a lower-potency hemp edible retailer:

(i) an application fee of $250 per retail location;

(ii) an initial license fee of $250 per retail location; and

(iii) a renewal license fee of $250 per retail location;new text begin and
new text end

deleted text begin (13) for a medical cannabis cultivator:
 deleted text end

deleted text begin (i) an application fee of $250;
 deleted text end

deleted text begin (ii) an initial license fee of $0; and
 deleted text end

deleted text begin (iii) a renewal license fee of $0;
 deleted text end

deleted text begin (14) for a medical cannabis processor:
 deleted text end

deleted text begin (i) an application fee of $250;
 deleted text end

deleted text begin (ii) an initial license fee of $0; and
 deleted text end

deleted text begin (iii) a renewal license fee of $0;
 deleted text end

deleted text begin (15) for a medical cannabis retailer:
 deleted text end

deleted text begin (i) an application fee of $250;
 deleted text end

deleted text begin (ii) an initial license fee of $0; and
 deleted text end

deleted text begin (iii) a renewal license fee of $0; and
 deleted text end

deleted text begin (16)deleted text end new text begin (13)new text end for a medical cannabis combination business:

(i) an application fee of $10,000;

(ii) an initial license fee of $20,000; and

(iii) a renewal license fee of $70,000.

Sec. 53.

Minnesota Statutes 2023 Supplement, section 342.12, is amended to read:


342.12 LICENSES; TRANSFERS; ADJUSTMENTS.

(a) deleted text begin Licensesdeleted text end new text begin A person holding a licensenew text end issued under this chapter may deleted text begin bedeleted text end freely deleted text begin transferreddeleted text end new text begin
transfer that license to another entitynew text end subject to the prior written approval of the office,
deleted text begin which approval may be given or withheld in the office's sole discretion, provided that a
social equity applicant may only transfer the applicant's license to another social equity
applicantdeleted text end new text begin unless the license is temporary or is held by a social equity applicantnew text end . A new
license must be obtained when:

(1) the form of the licensee's legal business structure converts or changes to a different
type of legal business structure; or

(2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency,
or receivership proceedings; merges with another legal organization; or assigns all or
substantially all of its assets for the benefit of creditors.

(b) deleted text begin Transfers betweendeleted text end new text begin Notwithstanding paragraph (a), during the first three years from
the date that a social equity applicant holds a license, thenew text end social equity deleted text begin applicantsdeleted text end new text begin applicant
may only transfer the license to another social equity applicant. Three years after a license
was initially issued, a social equity applicant may transfer the license to any entity. A license
transfer by a social equity applicantnew text end must be reviewed by the Division of Social Equity.

(c) Licenses must be renewed annually.

(d) License holders may petition the office to adjust the tier of a license issued within a
license category provided that the license holder meets all applicable requirements.

(e) The office by rule may permit new text begin the new text end relocation of a licensed cannabis businessdeleted text begin ,deleted text end new text begin ; permit
the relocation of an approved operational location, including a grow or retail location;new text end adopt
requirements for the submission of a license relocation applicationdeleted text begin ,deleted text end new text begin ;new text end establish standards for
the approval of a relocation applicationdeleted text begin ,deleted text end new text begin ;new text end and charge a fee not to exceed $250 for reviewing
and processing applications. Relocation of a licensed premises pursuant to this paragraph
does not extend or otherwise modify the license term of the license subject to relocation.

Sec. 54.

new text begin [342.125] TEMPORARY LICENSES.
 new text end

new text begin Subdivision 1. new text end

new text begin Temporary license. new text end

new text begin (a) The office may establish a temporary license
and application process for a limited number of licenses, but the office shall issue no more
than the following number of temporary licenses per application period:
 new text end

new text begin (1) cannabis microbusiness licenses, 100;
 new text end

new text begin (2) cannabis mezzobusiness licenses, 11;
 new text end

new text begin (3) cannabis cultivator licenses, 13;
 new text end

new text begin (4) cannabis manufacturer licenses, six;
 new text end

new text begin (5) cannabis retailer licenses, 50;
 new text end

new text begin (6) cannabis wholesaler licenses, 20;
 new text end

new text begin (7) cannabis transporter licenses, 20;
 new text end

new text begin (8) cannabis testing facility licenses, 25;
 new text end

new text begin (9) cannabis event organizer licenses, ten; and
 new text end

new text begin (10) cannabis delivery service licenses, ten.
 new text end

new text begin (b) The temporary license period begins on the day that the office issues a temporary
license to the applicant and is effective for 18 months after the date that the temporary
license was issued.
 new text end

new text begin Subd. 2. new text end

new text begin Eligibility. new text end

new text begin (a) Only a social equity applicant as described in section 342.17 or
a local unit of government is eligible for a temporary license.
 new text end

new text begin (b) An applicant for a temporary license must:
 new text end

new text begin (1) complete an initial application according to section 342.14, subdivision 1, on a form
approved by the office; and
 new text end

new text begin (2) pay the application fee required by section 342.11, paragraph (b), to the office.
 new text end

new text begin (c) As part of the application process, the office must verify the applicant's status as a
social equity applicant.
 new text end

new text begin (d) The office may not issue a temporary license in violation of section 342.18,
subdivision 2.
 new text end

new text begin (e) The office shall not require an applicant to possess or own any property on which or
facility in which to operate a cannabis business at the time of the initial application.
 new text end

new text begin Subd. 3. new text end

new text begin Application process. new text end

new text begin (a) The office must announce the commencement of a
temporary license application period at least 14 days before the date that the office begins
to accept applications for temporary licenses. The announcement must include:
 new text end

new text begin (1) the types of licenses that are available during the temporary license application
period;
 new text end

new text begin (2) the number of licenses available by license type;
 new text end

new text begin (3) the date on which the temporary license application period will begin; and
 new text end

new text begin (4) the date on which the temporary license application period will end.
 new text end

new text begin (b) The office must accept applications for temporary licenses for 30 calendar days
during a temporary license application period.
 new text end

new text begin (c) The office may deny an application for a temporary license that:
 new text end

new text begin (1) is incomplete;
 new text end

new text begin (2) contains a materially false statement about the applicant or omits material information
about the applicant;
 new text end

new text begin (3) fails to meet the minimum qualifications for the license in section 342.18, subdivision
3; or
 new text end

new text begin (4) is not submitted by the deadline established by the office.
 new text end

new text begin (d) The office may request additional information from any applicant if the office
determines that the information is necessary to review or process the application. If the
applicant does not provide the additional requested information within 14 calendar days,
the office may deny the application.
 new text end

new text begin Subd. 4. new text end

new text begin Lottery. new text end

new text begin (a) If the number of available temporary licenses is less than the
number of social equity applicants qualified for temporary licenses, the office must conduct
a lottery. The lottery must be impartial, random, and in a format determined by the office.
 new text end

new text begin (b) The office must include in the lottery any social equity applicant that meets the
requirements under subdivisions 2 and 3.
 new text end

new text begin (c) The office may rescind a social equity applicant's status as a selected lottery applicant
if:
 new text end

new text begin (1) there are grounds for revocation under section 342.21;
 new text end

new text begin (2) the social equity applicant is disqualified under section 342.15; or
 new text end

new text begin (3) the social equity applicant is determined to be in arrears on property, business, or
personal taxes.
 new text end

new text begin Subd. 5. new text end

new text begin Local unit of government. new text end

new text begin The office shall only issue a temporary license to
a local unit of government if, after assigning temporary licenses to social equity applicants,
there are remaining temporary licenses. A temporary license held by a local unit of
government must not count towards the limited number of licenses issued by a local
government unit under section 342.13, paragraph (h).
 new text end

new text begin Subd. 6. new text end

new text begin Authority and restrictions. new text end

new text begin (a) The holder of a temporary license may take
the necessary steps to prepare for business operations, including:
 new text end

new text begin (1) establishing legal control of the site of the cannabis business through lease, purchase,
or other means;
 new text end

new text begin (2) gaining zoning or planning approval for the site of the cannabis business from a local
unit of government; or
 new text end

new text begin (3) raising capital for the license holder's business operations.
 new text end

new text begin (b) The holder of a temporary license shall not:
 new text end

new text begin (1) engage in purchasing, possessing, cultivating, manufacturing, or selling cannabis or
cannabis products;
 new text end

new text begin (2) grow, process, distribute, dispense, or otherwise handle cannabis;
 new text end

new text begin (3) make any change or transfer of ownership or control that would require a new business
registration with the secretary of state; or
 new text end

new text begin (4) make any transfer of ownership interest that causes the holder of the temporary
license to no longer qualify as a social equity applicant as defined in section 342.17.
 new text end

new text begin Subd. 7. new text end

new text begin Revocation and other penalties. new text end

new text begin (a) The office may revoke a temporary license
if the holder of the temporary license or, if the license holder is a business entity, any
cooperative member or director, manager, or general partner of the business entity:
 new text end

new text begin (1) fraudulently or deceptively obtained the temporary license;
 new text end

new text begin (2) fails to reveal any material fact pertaining to the licensee's qualification for a license;
 new text end

new text begin (3) fails to convert a temporary license into a license that is not temporary within 18
months of the date that the temporary license was issued;
 new text end

new text begin (4) violates this chapter;
 new text end

new text begin (5) is not registered or in good standing with the Office of the Secretary of State; or
 new text end

new text begin (6) is in arrears on property, business, or personal taxes.
 new text end

new text begin Subd. 8. new text end

new text begin Conversion of temporary license. new text end

new text begin (a) The office must convert a temporary
license into a license after the office:
 new text end

new text begin (1) adopts initial rules pursuant to section 342.02, subdivision 5; and
 new text end

new text begin (2) finds that the license holder or, if the license holder is a business entity, every
cooperative member or director, manager, or general partner of the business entity, has not
violated this chapter.
 new text end

new text begin (b) The office must not convert a temporary license into a license that is not temporary
if the ownership of the temporary license holder's business has changed since being granted
a temporary license and the temporary license holder has not filed an updated ownership
disclosure with information consistent with the original application and section 342.14,
subdivision 1, paragraph (b).
 new text end

new text begin (c) The office must not convert a temporary license into a license if the cannabis business
for which the license is held does not meet local zoning and land use laws.
 new text end

new text begin (d) A license that is converted from a temporary license according to this subdivision
expires 18 months after the date of the conversion.
 new text end

new text begin Subd. 9. new text end

new text begin Applicants; right to a reconsideration. new text end

new text begin (a) An applicant that is not issued a
temporary license or an applicant that the office has not entered into the lottery may request
a records review of the submitted application within seven calendar days of receiving
notification that the application does not meet the minimum qualifications for a license
under section 342.18, subdivision 3.
 new text end

new text begin (b) Upon an applicant's request, the office must allow the applicant to examine the
applicant's records received by the office.
 new text end

new text begin (c) If the office determines that an applicant is ineligible for a temporary license, the
office must inform the applicant of any reasons that form the basis of the office's
determination.
 new text end

new text begin (d) The following applicants may request reconsideration by the director:
 new text end

new text begin (1) an applicant selected in a lottery whose license is later revoked by the office; or
 new text end

new text begin (2) an applicant who previously held a temporary license until the temporary license
was revoked by the office.
 new text end

new text begin (e) An applicant who does not meet the minimum qualifications for a license under
section 342.18, subdivision 3, and is not selected in the lottery may not request
reconsideration.
 new text end

new text begin Subd. 10. new text end

new text begin Multiple lotteries; application retention. new text end

new text begin (a) Upon receiving notification
that an applicant was not selected in the lottery, the applicant may request that the office
retain the applicant's application for subsequent lotteries.
 new text end

new text begin (b) The office must retain any application requested for retention under paragraph (a)
for one year after the date of the request.
 new text end

new text begin (c) The office may contact an applicant with a retained application for any additional
information required for a subsequent lottery.
 new text end

new text begin (d) Any application retained by the office that meets the specifications and requirements
of a subsequent lottery within the one-year retention period, may be entered into the lottery
if the applicant:
 new text end

new text begin (1) pays the relevant application fee;
 new text end

new text begin (2) amends the application upon the request of the office; and
 new text end

new text begin (3) provides the office with any additional information requested by the office.
 new text end

new text begin (e) The office must not enter a retained application into a subsequent lottery if the
applicant or, if the applicant is a business entity, any cooperative member or director,
manager, or general partner of the business entity has violated this chapter.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 55.

Minnesota Statutes 2023 Supplement, section 342.13, is amended to read:


342.13 LOCAL CONTROL.

(a) A local unit of government may not prohibit the possession, transportation, or use
of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived
consumer products authorized under this chapter.

(b) Except as provided in section 342.22, a local unit of government may not prohibit
the establishment or operation of a cannabis business licensed under this chapter.

(c) A local unit of government may adopt reasonable restrictions on the time, place, and
manner of the operation of a cannabis business provided that such restrictions do not prohibit
the establishment or operation of cannabis businesses. A local unit of government may
prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a
day care, residential treatment facility, or an attraction within a public park that is regularly
used by minors, including a playground or athletic field.

(d) The office shall work with local units of government to:

(1) develop model ordinances for reasonable restrictions on the time, place, and manner
of the operation of a cannabis business;

(2) develop standardized forms and procedures for the issuance of a retail registration
pursuant to section 342.22; and

(3) develop model policies and procedures for the performance of compliance checks
required under section 342.22.

(e) If a local unit of government is conducting studies or has authorized a study to be
conducted or has held or has scheduled a hearing for the purpose of considering adoption
or amendment of reasonable restrictions on the time, place, and manner of the operation of
a cannabis business, the governing body of the local unit of government may adopt an
interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting
the planning process and the health, safety, and welfare of its citizens. Before adopting the
interim ordinance, the governing body must hold a public hearing. The interim ordinance
may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction
or a portion thereof until January 1, 2025.

(f) deleted text begin Within 30 days of receiving a copy of an application from the office, a local unit of
government shall certify on a form provided by the office whether a proposed cannabis
business complies with local zoning ordinances and, if applicable, whether the proposed
business complies with the state fire code and building code.deleted text end The office may not issue deleted text begin a
licensedeleted text end new text begin an endorsement to a cannabis business new text end if deleted text begin adeleted text end new text begin thenew text end cannabis business does not meet local
zoning and land use laws.

deleted text begin (g) Upon receipt of an application for a license issued under this chapter, the office shall
contact the local unit of government in which the business would be located and provide
the local unit of government with 30 days in which to provide input on the application. The
local unit of government may provide the office with any additional information it believes
is relevant to the office's decision on whether to issue a license, including but not limited
to identifying concerns about the proposed location of a cannabis business or sharing public
information about an applicant.
 deleted text end

deleted text begin (h)deleted text end new text begin (g)new text end The office by rule shall establish an expedited complaint process to receive,
review, and respond to complaints made by a local unit of government about a cannabis
business. deleted text begin Complaints may include alleged violations of local ordinances or other alleged
violations.deleted text end At a minimum, the expedited complaint process shall require the office to provide
an initial response to the complaint within seven days and perform any necessary inspections
within 30 days. Nothing in this paragraph prohibits a local unit of government from enforcing
a local ordinance. If a local unit of government notifies the office that a cannabis business
other than a cannabis retailer, cannabis microbusiness with a retail operations endorsement,
cannabis mezzobusiness, lower-potency hemp edible retailer, deleted text begin medical cannabis retailer,deleted text end or
medical cannabis combination business poses an immediate threat to the health or safety
of the public, the office must respond within one business day and may take any action
described in section 342.19 or 342.21.

deleted text begin (i)deleted text end new text begin (h)new text end A local government unit that issues cannabis retailer registration under section
342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis
mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with
a retail operations endorsement to no fewer than one registration for every 12,500 residents.

deleted text begin (j)deleted text end new text begin (i)new text end If a county has one active registration for every 12,500 residents, a city or town
within the county is not obligated to register a cannabis business.

deleted text begin (k)deleted text end new text begin (j)new text end Nothing in this section shall prohibit a local government unit from allowing
licensed cannabis retailers in excess of the minimums set in paragraph deleted text begin (i)deleted text end new text begin (h)new text end .

deleted text begin (l)deleted text end new text begin (k)new text end Notwithstanding the foregoing provisions, the state shall not issue a license to
any cannabis business to operate in Indian country, as defined in United States Code, title
18, section 1151, of a Minnesota Tribal government without the consent of the Tribal
government.

Sec. 56.

Minnesota Statutes 2023 Supplement, section 342.14, is amended to read:


342.14 CANNABIS LICENSE APPLICATION AND RENEWAL.

Subdivision 1.

Application; contents.

(a) The office by rule shall establish forms and
procedures for the processing of cannabis licenses issued under this chapter. deleted text begin At a minimum,
any application to obtain or renew a cannabis license shalldeleted text end new text begin The office may direct an applicant
tonew text end include the following informationdeleted text begin , if applicabledeleted text end new text begin in an application to obtain or renew a
cannabis licensenew text end :

(1) the name, address, and date of birth of the applicant;

(2) the disclosure of ownership and control required under paragraph (b);

(3) the disclosure of whether the applicant or, if the applicant is a business, any officer,
director, manager, and general partner of the business has ever filed for bankruptcy;

(4) the address and legal property description of the businessnew text begin , if applicable, except an
applicant is not required to secure a physical premises for the business at the time of
applicationnew text end ;

(5) a general description of the location or locations that the applicant plans to operate,
including the planned square feet of planned space for cultivation, wholesaling, and retailing,
as applicable;

(6) a copy of the security plan;

(7) proof of trade name registration;

(8) a copy of the applicant's business plan showing the expected size of the business;
anticipated growth; the methods of record keeping; the knowledge and experience of the
applicant and any officer, director, manager, and general partner of the business; the
environmental plan; and other relevant financial and operational components;

(9) an attestation signed by a bona fide labor organization stating that the applicant has
entered into a labor peace agreement;

(10) certification that the applicant will comply with the requirements of this chapter
relating to the ownership and operation of a cannabis business;

(11) identification of one or more controlling persons or managerial employees as agents
who shall be responsible for dealing with the office on all matters; and

(12) a statement that the applicant agrees to respond to the office's supplemental requests
for information.

(b) An applicant must file and update as necessary a disclosure of ownership and control.
The office by rule shall establish the contents and form of the disclosure. Except as provided
in paragraph (f), the disclosure shall, at a minimum, include the following:

(1) the management structure, ownership, and control of the applicant or license holder,
including the name of each cooperative member, officer, director, manager, general partner,
or business entity; the office or position held by each person; each person's percentage
ownership interest, if any; and, if the business has a parent company, the name of each
owner, board member, and officer of the parent company and the owner's, board member's,
or officer's percentage ownership interest in the parent company and the cannabis business;

(2) a statement from the applicant and, if the applicant is a business, from every officer,
director, manager, and general partner of the business, indicating whether that person has
previously held, or currently holds, an ownership interest in a cannabis business in Minnesota,
any other state or territory of the United States, or any other country;

(3) if the applicant is a corporation, copies of the applicant's articles of incorporation
and bylaws and any amendments to the applicant's articles of incorporation or bylaws;

(4) copies of any partnership agreement, operating agreement, or shareholder agreement;

(5) copies of any promissory notes, security instruments, or other similar agreements;

(6) an explanation detailing the funding sources used to finance the business;

(7) a list of operating and investment accounts for the business, including any applicable
financial institution and account number; and

(8) a list of each outstanding loan and financial obligation obtained for use in the business,
including the loan amount, loan terms, and name and address of the creditor.

(c) An application may include:

(1) proof that the applicant is a social equity applicant;

(2) a description of the training and education that will be provided to any employee;
or

(3) a copy of business policies governing operations to ensure compliance with this
chapter.

(d) Commitments made by an applicant in its application, including but not limited to
the maintenance of a labor peace agreement, shall be an ongoing material condition of
maintaining and renewing the license.

(e) An application on behalf of a corporation or association shall be signed by at least
two officers or managing agents of that entity.

(f) The office maydeleted text begin ,deleted text end by ruledeleted text begin ,deleted text end establish exceptions to the disclosures required under
paragraph (b) for members of a cooperative who hold less than a five percent ownership
interest in the cooperative.

Subd. 2.

Application; process.

(a) An applicant must submit all required information
to the office on the forms and in the manner prescribed by the office.

(b) If the office receives an application that fails to provide the required information,
the office shall issue a deficiency notice to the applicant. The applicant shall have ten
business days from the date of the deficiency notice to submit the required information.

(c) Failure by an applicant to submit all required information will result in the application
being rejected.

deleted text begin (d) Upon receipt of a completed application and fee, the office shall forward a copy of
the application to the local unit of government in which the business operates or intends to
operate with a form for certification as to whether a proposed cannabis business complies
with local zoning ordinances and, if applicable, whether the proposed business complies
with the state fire code and building code.
 deleted text end

deleted text begin (e)deleted text end new text begin (d)new text end Within 90 days of receiving a completed application and the results of any required
criminal history check, the office shall issue the appropriate license or send the applicant a
notice of rejection setting forth specific reasons that the office did not approve the application.

new text begin Subd. 3. new text end

new text begin License revocation. new text end

new text begin The office may revoke a cannabis business license if the
licensee has not made good faith efforts to obtain an endorsement within 18 months of the
date that the license was issued. The office may give a licensee a onetime extension to obtain
an endorsement if the licensee demonstrates that the licensee made good faith efforts to
obtain an endorsement within 18 months of the date that the license was issued.
 new text end

Sec. 57.

Minnesota Statutes 2023 Supplement, section 342.15, subdivision 1, is amended
to read:


Subdivision 1.

Criminal history check.

(a) Upon request by the office, every license
applicantnew text begin , license holder,new text end or, in the case of a business entity, every new text begin individual responsible
for conducting the affairs of the entity, including but not limited to every owner and every
new text end cooperative member or director, manager, and general partner of the business entity, for a
cannabis business license, deleted text begin or in the case of a business entity, every cooperative member or
director, manager, and general partner of the business entity, and prospective cannabis
workerdeleted text end must submit a completed criminal history records check consent form, a full set of
classifiable fingerprints, and the required fees to the office. Upon receipt of this information,
the office must submit the completed criminal history records check consent form, full set
of classifiable fingerprints, and required fees to the Bureau of Criminal Apprehension.

new text begin (b) new text end After receiving this information, the bureau must conduct a deleted text begin Minnesotadeleted text end new text begin statenew text end criminal
history records check of deleted text begin the license applicant or prospective cannabis workerdeleted text end new text begin an individual
identified in paragraph (a)new text end . The bureau may exchange deleted text begin a license applicant's or prospective
cannabis worker'sdeleted text end new text begin an individual'snew text end fingerprints with the Federal Bureau of Investigation to
obtain the deleted text begin license applicant's or prospective cannabis worker'sdeleted text end national criminal history
record informationnew text begin of the individualnew text end . The bureau must return the results of the deleted text begin Minnesotadeleted text end new text begin
statenew text end and federal criminal history records checks to the office to determine if the deleted text begin license
applicant or prospective cannabis workerdeleted text end new text begin individualnew text end is disqualified under rules adopted
pursuant to this section.

deleted text begin (b)deleted text end new text begin (c) new text end The office may, by rule, establish exceptions to the requirement under deleted text begin paragraphdeleted text end new text begin
paragraphsnew text end (a) new text begin and (b) new text end for members of a cooperative who hold less than a five percent
ownership interest in the cooperative.

Sec. 58.

Minnesota Statutes 2023 Supplement, section 342.15, subdivision 2, is amended
to read:


Subd. 2.

Criminal offenses; disqualifications.

The office may by rule determine whether
any felony convictions deleted text begin shalldeleted text end new text begin , including but not limited to convictions for noncannabis
controlled substance crimes in the first or second degree, human trafficking, labor trafficking,
fraud, or financial crimes,new text end disqualify deleted text begin a persondeleted text end new text begin an individualnew text end from holding or receiving a
cannabis business license issued under this chapter or working for a cannabis business, and
the length of any such disqualification. In adopting rules pursuant to this subdivision, the
office shall not disqualify deleted text begin a persondeleted text end new text begin an individualnew text end for a violation of section 152.025.

Sec. 59.

Minnesota Statutes 2023 Supplement, section 342.15, is amended by adding a
subdivision to read:


new text begin Subd. 5. new text end

new text begin Civil and regulatory offenses; disqualifications. new text end

new text begin The office may determine
whether any civil or regulatory violations, as determined by another state agency, local unit
of government, or any other jurisdiction, disqualify an individual from holding or receiving
a cannabis business license issued under this chapter or disqualify an individual from working
for a cannabis business, and the length of the disqualification. Upon the office's request, a
state agency, as defined in section 13.02, subdivision 17, may release civil investigative
data, including data classified as protected nonpublic or confidential under section 13.39,
subdivision 2, if the request is related to a specific applicant and the data is necessary to
make a determination under this section.
 new text end

Sec. 60.

new text begin [342.151] EMPLOYEES OF LICENSE HOLDERS.
 new text end

new text begin Subdivision 1. new text end

new text begin Criminal history check. new text end

new text begin A license holder may employ or contract with
as many unlicensed individuals as may be necessary, provided that the license holder is at
all times accountable for the good conduct of every individual employed by or contracted
with the license holder. Before hiring an individual as a cannabis worker, the license holder
must submit to the Bureau of Criminal Apprehension the individual's full set of fingerprints
and written consent for the bureau to conduct a state and national criminal history check.
The bureau may exchange an individual's fingerprints with the Federal Bureau of
Investigation. The Bureau of Criminal Apprehension must determine whether the individual
is qualified to be employed as a cannabis worker and must notify the license holder of the
bureau's determination. The license holder must not employ an individual who is disqualified
from being employed as a cannabis worker.
 new text end

new text begin Subd. 2. new text end

new text begin Disqualification. new text end

new text begin (a) A license holder must not employ an individual as a
cannabis worker if the individual has been convicted of any of the following crimes that
would constitute a felony:
 new text end

new text begin (1) human trafficking;
 new text end

new text begin (2) noncannabis controlled substance crimes in the first or second degree;
 new text end

new text begin (3) labor trafficking;
 new text end

new text begin (4) fraud;
 new text end

new text begin (5) embezzlement;
 new text end

new text begin (6) extortion;
 new text end

new text begin (7) money laundering; or
 new text end

new text begin (8) insider trading;
 new text end

new text begin if committed in this state or any other jurisdiction for which a full pardon or similar relief
has not been granted.
 new text end

new text begin (b) A license holder must not employ an individual as a cannabis worker if the individual
made any false statement in an application for employment.
 new text end

Sec. 61.

Minnesota Statutes 2023 Supplement, section 342.17, is amended to read:


342.17 SOCIAL EQUITY APPLICANTS.

(a) An applicant qualifies as a social equity applicant if the applicant:

(1) was convicted of an offense involving the possession or sale of cannabis or marijuana
prior to May 1, 2023;

(2) had a parent, guardian, child, spouse, or dependent who was convicted of an offense
involving the possession or sale of cannabis or marijuana prior to May 1, 2023;

(3) was a dependent of an individual who was convicted of an offense involving the
possession or sale of cannabis or marijuana prior to May 1, 2023;

(4) is a new text begin military veteran, including status as a new text end service-disabled veteran, current or former
member of the national guarddeleted text begin , ordeleted text end new text begin ;
new text end

new text begin (5)new text end any military veteran or current or former member of the national guard who lost
honorable status due to an offense involving the possession or sale of new text begin cannabis or new text end marijuana;

deleted text begin (5)deleted text end new text begin (6)new text end has been a resident for the last five years of one or more subareas, such as census
tracts or neighborhoods, that experienced a disproportionately large amount of cannabis
enforcement as determined by the study conducted by the office pursuant to section 342.04,
paragraph (b), and reported in the preliminary report, final report, or both;

deleted text begin (6) is an emerging farmer as defined in section 17.055, subdivision 1; or
 deleted text end

new text begin (7) is currently a farmer or an aspiring cannabis farmer who faces barriers to education
or employment; or
 new text end

deleted text begin (7)deleted text end new text begin (8)new text end has been a resident for the last five years of one or more census tracts where, as
reported in the most recently completed decennial census published by the United States
Bureau of the Census, either:

(i) the poverty rate was 20 percent or more; or

(ii) the median family income did not exceed 80 percent of statewide median family
income or, if in a metropolitan area, did not exceed the greater of 80 percent of the statewide
median family income or 80 percent of the median family income for that metropolitan
area.

(b) The qualifications described in paragraph (a) apply to each individual applicant or,
in the case of a business entity, deleted text begin every cooperative member or director, manager, and general
partnerdeleted text end new text begin apply to at least 65 percent of the controlling ownershipnew text end of the business entity.

Sec. 62.

new text begin [342.175] SOCIAL EQUITY LICENSE CLASSIFICATION.
 new text end

new text begin Subdivision 1. new text end

new text begin Social equity license classification. new text end

new text begin (a) The office must make a social
equity classification available to a social equity applicant under section 342.17.
 new text end

new text begin (b) The office must classify any type of license under section 342.10 as a social equity
license if the license is held by a social equity applicant.
 new text end

new text begin Subd. 2. new text end

new text begin Social equity applicants; temporary licenses. new text end

new text begin After accepting and reviewing
an application for a license from a social equity applicant, the office may issue a temporary
license according to section 342.125 to the social equity applicant.
 new text end

Sec. 63.

Minnesota Statutes 2023 Supplement, section 342.18, subdivision 3, is amended
to read:


Subd. 3.

Application deleted text begin score; license prioritydeleted text end new text begin reviewnew text end .

(a) The office shall deleted text begin award points
todeleted text end new text begin reviewnew text end each completed application for a license to operate a cannabis business in the
following categories:

deleted text begin (1) status as a social equity applicant or as an applicant who is substantially similar to
a social equity applicant as described in paragraph (c);
 deleted text end

deleted text begin (2) status as a veteran or retired national guard applicant who does not meet the definition
of social equity applicant;
 deleted text end

deleted text begin (3)deleted text end new text begin (1)new text end security and record keeping;

deleted text begin (4)deleted text end new text begin (2)new text end employee training plan;

deleted text begin (5)deleted text end new text begin (3)new text end business plan and financial situation;

deleted text begin (6)deleted text end new text begin (4)new text end labor and employment practices;

deleted text begin (7)deleted text end new text begin (5)new text end knowledge and experience; and

deleted text begin (8)deleted text end new text begin (6)new text end environmental plan.

deleted text begin (b) The office may award additional points to an application if the license holder would
expand service to an underrepresented market, including but not limited to participation in
the medical cannabis program.
 deleted text end

deleted text begin (c) The office shall establish application materials permitting individual applicants to
demonstrate the impact that cannabis prohibition has had on that applicant, including but
not limited to the arrest or imprisonment of the applicant or a member of the applicant's
immediate family, and the office may award points to such applicants in the same manner
as points are awarded to social equity applicants.
 deleted text end

deleted text begin (d)deleted text end new text begin (b)new text end The office shall new text begin by rule new text end establish policies and guidelines, which new text begin the office new text end must
deleted text begin be madedeleted text end new text begin makenew text end available to the public, regarding the deleted text begin number of points availabledeleted text end new text begin minimum
qualificationsnew text end in each category and the deleted text begin basis for awarding those points. Status as a social
equity applicant must account for at least 20 percent of the total available points. In
determining the number of points to award to a cooperative or business applying as a social
equity applicant, the office shall consider the number or ownership percentage of cooperative
members, officers, directors, managers, and general partners who qualify as social equity
applicantsdeleted text end new text begin criteria that the office uses to determine whether an applicant meets the minimum
qualifications in each categorynew text end .

deleted text begin (e) Consistent with the goals identified in subdivision 1, the office shall issue licenses
in each license category, giving priority to applicants who receive the highest score under
paragraphs (a) and (b). If there are insufficient licenses available for entities that receive
identical scores, the office shall utilize a lottery to randomly select license recipients from
among those entities.
 deleted text end

Sec. 64.

Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a
subdivision to read:


new text begin Subd. 4. new text end

new text begin Maximum number of licenses. new text end

new text begin (a) Through as many licensing periods as the
office deems necessary, the office shall issue no more than the maximum number of licenses
in each license category listed in paragraphs (e) and (f) to applicants that meet the minimum
qualifications in subdivision 3. After 24 months from the beginning of the license application
process, the office may adjust the maximum number of licenses of any type listed in this
subdivision based on market demand, consistent with the objectives in section 342.02,
subdivision 1, and the annual report required under section 342.04, paragraph (f).
 new text end

new text begin (b) If there are insufficient licenses available for all applicants that meet the minimum
qualifications in subdivision 3, the office shall hold a lottery to randomly select license
recipients from among the applicants. The office may issue as many licenses as the office
deems necessary of a license type that is not listed in this subdivision. The office is not
required to issue a license for a license type that is not listed in this subdivision.
 new text end

new text begin (c) Cannabis microbusiness and cannabis mezzobusiness license holders with a retail
endorsement must obtain at least one other endorsement for authorized actions under the
license category within 18 months of license issuance or the office may revoke the license
holder's license or take appropriate enforcement action.
 new text end

new text begin (d) The office is not required to issue licenses to meet the maximum number of licenses
that may be issued under paragraphs (e) and (f).
 new text end

new text begin (e) For licenses that are available to social equity applicants, the maximum number of
licenses that the office may issue are:
 new text end

new text begin (1) cultivator licenses, 25;
 new text end

new text begin (2) product manufacturer licenses, 12;
 new text end

new text begin (3) retailer licenses, 100; and
 new text end

new text begin (4) cannabis mezzobusiness licenses, 22.
 new text end

new text begin (f) For licenses that are available to all applicants, the maximum number of licenses that
the office may issue are:
 new text end

new text begin (1) cultivator licenses, 25;
 new text end

new text begin (2) product manufacturer licenses, 12;
 new text end

new text begin (3) retailer licenses, 100; and
 new text end

new text begin (4) cannabis mezzobusiness licenses, 22.
 new text end

Sec. 65.

Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a
subdivision to read:


new text begin Subd. 5. new text end

new text begin Conversion to hemp business license. new text end

new text begin (a) After the office adopts initial rules
pertaining to cannabis, the office may permit a holder of a hemp-derived cannabinoid
business registration pursuant to section 151.72 to convert the holder's registration to a
comparable lower-potency hemp edible business license if:
 new text end

new text begin (1) the registration was active before the office adopted initial rules pertaining to cannabis;
 new text end

new text begin (2) the registrant submits documentation to the office sufficient to meet the minimum
requirements in section 342.44;
 new text end

new text begin (3) the registrant pays an application and licensing fee as required by section 342.11;
and
 new text end

new text begin (4) the registrant is in good standing with the state.
 new text end

new text begin (b) A registrant with an active hemp-derived cannabinoid business registration pursuant
to section 151.72 may continue operations under an active registration for no more than 30
days after the office begins accepting applications for a lower-potency hemp edible business
license.
 new text end

new text begin (c) Upon the submission of an application for a lower-potency hemp edible business
license to the office, a registrant's hemp-derived cannabinoid business registration shall
remain active until the office makes a determination regarding the registrant's application,
as long as the registrant remains in good standing with the state.
 new text end

Sec. 66.

Minnesota Statutes 2023 Supplement, section 342.19, subdivision 1, is amended
to read:


Subdivision 1.

Authority to inspect.

(a) In order to carry out the purposes of this chapter,
the office, upon presenting appropriate credentials to the owner, operator, or agent in charge,
is authorized to:

(1) enter deleted text begin any cannabis business or hemp businessdeleted text end new text begin the place of business of any cannabis
business, hemp business, or business engaged in the cultivation, manufacture, or retail sale
of cannabis without a license under this chapternew text end without delay and at reasonable times;

(2) inspect and investigate during regular working hours and at other reasonable times,
within reasonable limits and in a reasonable manner, deleted text begin any cannabis business or hemp businessdeleted text end new text begin
the place of business of any cannabis business, hemp business, or business engaged in the
cultivation, manufacture, or retail sale of cannabis without a license under this chapternew text end and
all relevant conditions, equipment, records, and materials therein; and

(3) question privately any employer, owner, operator, agent, or employee of deleted text begin a cannabis
business or hemp businessdeleted text end new text begin any cannabis business, hemp business, or business engaged in
the cultivation, manufacture, or retail sale of cannabis without a license under this chapternew text end .

(b) An employer, owner, operator, agent, or employee must not refuse the office entry
or otherwise deter or prohibit the office from taking action under paragraph (a).

Sec. 67.

Minnesota Statutes 2023 Supplement, section 342.19, subdivision 3, is amended
to read:


Subd. 3.

Aiding of inspection.

Subject to rules issued by the office, a representative of
a deleted text begin cannabis business or hemp business shalldeleted text end new text begin business participating in the cannabis industry
or hemp consumer industry mustnew text end be given an opportunity to accompany the office during
the physical inspection of deleted text begin any cannabis business or hempdeleted text end new text begin thenew text end business for the purpose of
aiding such inspection.

Sec. 68.

Minnesota Statutes 2023 Supplement, section 342.19, subdivision 4, is amended
to read:


Subd. 4.

Complaints and reports; priority of inspection.

(a) The office may conduct
inspections of any deleted text begin licensed cannabis business or hemp businessdeleted text end new text begin cannabis business, hemp
business, or a business engaged in the cultivation, manufacture, or retail sale of cannabis
without a license under this chapternew text end at any time to ensure compliance with the ownership
and operation requirements of this chapter.

(b) Any person may report a suspected violation of a safety or health standard. If upon
receipt of such notification the office determines that there are reasonable grounds to believe
that such violation or danger exists, the office shall make a special inspection as soon as
practicable to determine if such danger or violation exists.

(c) The office shall prioritize inspections deleted text begin of cannabis businesses and hemp businessesdeleted text end
where there are reasonable grounds to believe that a violation new text begin by a person or business new text end poses
imminent danger to the public or customers. Inspections must take place within one business
day of the receipt of a credible report.

(d) The office shall promptly inspect deleted text begin cannabis businesses and hemp businessesdeleted text end new text begin the place
of business of any cannabis business, hemp business, or a business engaged in the cultivation,
manufacture, or retail sale of cannabis without a license under this chapternew text end that deleted text begin aredeleted text end new text begin isnew text end the
subject of complaint by a local unit of government.

Sec. 69.

Minnesota Statutes 2023 Supplement, section 342.19, subdivision 5, is amended
to read:


Subd. 5.

Violations; administrative orders and penalties.

(a) The office may issue an
administrative order to any deleted text begin licensed cannabis business or hemp businessdeleted text end new text begin cannabis business,
hemp business, or a business engaged in the cultivation, manufacture, or retail sale of
cannabis without a license under this chapternew text end that the office determines has committed a
violation of this chapter or rules adopted pursuant to this chapter. The administrative order
may require the business to correct the violation or to cease and desist from committing the
violation. The order must state the deficiencies that constitute the violation and the time by
which the violation must be corrected. If the business believes that the information in the
administrative order is in error, the business may ask the office to consider the parts of the
order that are alleged to be in error. The request must be in writing, delivered to the office
by certified mail within seven days after receipt of the order, and provide documentation
to support the allegation of error. The office must respond to a request for reconsideration
within 15 days after receiving the request. A request for reconsideration does not stay the
correction order unless the office issues a supplemental order granting additional time. The
office's disposition of a request for reconsideration is final.

(b) For each violation of this chapter or rules adopted pursuant to this chapter, the office
may issue to each deleted text begin cannabis business or hempdeleted text end new text begin individual ornew text end business a monetary penalty of
up to $10,000, an amount that deprives the new text begin individual or new text end business of any economic advantage
gained by the violation, or both.

(c) An administrative penalty may be recovered in a civil action in the name of the state
brought in the district court of the county where the violation is alleged to have occurred
or the district court where the office is housed.

(d) In addition to penalties listed in this subdivision, a person or business who violates
the provisions of this chapter is subject to any applicable criminal penalty.

Sec. 70.

Minnesota Statutes 2023 Supplement, section 342.22, is amended to read:


342.22 RETAILERS; LOCAL REGISTRATION AND ENFORCEMENT.

Subdivision 1.

Registration required.

Before new text begin receiving a retail operations endorsement
and new text end making retail sales to customers or patients, a cannabis microbusiness deleted text begin with a retail
operations endorsementdeleted text end , cannabis mezzobusiness deleted text begin with a retail operations endorsementdeleted text end ,
cannabis retailer, deleted text begin medical cannabis retailer,deleted text end medical cannabis combination business, or
lower-potency hemp edible retailer must register with the city, town, or county in which
the retail establishment is located. A county may issue a registration in cases where a city
or town has provided consent for the county to issue the registration for the jurisdiction.

Subd. 2.

Registration fee.

(a) A local unit of government may impose an initial retail
registration fee of $500 or up to half the amount of the applicable initial license fee under
section 342.11, whichever is less. The local unit of government may also impose a renewal
retail registration fee of $1,000 or up to half the amount of the applicable renewal license
fee under section 342.11, whichever is less. The initial registration fee shall include the fee
for initial registration and the first annual renewal. Any renewal fee imposed by the local
unit of government shall be charged at the time of the second renewal and each subsequent
annual renewal thereafter.

(b) The local unit of government may not charge an application fee.

deleted text begin (c) A cannabis business with a cannabis retailer license and a medical cannabis retailer
license for the same location may only be charged a single registration fee.
 deleted text end

deleted text begin (d)deleted text end new text begin (c)new text end Registration fees are nonrefundable.

Subd. 3.

Issuance of registration.

(a) A local unit of government shall issue a retail
registration to a cannabis microbusiness with a retail operations endorsement, cannabis
mezzobusiness with a retail operations endorsement, cannabis retailer, deleted text begin medical cannabis
retailer,deleted text end or lower-potency hemp edible retailer that:

(1) has deleted text begin a valid license issueddeleted text end new text begin an application that has been approvednew text end by the office;

(2) has paid the registration fee or renewal fee pursuant to subdivision 2;

(3) is found to be in compliance with the requirements of this chapter at any preliminary
compliance check that the local unit of government performs; and

(4) if applicable, is current on all property taxes and assessments at the location where
the retail establishment is located.

(b) Before issuing a retail registration, the local unit of government may conduct a
preliminary compliance check to ensure that the cannabis business or hemp business is in
compliance with deleted text begin thedeleted text end new text begin anynew text end applicable deleted text begin operation requirements and the limits on the types of
cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products that may be solddeleted text end new text begin local ordinance established pursuant to section 342.13new text end .

(c) A local unit of government shall renew the retail registration of a cannabis business
or hemp business when the office renews the license of the cannabis business or hemp
business.

(d) A retail registration issued under this section may not be transferred.

Subd. 4.

Compliance checks.

(a) A local unit of government shall conduct compliance
checks of every cannabis business and hemp business with a retail registration issued by
the local unit of government. deleted text begin The checksdeleted text end new text begin During a compliance check, a local unit of
governmentnew text end shall assess new text begin a business's new text end compliance with age verification requirementsdeleted text begin , thedeleted text end new text begin
and compliance with anynew text end applicable deleted text begin operation requirements, and the applicable limits on
the types of cannabis flower, cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products being solddeleted text end new text begin local ordinance established pursuant to section
342.13new text end .

(b) deleted text begin Thedeleted text end new text begin Anew text end local unit of government must conduct unannounced age verification
compliance checks new text begin of every cannabis business and hemp business new text end at least once each calendar
year. Age verification compliance checks must involve persons at least 17 years of age but
under the age of 21 who, with the prior written consent of a parent or guardian if the person
is under the age of 18, attempt to purchase adult-use cannabis flower, adult-use cannabis
products, lower-potency hemp edibles, or hemp-derived consumer products under the direct
supervision of a law enforcement officer or an employee of the local unit of government.

deleted text begin (c) Checks to ensure compliance with the applicable operation requirements and the
limits on the types of cannabis flower, cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products that may be sold must be performed at least once each
calendar year and may be performed by a law enforcement officer or an employee of the
local unit of government.
 deleted text end

Subd. 5.

Registration suspension and cancellation; notice to office; penalties.

(a) If
a local unit of government determines that a cannabis business or hemp business with a
retail registration issued by the local unit of government is not operating in compliance with
the requirements of deleted text begin this chapterdeleted text end new text begin a local ordinance authorized under section 342.13new text end or that
the operation of the business poses an immediate threat to the health or safety of the public,
the local unit of government may suspend the retail registration of the cannabis business or
hemp business. The local unit of government must immediately notify the office of the
suspension and shall include a description of the grounds for the suspension.

(b) The office shall review the retail registration suspension and may order reinstatement
of the retail registration or take any action described in section 342.19 or 342.21.

(c) The retail registration suspension must be for up to 30 days unless the office suspends
the license and operating privilege of the cannabis business or hemp business for a longer
period or revokes the license.

(d) The local unit of government may reinstate the retail registration if the local unit of
government determines that any violation has been cured. The local unit of government
must reinstate the retail registration if the office orders reinstatement.

(e) No cannabis microbusiness deleted text begin with a retail operations endorsementdeleted text end , cannabis
mezzobusiness deleted text begin with a retail operations endorsementdeleted text end , cannabis retailer, deleted text begin medical cannabis
retailer,deleted text end medical cannabis combination business, or lower-potency hemp edible retailer may
make any sale to a customer or patient without a valid retail registrationnew text begin with a local unit
of government and a valid endorsement from the officenew text end . A local unit of government may
impose a civil penalty of up to $2,000 for each violation of this paragraph.

Sec. 71.

Minnesota Statutes 2023 Supplement, section 342.24, subdivision 1, is amended
to read:


Subdivision 1.

Individuals under 21 years of age.

(a) A cannabis business may not
employ an individual under 21 years of age and may not contract with an individual under
21 years of age if the individual's scope of work involves the handling of cannabis plants,
cannabis flower, artificially derived cannabinoids, or cannabinoid products.

(b) A cannabis business may not permit an individual under 21 years of age to enter the
business premises other than entry by a deleted text begin patientdeleted text end new text begin personnew text end enrolled in the registry program.

(c) A cannabis business may not sell or give cannabis flower, cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products to an individual under
21 years of age unless the individual is deleted text begin a patient; registered designated caregiver; or a parent,
legal guardian, or spouse of a patient who is authorized to use, possess, or transport medical
cannabis flower or medical cannabinoid productsdeleted text end new text begin enrolled in the patient registry program
and the cannabis business holds a medical cannabis retail endorsementnew text end .

Sec. 72.

Minnesota Statutes 2023 Supplement, section 342.24, subdivision 2, is amended
to read:


Subd. 2.

Use of cannabis flower and products within a licensed cannabis business.

(a)
A cannabis business may not permit an individual who is not an employee to consume
cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer
products within its licensed premises unless the business is licensed to permit on-site
consumption.

(b) Except as otherwise provided in this subdivision, a cannabis business may not permit
an employee to consume cannabis flower, cannabis products, lower-potency hemp edibles,
or hemp-derived consumer products within its licensed premises or while the employee is
otherwise engaged in activities within the course and scope of employment.

(c) A cannabis business may permit an employee to use deleted text begin medicaldeleted text end cannabis flower and
deleted text begin medicaldeleted text end cannabinoid products if that individual is a patientnew text begin enrolled in the registry program
and consuming cannabis as prescribednew text end .

(d) For quality control, employees of a licensed cannabis business may sample cannabis
flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products.
Employees may not interact directly with customers for at least three hours after sampling
a product. Employees may not consume more than three samples in a single 24-hour period.
All samples must be recorded in the statewide monitoring system.

Sec. 73.

Minnesota Statutes 2023 Supplement, section 342.28, is amended by adding a
subdivision to read:


new text begin Subd. 1a. new text end

new text begin Cannabis research. new text end

new text begin A cannabis researcher employed by or affiliated with
institutions of higher education that are regionally or nationally accredited may apply for a
cannabis microbusiness license to conduct cannabis crop research. A cannabis researcher
with a cannabis microbusiness license may perform activities identified in subdivision 1,
clauses (1) to (9) and (13). Cannabis grown for research purposes must not be offered for
sale or otherwise enter the stream of commerce.
 new text end

Sec. 74.

Minnesota Statutes 2023 Supplement, section 342.28, subdivision 2, is amended
to read:


Subd. 2.

Size limitations.

(a) A cannabis microbusiness that cultivates cannabis at an
indoor facility may cultivate up to 5,000 square feet of plant canopy. The office may adjust
plant canopy limits upward new text begin or downward but not below 5,000 square feet new text end to meet market
demand consistent with the goals identified in section 342.02, subdivision 1.

(b) A cannabis microbusiness that cultivates cannabis at an outdoor location may cultivate
up to one-half acre deleted text begin of mature, flowering plants unless the office increases that limit. The
office may increase the limit to no more than one acre if the office determines that expansion
isdeleted text end new text begin . The office may adjust size limits upward or downward but not below one-half acre to
meet market demandnew text end consistent with the goals identified in section 342.02, subdivision 1.

(c) The office shall establish a limit on the manufacturing of cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products a cannabis microbusiness
that manufactures such products may perform. The limit must be equivalent to the amount
of cannabis flower that can be harvested from a facility with a plant canopy of 5,000 square
feet in a year, but may be increased if the office expands the allowable area of cultivation
under paragraph (a).

(d) A cannabis microbusiness with the appropriate endorsement may operate one retail
location.

Sec. 75.

Minnesota Statutes 2023 Supplement, section 342.29, subdivision 1, is amended
to read:


Subdivision 1.

Authorized actions.

A cannabis mezzobusiness license, consistent with
the specific license endorsement or endorsements, entitles the license holder to perform any
or all of the following within the limits established by this section:

(1) grow cannabis plants from seed or immature plant to mature plant and harvest
cannabis flower from a mature plant for use as adult-use cannabis flower or for use in
adult-use cannabis products;

deleted text begin (2) grow cannabis plants from seed or immature plant to mature plant and harvest
cannabis flower from a mature plant for use as medical cannabis flower or for use in medical
cannabinoid products;
 deleted text end

deleted text begin (3)deleted text end new text begin (2)new text end make cannabis concentrate;

deleted text begin (4)deleted text end new text begin (3)new text end make hemp concentrate, including hemp concentrate with a delta-9
tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

deleted text begin (5)deleted text end new text begin (4)new text end manufacture artificially derived cannabinoids;

deleted text begin (6)deleted text end new text begin (5)new text end manufacture adult-use cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products for public consumption;

deleted text begin (7)deleted text end new text begin (6) manufacture andnew text end process deleted text begin medicaldeleted text end cannabinoid products;

deleted text begin (8)deleted text end new text begin (7)new text end purchase immature cannabis plants and seedlings and cannabis flower from a
cannabis microbusiness, another cannabis mezzobusiness, a cannabis manufacturer, or a
cannabis wholesaler;

deleted text begin (9)deleted text end new text begin (8)new text end purchase cannabis concentrate, hemp concentrate, and synthetically derived
cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis
manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products;

deleted text begin (10)deleted text end new text begin (9)new text end purchase hemp plant parts and propagules from a licensed hemp grower licensed
under chapter 18K;

deleted text begin (11)deleted text end new text begin (10)new text end purchase hemp concentrate from an industrial hemp processor licensed under
chapter 18K;

deleted text begin (12)deleted text end new text begin (11)new text end package and label adult-use cannabis flower, adult-use cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;

deleted text begin (13)deleted text end new text begin (12)new text end sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
other products authorized by law to other cannabis businesses and to customers; and

deleted text begin (14)deleted text end new text begin (13)new text end perform other actions approved by the office.

Sec. 76.

Minnesota Statutes 2023 Supplement, section 342.29, subdivision 4, is amended
to read:


Subd. 4.

Multiple licenses; limits.

(a) A person, cooperative, or business holding a
cannabis mezzobusiness license may also hold a cannabis event organizer license deleted text begin and a
medical cannabis retailer licensedeleted text end .

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a
cannabis mezzobusiness license may own or operate any other cannabis business or hemp
business or hold more than one cannabis mezzobusiness license.

(c) For purposes of this subdivision, a restriction on the number or type of license that
a business may hold applies to every cooperative member or every director, manager, and
general partner of a cannabis business.

Sec. 77.

Minnesota Statutes 2023 Supplement, section 342.30, subdivision 4, is amended
to read:


Subd. 4.

Multiple licenses; limits.

(a) A person, cooperative, or business holding a
cannabis cultivator license may also hold a cannabis manufacturing license, deleted text begin medical cannabis
cultivator license,deleted text end medical cannabis producer license, license to grow industrial hemp, and
cannabis event organizer license.

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a
cannabis cultivator license may own or operate any other cannabis business or hemp business.
This prohibition does not prevent the transportation of cannabis flower from a cannabis
cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business
and located on the same premises.

(c) The office by rule may limit the number of cannabis cultivator licenses a person,
cooperative, or business may hold.

(d) For purposes of this subdivision, a restriction on the number or type of license a
business may hold applies to every cooperative member or every director, manager, and
general partner of a cannabis business.

Sec. 78.

Minnesota Statutes 2023 Supplement, section 342.31, subdivision 4, is amended
to read:


Subd. 4.

Multiple licenses; limits.

(a) A person, cooperative, or business holding a
cannabis manufacturer license may also hold a cannabis cultivator licensedeleted text begin , a medical cannabis
cultivator license, a medical cannabis processor license,deleted text end and a cannabis event organizer
license.

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a
cannabis manufacturer license may own or operate any other cannabis business or hemp
business. This prohibition does not prevent transportation of cannabis flower from a cannabis
cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business
and located on the same premises.

(c) The office by rule may limit the number of cannabis manufacturer licenses that a
person or business may hold.

(d) For purposes of this subdivision, a restriction on the number or type of license that
a business may hold applies to every cooperative member or every director, manager, and
general partner of a cannabis business.

Sec. 79.

Minnesota Statutes 2023 Supplement, section 342.32, subdivision 4, is amended
to read:


Subd. 4.

Multiple licenses; limits.

(a) A person, cooperative, or business holding a
cannabis retailer license may also hold a cannabis delivery service licensedeleted text begin , a medical cannabis
retailer license,deleted text end and a cannabis event organizer license.

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a
cannabis retailer license may own or operate any other cannabis business or hemp business.

(c) No person, cooperative, or business may hold a license to own or operate more than
one cannabis retail business in one city and three retail businesses in one county.

(d) The office by rule may limit the number of cannabis retailer licenses a person,
cooperative, or business may hold.

(e) For purposes of this subdivision, a restriction on the number or type of license a
business may hold applies to every cooperative member or every director, manager, and
general partner of a cannabis business.

Sec. 80.

Minnesota Statutes 2023 Supplement, section 342.35, subdivision 1, is amended
to read:


Subdivision 1.

Authorized actions.

A cannabis transporter license entitles the license
holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis
products, artificially derived cannabinoids, hemp plant parts, hemp concentrate,
lower-potency hemp edibles, and hemp-derived consumer products from cannabis
microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,
cannabis wholesalers, lower-potency hemp edible manufacturers, deleted text begin medical cannabis retailers,
medical cannabis processors,deleted text end and industrial hemp growers to cannabis microbusinesses,
cannabis mezzobusinesses, cannabis manufacturers, cannabis testing facilities, cannabis
wholesalers, cannabis retailers, lower-potency hemp edible retailers, deleted text begin medical cannabis
processors, medical cannabis retailers,deleted text end and medical cannabis combination businesses and
perform other actions approved by the office.

Sec. 81.

Minnesota Statutes 2023 Supplement, section 342.37, subdivision 1, is amended
to read:


Subdivision 1.

Authorized actions.

A cannabis testing facility license entitles the license
holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis
products, hemp plant parts, hemp concentrate, artificially derived cannabinoids,
lower-potency hemp edibles, and hemp-derived consumer products from cannabis
microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,
cannabis wholesalers, lower-potency hemp edible manufacturers, deleted text begin medical cannabis
cultivators, medical cannabis processors,deleted text end medical cannabis combination businesses, and
industrial hemp growers.

Sec. 82.

Minnesota Statutes 2023 Supplement, section 342.40, subdivision 7, is amended
to read:


Subd. 7.

Cannabis event sales.

(a) Cannabis microbusinesses with a retail endorsement,
cannabis mezzobusinesses with a retail endorsement, cannabis retailers, and lower-potency
hemp edible retailers, including the cannabis event organizer, may be authorized to sell
cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency
hemp edibles, and hemp-derived consumer products to customers at a cannabis event.

(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must
take place in a retail area as designated in the premises diagram.

(c) Authorized retailers may only conduct sales within their specifically assigned area.

(d) Authorized retailers must verify the age of all customers pursuant to section 342.27,
subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis
flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer
products to an individual under 21 years of age.

(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use
cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived
consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis
products must be stored in a sample jar or display case and be accompanied by a label or
notice containing the information required to be affixed to the packaging or container
containing adult-use cannabis flower and adult-use cannabis products sold to customers. A
sample may not consist of more than eight grams of adult-use cannabis flower or adult-use
cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams
of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use
cannabis flower or adult-use cannabis product before purchase.

(f) The notice requirements under section 342.27, subdivision 6, apply to authorized
retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products,
and hemp-derived consumer products for sale at a cannabis event.

(g) Authorized retailers may not:

(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp
edibles, or hemp-derived consumer products to a person who is visibly intoxicated;

(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis
products, lower-potency hemp edibles, or hemp-derived consumer products than a customer
is legally permitted to possess;

(3) sell deleted text begin medical cannabis flower or medicaldeleted text end cannabinoid products;

(4) give away cannabis plants, cannabis flower, cannabis products, lower-potency hemp
edibles, or hemp-derived consumer products; or

(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products in vending machines.

(h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis
product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis
plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles,
and hemp-derived consumer products for sale at a cannabis event must be stored in a secure,
locked container that is not accessible to the public. Such items being stored at a cannabis
event shall not be left unattended.

(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis
event must comply with this chapter and rules adopted pursuant to this chapter regarding
the testing, packaging, and labeling of those items.

(j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold,
damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring
system.

Sec. 83.

Minnesota Statutes 2023 Supplement, section 342.41, subdivision 1, is amended
to read:


Subdivision 1.

Authorized actions.

A cannabis delivery service license entitles the
license holder to purchase cannabis flower, cannabis products, lower-potency hemp edibles,
and hemp-derived consumer products from licensed cannabis microbusinesses with a retail
endorsement, cannabis mezzobusinesses with a retail endorsement, cannabis retailers,
deleted text begin medical cannabis retailers,deleted text end and medical cannabis combination businesses; transport and
deliver cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived
consumable products to customers; and perform other actions approved by the office.

Sec. 84.

Minnesota Statutes 2023 Supplement, section 342.41, subdivision 3, is amended
to read:


Subd. 3.

Multiple licenses; limits.

(a) A person, cooperative, or business holding a
cannabis delivery service license may also hold a cannabis retailer license, a cannabis
wholesaler license, a cannabis transporter license, new text begin and new text end a cannabis event organizer licensedeleted text begin ,
and a medical cannabis retailer licensedeleted text end subject to the ownership limitations that apply to
those licenses.

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a
cannabis delivery service license may own or operate any other cannabis business or hemp
business.

(c) The office by rule may limit the number of cannabis delivery service licenses that a
person or business may hold.

(d) For purposes of this subdivision, a restriction on the number or type of license that
a business may hold applies to every cooperative member or every director, manager, and
general partner of a cannabis business.

Sec. 85.

new text begin [342.465] LOWER-POTENCY HEMP EDIBLES; PROHIBITED CONDUCT.
 new text end

new text begin No person may sell, give, furnish, or in any way procure for another person lower-potency
hemp edibles for the use of an obviously impaired person.
 new text end

Sec. 86.

Minnesota Statutes 2023 Supplement, section 342.51, is amended to read:


342.51 MEDICAL CANNABIS deleted text begin RETAILERSdeleted text end new text begin RETAIL ENDORSEMENTnew text end .

Subdivision 1.

Authorized actions.

(a)new text begin The office must issue a medical cannabis retail
endorsement to a cannabis business, if the business:
new text end

new text begin (1) submits a medical cannabis retail endorsement application to the office;
 new text end

new text begin (2) has at least one employee who earned a medical cannabis consultant certificate issued
by the office and has completed the required training or has at least one employee who is
a licensed pharmacist under chapter 151; and
 new text end

new text begin (3) otherwise meets all applicable requirements established by the office.
 new text end

new text begin (b)new text end A medical cannabis deleted text begin retailer licensedeleted text end new text begin retail endorsementnew text end entitles the license holder to
deleted text begin purchase medical cannabis flower and medical cannabinoid products from medical cannabis
cultivators and medical cannabis processors and sell or distribute medical cannabis flower
and medical cannabinoid products to any person authorized to receive medical cannabis
flower or medical cannabinoid products.deleted text end new text begin sell or distribute the following products to any
person enrolled in the medical cannabis patient registry under section 342.52:
new text end

new text begin (1) cannabis plants, cannabis flower, cannabis products, artificially derived cannabinoids,
lower-potency hemp edibles, and hemp-derived consumer products that are a product
category approved by the office and that comply with this chapter and rules adopted pursuant
to this chapter regarding the testing, packaging, and labeling of cannabis plants, cannabis
flower, cannabis products, artificially derived cannabinoids, lower-potency hemp edibles,
and hemp-derived consumer products; and
 new text end

new text begin (2) associated paraphernalia.
 new text end

deleted text begin (b)deleted text end new text begin (c)new text end A medical cannabis deleted text begin retailer licensedeleted text end new text begin retail endorsementnew text end holder must verify that all
deleted text begin medical cannabis flower and medical cannabinoiddeleted text end products new text begin under paragraph (b), clause (1),
new text end have passed safety, potency, and consistency testing at a cannabis testing facility approved
by the office for the testing of deleted text begin medical cannabis flower and medical cannabinoiddeleted text end products
new text begin under paragraph (b), clause (1), new text end before the deleted text begin medical cannabis retailerdeleted text end new text begin businessnew text end may distribute
the deleted text begin medical cannabis flower or medical cannabinoid productdeleted text end new text begin productsnew text end to any person
deleted text begin authorized to receive medical cannabis flower or medical cannabinoid productsdeleted text end new text begin enrolled in
the medical cannabis patient registry program under section 342.52new text end .

Subd. 2.

Distribution requirements.

(a) Prior to distribution of deleted text begin medical cannabis flower
or medical cannabinoid products, a medical cannabis retailer licenseedeleted text end new text begin products listed in
subdivision 1, paragraph (b), to a person enrolled in the patient registry program, an employee
with a valid medical cannabis consultant certificate issued by the office or a licensed
pharmacist under chapter 151new text end must:

(1) review and confirm the patient'snew text begin enrollment in thenew text end registry deleted text begin verificationdeleted text end new text begin programnew text end ;

(2) verify that the person requesting the distribution of deleted text begin medical cannabis flower or
medical cannabinoiddeleted text end products new text begin listed under subdivision 1, paragraph (b), new text end is the patient, the
patient's registered designated caregiver, or the patient's parent, legal guardian, or spouse
using the procedures deleted text begin specified in section 152.11, subdivision 2ddeleted text end new text begin established by the officenew text end ;

deleted text begin (3) ensure that a pharmacist employee of the medical cannabis retailer has consulted
with the patient if required according to subdivision 3; and
 deleted text end

new text begin (3) provide consultation to the patient to determine the proper type of product, dosage,
and paraphernalia for the patient if required under subdivision 3;
 new text end

(4) apply a patient-specific label on the deleted text begin medical cannabis flower or medical cannabinoiddeleted text end
product that includes recommended dosage requirements and other information as required
deleted text begin by rules adopteddeleted text end by the officedeleted text begin .deleted text end new text begin ; and
new text end

new text begin (5) provide the patient with any other information required by the office.
 new text end

(b) A medical cannabis deleted text begin retailerdeleted text end new text begin retail endorsement holdernew text end may not deliver deleted text begin medical
cannabis flower or medical cannabinoiddeleted text end products new text begin listed in subdivision 1, paragraph (b), to
a person enrolled in the patient registry program new text end unless the medical cannabis deleted text begin retailerdeleted text end new text begin retail
endorsement holdernew text end also holds a cannabis delivery service license. new text begin The new text end delivery of deleted text begin medical
cannabis flower and medical cannabinoid products aredeleted text end new text begin a product listed in subdivision 1,
paragraph (b), isnew text end subject to the provisions of section 342.42.

Subd. 3.

Final approval for distribution deleted text begin of medical cannabis flower and medical
cannabinoid productsdeleted text end .

(a) A cannabis worker who is employed by a medical cannabis
deleted text begin retailer anddeleted text end new text begin retail endorsement holdernew text end who is licensed as a pharmacist pursuant to chapter
151 deleted text begin shall bedeleted text end new text begin or certified as a medical cannabis consultant by the office isnew text end the only person
who may give final approval for the distribution of deleted text begin medical cannabis flower and medical
cannabinoiddeleted text end productsnew text begin listed in subdivision 1, paragraph (b)new text end . Prior to the distribution of
deleted text begin medical cannabis flower or medical cannabinoiddeleted text end productsnew text begin listed in subdivision 1, paragraph
(b)new text end , a pharmacist new text begin or certified medical cannabis consultant new text end employed by deleted text begin thedeleted text end new text begin a business with
anew text end medical cannabis deleted text begin retailerdeleted text end new text begin retail endorsementnew text end must consult with the patient to determine
the proper type of deleted text begin medical cannabis flower, medical cannabinoiddeleted text end product, deleted text begin or medical cannabisdeleted text end new text begin
proper type ofnew text end paraphernalianew text begin ,new text end and proper dosage for the patient after reviewing the range of
chemical compositions of deleted text begin medical cannabis flower or medical cannabinoiddeleted text end new text begin thenew text end productdeleted text begin .deleted text end new text begin
intended for distribution:
new text end

new text begin (1) if the patient is purchasing the product for the first time;
 new text end

new text begin (2) if the patient purchases a product that the patient must administer using a different
method than the patient's previous method of administration;
 new text end

new text begin (3) if the patient purchases a product with a cannabinoid concentration of at least double
the patient's prior dosage; or
 new text end

new text begin (4) upon the request of the patient.
 new text end

new text begin (b) new text end For purposes of this subdivision, a consultation may be conducted remotely by secure
videoconference, telephone, or other remote means, as long as:

(1) the pharmacist new text begin or consultant new text end engaging in the consultation is able to confirm the
identity of the patient; and

(2) the consultation adheres to patient privacy requirements that apply to health care
services delivered through telemedicine.

deleted text begin (b) Notwithstanding paragraph (a), a pharmacist consultation is not required prior to the
distribution of medical cannabis flower or medical cannabinoid products when a medical
cannabis retailer is distributing medical cannabis flower or medical cannabinoid products
to a patient according to a patient-specific dosage plan established with that medical cannabis
retailer and is not modifying the dosage or product being distributed under that plan. Medical
cannabis flower or medical cannabinoid products distributed under this paragraph must be
distributed by a pharmacy technician employed by the medical cannabis retailer.
 deleted text end

deleted text begin Subd. 4. deleted text end

deleted text begin 90-day supply. deleted text end

deleted text begin A medical cannabis retailer shall not distribute more than a
90-day supply of medical cannabis flower or medical cannabinoid products to a patient,
registered designated caregiver, or parent, legal guardian, or spouse of a patient according
to the dosages established for the individual patient.
 deleted text end

Subd. 5.

Distribution to recipient in a motor vehicle.

A medical cannabis deleted text begin retailerdeleted text end new text begin retail
endorsement holdernew text end may distribute deleted text begin medical cannabis flower and medical cannabinoid
productsdeleted text end new text begin a product listed in subdivision 1, paragraph (b),new text end to a deleted text begin patient, registered designated
caregiver, or parent, legal guardian, or spouse of a patientdeleted text end new text begin person enrolled in the patient
registry programnew text end who is at a dispensary location but remains in a motor vehicle, provided
that:

(1) staff receive payment and distribute deleted text begin medical cannabis flower and medical cannabinoid
productsdeleted text end new text begin a product listed in subdivision 1, paragraph (b),new text end in a designated zone that is as
close as feasible to the front door of the facility;

(2) the medical cannabis deleted text begin retailerdeleted text end new text begin retail endorsement holdernew text end ensures that the receipt of
payment and distribution of deleted text begin medical cannabis flower and medical cannabinoid productsdeleted text end new text begin a
product listed in subdivision 1, paragraph (b),new text end are visually recorded by a closed-circuit
television surveillance camera and provides any other necessary security safeguards;

(3) the medical cannabis deleted text begin retailerdeleted text end new text begin retail endorsement holdernew text end does not store deleted text begin medical cannabis
flower or medical cannabinoid productsdeleted text end new text begin a product listed in subdivision 1, paragraph (b),new text end
outside a restricted access area and staff transport deleted text begin medical cannabis flower and medical
cannabinoid productsdeleted text end new text begin the productnew text end from a restricted access area to the designated zone for
distribution only after confirming that the deleted text begin patient, designated caregiver, or parent, guardian,
or spousedeleted text end new text begin person enrolled in the patient registry programnew text end has arrived in the designated zone;

(4) the payment new text begin for new text end and distribution of deleted text begin medical cannabis flower and medical cannabinoid
productsdeleted text end new text begin a product listed in subdivision 1, paragraph (b),new text end take place only after deleted text begin a pharmacist
consultation takes place, if required under subdivision 3deleted text end new text begin meeting the requirements in
subdivision 2new text end ;

(5) immediately following new text begin the new text end distribution of deleted text begin medical cannabis flower or medical
cannabinoid productsdeleted text end new text begin a product listed in subdivision 1, paragraph (b)new text end , staff deleted text begin enterdeleted text end new text begin recordnew text end the
transaction in the statewide monitoring system; and

(6) immediately following new text begin the new text end distribution of deleted text begin medical cannabis flower and medical
cannabinoid productsdeleted text end new text begin a product listed in subdivision 1, paragraph (b)new text end , staff take the payment
received into the facility.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 87.

Minnesota Statutes 2023 Supplement, section 342.515, is amended to read:


342.515 MEDICAL CANNABIS COMBINATION BUSINESSES.

Subdivision 1.

Authorized actions.

new text begin (a) A person, cooperative, or business holding a
medical cannabis combination business license is prohibited from owning or operating any
other cannabis business or hemp business or holding an active registration agreement under
section 152.25, subdivision 1.
 new text end

new text begin (b) A person or business may hold only one medical cannabis combination business
license.
 new text end

new text begin (c) new text end A medical cannabis combination business license entitles the license holder to perform
any or all of the following within the limits established by this section:

(1) grow cannabis plants from seed or immature plant to mature plant and harvest
deleted text begin adult-usedeleted text end cannabis flower and deleted text begin medicaldeleted text end cannabis flower from a mature plant;

(2) make cannabis concentrate;

(3) make hemp concentrate, including hemp concentrate with a delta-9
tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

(4) manufacture artificially derived cannabinoids;

(5) manufacture deleted text begin medicaldeleted text end cannabinoid products;

(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products for public consumption;

(7) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis
microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis wholesaler,
deleted text begin a medical cannabis cultivator,deleted text end or another medical cannabis combination business;

(8) purchase hemp plant parts and propagules from an industrial hemp grower licensed
under chapter 18K;

(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids
from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a
cannabis wholesaler, deleted text begin a medical cannabis processor,deleted text end or another medical cannabis combination
business;

(10) purchase hemp concentrate from an industrial hemp processor licensed under chapter
18K;

(11) package and label deleted text begin medicaldeleted text end cannabis new text begin flower new text end and deleted text begin medicaldeleted text end cannabinoid products for
sale to deleted text begin medical cannabis processors, medical cannabis retailers,deleted text end other medical cannabis
combination businessesdeleted text begin ,deleted text end and patients enrolled in the registry program, registered designated
caregivers, and parents, legal guardians, and spouses of an enrolled patient;

(12) package and label adult-use cannabis flower, adult-use cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;

(13) sell deleted text begin medicaldeleted text end cannabis flower and deleted text begin medicaldeleted text end cannabinoid products to patients enrolled
in the registry program, registered designated caregivers, and parents, legal guardians, and
spouses of an enrolled patient;

(14) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
other products authorized by law to other cannabis businesses and to customers; and

(15) perform other actions approved by the office.

Subd. 2.

Cultivation; size limitations.

(a) A medical cannabis combination business
may cultivate cannabis to be sold as deleted text begin medicaldeleted text end cannabis flower or used in deleted text begin medicaldeleted text end cannabinoid
products in an area of up to 60,000 square feet of plant canopynew text begin subject to the limits on
adult-use cannabis cultivation in paragraph (c)new text end .

(b) A medical cannabis combination business may cultivate cannabis to be sold as
adult-use cannabis flower or used in adult-use cannabis products in an area authorized by
the office as described in paragraph (c).

(c) The office shall authorize a medical cannabis combination business to cultivate
cannabis for sale in the adult-use market in an area of plant canopy that is equal to one-half
of the area the business used to cultivate cannabis sold in the medical market in the preceding
year. The office shall establish an annual verification and authorization procedure. The
office may increase the area of plant canopy in which a medical cannabis combination
business is authorized to cultivate cannabis for sale in the adult-use market between
authorization periods if the business demonstrates a significant increase in the sale of medical
cannabis and medical cannabis products.

Subd. 3.

Manufacturing; size limitations.

The office may establish limits on cannabis
manufacturing that are consistent with the area of plant canopy a business is authorized to
cultivate.

Subd. 4.

Retail locations.

A medical cannabis combination business may operate up to
one retail location in each congressional district. deleted text begin A medical cannabis combination business
must offer medical cannabis flower, medical cannabinoid products, or both at every retail
location.deleted text end new text begin Each retail location of a medical cannabis combination business must continuously
make cannabis flower or cannabinoid products available to patients enrolled in the registry
program, registered designated caregivers, and parents, legal guardians, and spouses of an
enrolled patient.
new text end

Subd. 5.

Failure to participate; suspension or revocation of license.

The office may
suspend or revoke a medical cannabis combination business license if the office determines
that the business is no longer actively participating in the medical cannabis market. The
office may, by rule, establish minimum requirements related to cannabis cultivation,
manufacturing of deleted text begin medicaldeleted text end cannabinoid products, retail sales of deleted text begin medicaldeleted text end cannabis flower and
deleted text begin medicaldeleted text end cannabinoid products, and other relevant criteria to demonstrate active participation
in the medical cannabis market.

Subd. 6.

Operations.

A medical cannabis combination business must comply with the
relevant requirements of sections 342.25, 342.26, 342.27, and 342.51, subdivisions 2 to 5.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 88.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 1, is amended
to read:


Subdivision 1.

Administration.

The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must administer
the medical cannabis new text begin patient new text end registry program.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 89.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 2, is amended
to read:


Subd. 2.

Application procedure for patients.

(a) A patient seeking to enroll in the
registry program must submit to the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end an application
established by the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end and a copy of the certification
specified in paragraph (b) or, if the patient is a veteran who receives care from the United
States Department of Veterans Affairs, the information required pursuant to subdivision 3.
The patient must provide at least the following information in the application:

(1) the patient's name, mailing address, and date of birth;

(2) the name, mailing address, and telephone number of the patient's health care
practitioner;

(3) the name, mailing address, and date of birth of the patient's registered designated
caregiver, if any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian,
or spouse will be acting as the patient's caregiver;

(4) a disclosure signed by the patient that includes:

(i) a statement that, notwithstanding any law to the contrary, the office deleted text begin of Cannabis
Management, the Division of Medical Cannabis,deleted text end or an employee of the office deleted text begin of Cannabis
Management or Division of Medical Cannabisdeleted text end may not be held civilly or criminally liable
for any injury, loss of property, personal injury, or death caused by an act or omission while
acting within the employee's scope of office or employment under this section; and

(ii) the patient's acknowledgment that enrollment in the registry program is conditional
on the patient's agreement to meet all other requirements of this section; and

(5) all other information required by the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end .

(b) As part of the application under this subdivision, a patient must submit a copy of a
certification from the patient's health care practitioner that is dated within 90 days prior to
the submission of the application and that certifies that the patient has been diagnosed with
a qualifying medical condition.

(c) A patient's health care practitioner may submit a statement to the deleted text begin Division of Medical
Cannabisdeleted text end new text begin officenew text end declaring that the patient is no longer diagnosed with a qualifying medical
condition. Within 30 days after receipt of a statement from a patient's health care practitioner,
the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must provide written notice to a patient stating that
the patient's enrollment in the registry program will be revoked in 30 days unless the patient
submits a certification from a health care practitioner that the patient is currently diagnosed
with a qualifying medical condition or, if the patient is a veteran, the patient submits
confirmation that the patient is currently diagnosed with a qualifying medical condition in
a form and manner consistent with the information required for an application made pursuant
to subdivision 3. If the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end revokes a patient's enrollment
in the registry program pursuant to this paragraph, the division must provide notice to the
patient and to the patient's health care practitioner.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 90.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 3, is amended
to read:


Subd. 3.

Application procedure for veterans.

(a) The deleted text begin Division of Medical Cannabisdeleted text end new text begin
officenew text end shall establish an alternative certification procedure for veterans who receive care
from the United States Department of Veterans Affairs to confirm that the veteran has been
diagnosed with a qualifying medical condition.

(b) A patient who is also a veteran and is seeking to enroll in the registry program must
submit to the deleted text begin Division of Medical Cannabisdeleted text end new text begin office a copy of the patient's veteran health
identification card issued by the United States Department of Veterans Affairs andnew text end an
application established by the deleted text begin Division of Medical Cannabisdeleted text end deleted text begin that includes the information
identified in subdivision 2, deleted text end deleted text begin paragraph (a), and the additional information required by the
deleted text end deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end to certify that the patient has been diagnosed with a
qualifying medical condition.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 91.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 4, is amended
to read:


Subd. 4.

Enrollment; denial of enrollment; revocation.

(a) Within 30 days after the
receipt of an application and certification or other documentation of a diagnosis with a
qualifying medical condition, the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must approve or
deny a patient's enrollment in the registry program. If the deleted text begin Division of Medical Cannabisdeleted text end new text begin
officenew text end approves a patient's enrollment in the registry program, the office must provide notice
to the patient and to the patient's health care practitioner.

(b) new text begin The office may deny new text end a patient's enrollment in the registry program deleted text begin must only be
denieddeleted text end new text begin onlynew text end if the patient:

(1) does not submit a certification from a health care practitioner or, if the patient is a
veteran, the documentation required under subdivision 3 that the patient has been diagnosed
with a qualifying medical condition;

(2) has not signed the disclosure required in subdivision 2;

(3) does not provide the information required by the deleted text begin Division of Medical Cannabisdeleted text end new text begin
officenew text end ;

(4) provided false information on the application; or

(5) at the time of application, is also enrolled in a federally approved clinical trial for
the treatment of a qualifying medical condition with medical cannabis.

(c) If the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end denies a patient's enrollment in the registry
program, the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must provide written notice to a patient
of all reasons for denying enrollment. Denial of enrollment in the registry program is
considered a final decision of the office and is subject to judicial review under chapter 14.

(d) new text begin The office may revoke new text end a patient's enrollment in the registry program deleted text begin may be revokeddeleted text end
only:

(1) pursuant to subdivision 2, paragraph (c);

(2) upon the death of the patient;

(3) if the patient's certifying health care practitioner has filed a declaration under
subdivision 2, paragraph (c), that the patient's qualifying diagnosis no longer exists and the
patient does not submit another certification within 30 days;

(4) if the patient does not comply with subdivision 6; or

(5) if the patient intentionally sells or diverts deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end
cannabinoid products in violation of this chapter.

new text begin (e) new text end If new text begin the office has revoked new text end a patient's enrollment in the registry program deleted text begin has been
revokeddeleted text end due to a violation of subdivision 6, the patient may apply for enrollment 12 months
after the date on which the patient's enrollment was revoked. The office must process such
an application in accordance with this subdivision.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 92.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 5, is amended
to read:


Subd. 5.

Registry verification.

When a patient is enrolled in the registry program, the
deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must assign the patient a patient registry number and
must issue the patient and the patient's registered designated caregiver, parent, legal guardian,
or spouse, if applicable, a registry verification. The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end
must also make the registry verification available to deleted text begin medicaldeleted text end cannabis deleted text begin retailersdeleted text end new text begin businesses
with a medical cannabis retail endorsementnew text end . The registry verification must include:

(1) the patient's name and date of birth;

(2) the patient registry number assigned to the patient; and

(3) the name and date of birth of the patient's registered designated caregiver, if any, or
the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or
spouse will act as a caregiver.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 93.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 9, is amended
to read:


Subd. 9.

Registered designated caregiver.

(a) The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end
must register a designated caregiver for a patient if the patient requires assistance in
administering deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products or in obtaining
deleted text begin medicaldeleted text end cannabis flower, deleted text begin medicaldeleted text end cannabinoid products, or deleted text begin medicaldeleted text end cannabis paraphernalia
from a deleted text begin medicaldeleted text end cannabis deleted text begin retailerdeleted text end new text begin business with a medical cannabis retail endorsement under
section 342.51new text end .

(b) In order to serve as a designated caregiver, a person must:

(1) be at least 18 years of age;

(2) agree to only possess deleted text begin the patient's medical cannabis flower and medical cannabinoiddeleted text end
products new text begin purchased under section 342.51 new text end for purposes of assisting the patient; and

(3) agree that if the application is approved, the person will not serve as a registered
designated caregiver for more than six registered patients at one time. Patients who reside
in the same residence count as one patient.

deleted text begin (c) The office shall conduct a criminal background check on the designated caregiver
prior to registration to ensure that the person does not have a conviction for a disqualifying
felony offense. Any cost of the background check shall be paid by the person seeking
registration as a designated caregiver. A designated caregiver must have the criminal
background check renewed every two years.
 deleted text end

deleted text begin (d)deleted text end new text begin (c)new text end Nothing in this section shall be construed to prevent a registered designated
caregiver from being enrolled in the registry program as a patient and possessing and
administering deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products as a patient.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 94.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 11, is amended
to read:


Subd. 11.

Notice of change of name or address.

Patients and registered designated
caregivers must notify the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end of any address or name
change within 30 days of the change having occurred. A patient or registered designated
caregiver is subject to a $100 fine for failure to notify the office of the change.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 95.

Minnesota Statutes 2023 Supplement, section 342.53, is amended to read:


342.53 DUTIES OF OFFICE OF CANNABIS MANAGEMENT; deleted text begin REGISTRY
PROGRAMdeleted text end new text begin ADDING OR MODIFYING QUALIFYING MEDICAL CONDITIONSnew text end .

The office may deleted text begin add an allowable form of medical cannabinoid product, and maydeleted text end add or
modify a qualifying medical condition upon deleted text begin itsdeleted text end new text begin the office'snew text end own initiative, upon a petition
from a member of the public or from the Cannabis Advisory Councilnew text begin ,new text end or as directed by law.
The office must evaluate all petitions and must make the addition or modification if the
office determines that the addition or modification is warranted by the best available evidence
and research. If the office wishes to deleted text begin add an allowable form ordeleted text end add or modify a qualifying
medical condition, the office must notify the chairs and ranking minority members of the
legislative committees and divisions with jurisdiction over health finance and policy by
January 15 of the year in which the change becomes effective. In this notification, the office
must specify the proposed addition or modification, the reasons for the addition or
modification, any written comments received by the office from the public about the addition
or modification, and any guidance received from the Cannabis Advisory Council. An addition
or modification by the office under this subdivision becomes effective on August 1 of that
year unless the legislature by law provides otherwise.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 96.

Minnesota Statutes 2023 Supplement, section 342.54, is amended to read:


342.54 DUTIES OF deleted text begin DIVISION OF MEDICAL CANNABISdeleted text end new text begin OFFICE OF
CANNABIS MANAGEMENTnew text end ; new text begin MEDICAL CANNABIS PATIENT new text end REGISTRY
PROGRAM.

Subdivision 1.

Duties related to health care practitioners.

The deleted text begin Division of Medical
Cannabisdeleted text end new text begin officenew text end must:

(1) provide notice of the registry program to health care practitioners in the state;

(2) allow health care practitioners to participate in the registry program if they request
to participate and meet the program's requirements;

(3) provide explanatory information and assistance to health care practitioners to
understand the nature of the therapeutic use of deleted text begin medicaldeleted text end cannabis flower and deleted text begin medicaldeleted text end
cannabinoid products within program requirements;

(4) make available to participating health care practitioners a certification form in which
a health care practitioner certifies that a patient has a qualifying medical condition; and

(5) supervise the participation of health care practitioners in the registry reporting system
in which health care practitioners report patient treatment and health records information
to the office in a manner that ensures stringent security and record keeping requirements
and that prevents the unauthorized release of private data on individuals as defined in section
13.02.

Subd. 2.

Duties related to the new text begin medical new text end registry program.

The deleted text begin Division of Medical
Cannabisdeleted text end new text begin officenew text end must:

(1) administer the registry program according to section 342.52;

(2) provide information to patients enrolled in the registry program on the existence of
federally approved clinical trials for the treatment of the patient's qualifying medical condition
with deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products as an alternative to enrollment
in the registry program;

(3) maintain safety criteria with which patients must comply as a condition of participation
in the registry program to prevent patients from undertaking any task under the influence
of deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products that would constitute negligence
or professional malpractice;

(4) review and publicly report on existing medical and scientific literature regarding the
range of recommended dosages for each qualifying medical condition, the range of chemical
compositions of deleted text begin medicaldeleted text end cannabis flower and deleted text begin medicaldeleted text end cannabinoid products that will likely
be medically beneficial for each qualifying medical condition, and any risks of noncannabis
drug interactions. This information must be updated by December 1 deleted text begin of each yeardeleted text end new text begin every three
yearsnew text end . The office may consult with an independent laboratory under contract with the office
or other experts in reporting and updating this information; and

(5) annually consult with cannabis businesses about medical cannabis that the businesses
cultivate, manufacture, and offer for sale and post on the deleted text begin Division of Medical Cannabisdeleted text end new text begin
officenew text end website a list of the deleted text begin medicaldeleted text end cannabis flower and deleted text begin medicaldeleted text end cannabinoid products offered
for sale by each deleted text begin medicaldeleted text end cannabis retailer.

Subd. 3.

Research.

(a) The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must conduct or contract
with a third party to conduct research and studies using data from health records submitted
to the registry program under section 342.55, subdivision 2, and data submitted to the registry
program under section 342.52, subdivisions 2 and 3. If the deleted text begin divisiondeleted text end new text begin officenew text end contracts with a
third party for research and studies, the third party must provide the deleted text begin divisiondeleted text end new text begin officenew text end with
access to all research and study results. The deleted text begin divisiondeleted text end new text begin officenew text end must submit reports on
intermediate or final research results to the legislature and major scientific journals. All
data used by the deleted text begin divisiondeleted text end new text begin officenew text end or a third party under this subdivision must be used or
reported in an aggregated nonidentifiable form as part of a scientific peer-reviewed
publication of research or in the creation of summary data, as defined in section 13.02,
subdivision 19.

(b) The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end may submit medical research based on the
data collected under sections 342.55, subdivision 2, and data collected through the statewide
monitoring system to any federal agency with regulatory or enforcement authority over
deleted text begin medicaldeleted text end cannabis flower and deleted text begin medicaldeleted text end cannabinoid products to demonstrate the effectiveness
of deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products for treating or alleviating the
symptoms of a qualifying medical condition.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 97.

Minnesota Statutes 2023 Supplement, section 342.55, subdivision 1, is amended
to read:


Subdivision 1.

Health care practitioner duties before patient enrollment.

Before a
patient's enrollment in the registry program, a health care practitioner must:

(1) determine, in the health care practitioner's medical judgment, whether a patient has
a qualifying medical condition and, if so determined, provide the patient with a certification
of that diagnosis;

(2) advise patients, registered designated caregivers, and parents, legal guardians, and
spouses acting as caregivers of any nonprofit patient support groups or organizations;

(3) provide to patients explanatory information from the deleted text begin Division of Medical Cannabisdeleted text end new text begin
officenew text end , including information about the experimental nature of the therapeutic use of deleted text begin medicaldeleted text end
cannabis flower and deleted text begin medicaldeleted text end cannabinoid products; the possible risks, benefits, and side
effects of the proposed treatment; and the application and other materials from the office;

(4) provide to patients a Tennessen warning as required under section 13.04, subdivision
2; and

(5) agree to continue treatment of the patient's qualifying medical condition and to report
findings to the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end .

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 98.

Minnesota Statutes 2023 Supplement, section 342.55, subdivision 2, is amended
to read:


Subd. 2.

Duties upon patient's enrollment in registry program.

Upon receiving
notification from the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end of the patient's enrollment in the
registry program, a health care practitioner must:

(1) participate in the patient registry reporting system under the guidance and supervision
of the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end ;

(2) report to the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end patient health records throughout
the patient's ongoing treatment in a manner determined by the office and in accordance with
subdivision 4;

(3) determine deleted text begin on a yearly basisdeleted text end new text begin every three yearsnew text end if the patient continues to have a
qualifying medical condition and, if so, issue the patient a new certification of that diagnosis.
The patient assessment conducted under this clause may be conducted via telehealth, as
defined in section 62A.673, subdivision 2; and

(4) otherwise comply with requirements established by the office deleted text begin of Cannabis
Management and the Division of Medical Cannabisdeleted text end .

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 99.

Minnesota Statutes 2023 Supplement, section 342.56, subdivision 1, is amended
to read:


Subdivision 1.

Limitations on consumption; locations of consumption.

(a) Nothing
in sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60 permits any person to engage in, and does not prevent
the imposition of any civil, criminal, or other penalties for:

(1) undertaking a task under the influence of deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end
cannabinoid products that would constitute negligence or professional malpractice;

(2) possessing or consuming deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products:

(i) on a school bus or van;

(ii) in a correctional facility;

(iii) in a state-operated treatment program, including the Minnesota sex offender program;
or

(iv) on the grounds of a child care facility or family or group family day care program;

(3) vaporizing or smoking medical cannabis:

(i) on any form of public transportation;

(ii) where the vapor would be inhaled by a nonpatient minor or where the smoke would
be inhaled by a minor; or

(iii) in any public place, including any indoor or outdoor area used by or open to the
general public or a place of employment, as defined in section 144.413, subdivision 1b; and

(4) operating, navigating, or being in actual physical control of a motor vehicle, aircraft,
train, or motorboat or working on transportation property, equipment, or facilities while
under the influence of deleted text begin medicaldeleted text end cannabis flower or a deleted text begin medicaldeleted text end cannabinoid product.

(b) Except for the use of deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid productsnew text begin by
a patient enrolled in the patient registry program under section 342.52new text end , the vaporizing or
smoking of cannabis flower, cannabis products, artificially derived cannabinoids, or
hemp-derived consumer products is prohibited in a multifamily housing building, including
balconies and patios appurtenant thereto. A violation of this paragraph is punishable through
a civil administrative fine in an amount of $250.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 100.

Minnesota Statutes 2023 Supplement, section 342.56, subdivision 2, is amended
to read:


Subd. 2.

Health care facilities.

(a) Health care facilities licensed under chapter 144A;
hospice providers licensed under chapter 144A; boarding care homes or supervised living
facilities licensed under section 144.50; assisted living facilities under chapter 144G; facilities
owned, controlled, managed, or under common control with hospitals licensed under chapter
144; and other health care facilities licensed by the commissioner of health or the
commissioner of human services may adopt reasonable restrictions on the use of deleted text begin medicaldeleted text end
cannabis flower or deleted text begin medicaldeleted text end cannabinoid products by a patient enrolled in the registry program
who resides at or is actively receiving treatment or care at the facility. The restrictions may
include a provision that the facility must not store or maintain a patient's supply of deleted text begin medicaldeleted text end
cannabis flower or deleted text begin medicaldeleted text end cannabinoid products on behalf of the patient; that a patient
store the patient's supply of deleted text begin medicaldeleted text end cannabis flower or medicinal cannabinoid products in
a locked container accessible only to the patient, the patient's designated caregiver, or the
patient's parent, legal guardian, or spouse; that the facility is not responsible for providing
medical cannabis for patients; and that deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid
products are used only in a location specified by the facility or provider. Nothing in this
subdivision requires facilities and providers listed in this subdivision to adopt such
restrictions.

(b) No facility or provider listed in this subdivision may unreasonably limit a patient's
access to or use of deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products to the extent
that such use is authorized under sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.59. No facility or provider
listed in this subdivision may prohibit a patient access to or use of deleted text begin medicaldeleted text end cannabis flower
or deleted text begin medicaldeleted text end cannabinoid products due solely to the fact that cannabis is a Schedule I drug
pursuant to the federal Uniform Controlled Substances Act. If a federal regulatory agency,
the United States Department of Justice, or the federal Centers for Medicare and Medicaid
Services takes one of the following actions, a facility or provider may suspend compliance
with this paragraph until the regulatory agency, the United States Department of Justice, or
the federal Centers for Medicare and Medicaid Services notifies the facility or provider that
it may resume permitting the use of deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products
within the facility or in the provider's service setting:

(1) a federal regulatory agency or the United States Department of Justice initiates
enforcement action against a facility or provider related to the facility's compliance with
the medical cannabis program; or

(2) a federal regulatory agency, the United States Department of Justice, or the federal
Centers for Medicare and Medicaid Services issues a rule or otherwise provides notification
to the facility or provider that expressly prohibits the use of medical cannabis in health care
facilities or otherwise prohibits compliance with the medical cannabis program.

(c) An employee or agent of a facility or provider listed in this subdivision or a person
licensed under chapter 144E is not violating this chapter or chapter 152 for the possession
of deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products while carrying out employment
duties, including providing or supervising care to a patient enrolled in the registry program,
or distribution of deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products to a patient
enrolled in the registry program who resides at or is actively receiving treatment or care at
the facility or from the provider with which the employee or agent is affiliated.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 101.

Minnesota Statutes 2023 Supplement, section 342.57, subdivision 1, is amended
to read:


Subdivision 1.

Presumption.

There is a presumption that a patient new text begin or other person
new text end enrolled in the registry program is engaged in the authorized use new text begin or possession new text end of deleted text begin medicaldeleted text end
cannabis flower and deleted text begin medicaldeleted text end cannabinoid products. This presumption may be rebutted by
evidence that the deleted text begin patient's use of medical cannabis flower or medical cannabinoid productsdeleted text end new text begin
use or possession of cannabis flower or cannabinoid products by a patient or other person
enrolled in the registry programnew text end was not for the purpose of new text begin assisting with, new text end treatingnew text begin ,new text end or
alleviating the patient's new text begin or other person's new text end qualifying medical condition or symptoms associated
with the patient's new text begin or other person's new text end qualifying medical condition.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 102.

Minnesota Statutes 2023 Supplement, section 342.57, subdivision 2, is amended
to read:


Subd. 2.

Criminal and civil protections.

(a) Subject to section 342.56, new text begin the use or
possession of cannabis flower, cannabinoid products, or cannabis paraphernalia by new text end the
following deleted text begin aredeleted text end new text begin persons isnew text end not deleted text begin violationsdeleted text end new text begin a violationnew text end of this chapter deleted text begin or chapter deleted text end deleted text begin 152deleted text end :

(1) deleted text begin use or possession of medical cannabis flower, medical cannabinoid products, or
medical cannabis paraphernaliadeleted text end by a patient new text begin or person new text end enrolled in the registry program or
by a visiting patient to whom deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products are
distributed under section 342.51, subdivision 5;

(2) deleted text begin possession of medical cannabis flower, medical cannabinoid products, or medical
cannabis paraphernaliadeleted text end by a registered designated caregiver or a parent, legal guardian, or
spouse of a patient new text begin or person new text end enrolled in the registry program; or

(3) deleted text begin possession of medical cannabis flower, medical cannabinoid products, or medical
cannabis paraphernaliadeleted text end by any person while new text begin that person is new text end carrying out duties required under
sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60.

(b) The office deleted text begin of Cannabis Managementdeleted text end , members of the Cannabis Advisory Council,
office deleted text begin of Cannabis Managementdeleted text end employees, agents or contractors of the office deleted text begin of Cannabis
Managementdeleted text end , and health care practitioners participating in the registry program are not
subject to any civil penalties or disciplinary action by the Board of Medical Practice, the
Board of Nursing, or any business, occupational, or professional licensing board or entity
solely for participating in the registry program either in a professional capacity or as a
patient. A pharmacist licensed under chapter 151 is not subject to any civil penalties or
disciplinary action by the Board of Pharmacy when acting in accordance with sections
deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60 either in a professional capacity or as a patient. Nothing in this
section prohibits a professional licensing board from taking action in response to a violation
of law.

(c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the
governor, or an employee of a state agency must not be held civilly or criminally liable for
any injury, loss of property, personal injury, or death caused by any act or omission while
acting within the scope of office or employment under sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60.

(d) Federal, state, and local law enforcement authorities are prohibited from accessing
the registry except when acting pursuant to a valid search warrant. Notwithstanding section
13.09, a violation of this paragraph is a gross misdemeanor.

(e) Notwithstanding any law to the contrary, the office and employees of the office must
not release data or information about an individual contained in any report or document or
in the registry and must not release data or information obtained about a patient enrolled in
the registry program, except as provided in sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60.
Notwithstanding section 13.09, a violation of this paragraph is a gross misdemeanor.

(f) No information contained in a report or document, contained in the registry, or
obtained from a patient under sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60 may be admitted as evidence
in a criminal proceeding, unless:

(1) the information is independently obtained; or

(2) admission of the information is sought in a criminal proceeding involving a criminal
violation of sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60.

(g) Possession of a registry verification or an application for enrollment in the registry
program:

(1) does not constitute probable cause or reasonable suspicion;

(2) must not be used to support a search of the person or property of the person with a
registry verification or application to enroll in the registry program; and

(3) must not subject the person or the property of the person to inspection by any
government agency.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 103.

Minnesota Statutes 2023 Supplement, section 342.57, subdivision 3, is amended
to read:


Subd. 3.

School enrollment; rental property.

(a) No school may refuse to enroll new text begin or
otherwise penalize new text end a patient new text begin or person enrolled in the registry program new text end as a pupil deleted text begin or otherwise
penalize a patientdeleted text end solely because the patient new text begin or person new text end is enrolled in the registry program,
unless failing to do so would violate federal law or regulations or cause the school to lose
a monetary or licensing-related benefit under federal law or regulations.

(b) No landlord may refuse to lease to a patient new text begin or person enrolled in the registry program
new text end or otherwise penalize a patient new text begin or person enrolled in the registry program new text end solely because
the patient new text begin or person new text end is enrolled in the registry program, unless failing to do so would violate
federal law or regulations or cause the landlord to lose a monetary or licensing-related
benefit under federal law or regulations.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 104.

Minnesota Statutes 2023 Supplement, section 342.57, subdivision 4, is amended
to read:


Subd. 4.

Medical care.

For purposes of medical care, including organ transplants, a
patient's use of deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products according to
sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60 is considered the equivalent of the authorized use of a
medication used at the discretion of a health care practitioner and does not disqualify a
patient from needed medical care.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 105.

Minnesota Statutes 2023 Supplement, section 342.57, subdivision 5, is amended
to read:


Subd. 5.

Employment.

(a) Unless a failure to do so would violate federal or state law
or regulations or cause an employer to lose a monetary or licensing-related benefit under
federal law or regulations, an employer may not discriminate against a person in hiring,
termination, or any term or condition of employment, or otherwise penalize a person, if the
discrimination is based on:

(1) the person's status as a patient new text begin or person new text end enrolled in the registry program; or

(2) a patient's positive drug test for cannabis components or metabolites, unless the
patient used, possessed, sold, transported, or was impaired by deleted text begin medicaldeleted text end cannabis flower or
a deleted text begin medicaldeleted text end cannabinoid product on work premises, during working hours, or while operating
an employer's machinery, vehicle, or equipment.

(b) An employee who is a patient and whose employer requires the employee to undergo
drug testing according to section 181.953 may present the employee's registry verification
as part of the employee's explanation under section 181.953, subdivision 6.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 106.

Minnesota Statutes 2023 Supplement, section 342.57, subdivision 6, is amended
to read:


Subd. 6.

Custody; visitation; parenting time.

A person must not be denied custody of
a minor child or visitation rights or parenting time with a minor child based solely on the
person's status as a patient new text begin or person new text end enrolled in the registry program. There must be no
presumption of neglect or child endangerment for conduct allowed under sections deleted text begin 342.47deleted text end new text begin
342.51new text end to 342.60, unless the person's behavior creates an unreasonable danger to the safety
of the minor as established by clear and convincing evidence.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 107.

Minnesota Statutes 2023 Supplement, section 342.57, subdivision 7, is amended
to read:


Subd. 7.

Action for damages.

In addition to any other remedy provided by law, a patient
new text begin or person enrolled in the registry program new text end may bring an action for damages against any
person who violates subdivision 3, 4, or 5. A person who violates subdivision 3, 4, or 5 is
liable to a patient new text begin or person enrolled in the registry program new text end injured by the violation for the
greater of the person's actual damages or a civil penalty of $100 and reasonable attorney
fees.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 108.

Minnesota Statutes 2023 Supplement, section 342.58, is amended to read:


342.58 VIOLATION BY HEALTH CARE PRACTITIONER; CRIMINAL
PENALTY.

A health care practitioner who knowingly refers patients to a medical cannabis business
or to a designated caregiver, who advertises as a retailer or producer of deleted text begin medicaldeleted text end cannabis
flower or deleted text begin medicaldeleted text end cannabinoid products, or who issues certifications while holding a financial
interest in a cannabis retailer or medical cannabis business is guilty of a misdemeanor and
may be sentenced to imprisonment for not more than 90 days or to payment of not more
than $1,000, or both.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 109.

Minnesota Statutes 2023 Supplement, section 342.60, is amended to read:


342.60 APPLIED RESEARCH.

The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end may conductdeleted text begin ,deleted text end or award grants to health care
providers or research organizations to conductdeleted text begin ,deleted text end applied research on the safety and efficacy
of using deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid products to treat a specific health
condition. A health care provider or research organization receiving a grant under this section
must provide the office with access to all data collected in applied research funded under
this section. The office may use data from applied research conducted or funded under this
section as evidence to approve additional qualifying medical conditions deleted text begin or additional
allowable forms of medical cannabisdeleted text end .

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025, or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is later.
 new text end

Sec. 110.

Minnesota Statutes 2023 Supplement, section 342.61, subdivision 4, is amended
to read:


Subd. 4.

Testing of samples; disclosures.

(a) On a schedule determined by the office,
every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, deleted text begin medical cannabis cultivator, medical cannabis processor,deleted text end or
medical cannabis combination business shall make each batch of cannabis flower, cannabis
products, artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived
consumer products grown, manufactured, or imported by the cannabis business or hemp
business available to a cannabis testing facility.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, deleted text begin medical cannabis cultivator, medical cannabis processor,deleted text end or
medical cannabis combination business must disclose all known information regarding
pesticides, fertilizers, solvents, or other foreign materials, including but not limited to
catalysts used in creating artificially derived cannabinoids, applied or added to the batch of
cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp
edibles, or hemp-derived consumer products subject to testing. Disclosure must be made
to the cannabis testing facility and must include information about all applications by any
person, whether intentional or accidental.

(c) The cannabis testing facility shall select one or more representative samples from
each batch, test the samples for the presence of contaminants, and test the samples for
potency and homogeneity and to allow the cannabis flower, cannabis product, artificially
derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be
accurately labeled with its cannabinoid profile. Testing for contaminants must include testing
for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide
residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include
testing for other contaminants. A cannabis testing facility must destroy or return to the
cannabis business or hemp business any part of the sample that remains after testing.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 111.

Minnesota Statutes 2023 Supplement, section 342.61, subdivision 5, is amended
to read:


Subd. 5.

Test results.

(a) If a sample meets the applicable testing standards, a cannabis
testing facility shall issue a certification to a cannabis microbusiness, cannabis
mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an
endorsement to import products, lower-potency hemp edible manufacturer, deleted text begin medical cannabis
cultivator, medical cannabis processor,deleted text end or medical cannabis combination business and the
cannabis business or hemp business may then sell or transfer the batch of cannabis flower,
cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or
hemp-derived consumer products from which the sample was taken to another cannabis
business or hemp business, or offer the cannabis flower, cannabis products, lower-potency
hemp edibles, or hemp-derived consumer products for sale to customers or patients. If a
sample does not meet the applicable testing standards or if the testing facility is unable to
test for a substance identified pursuant to subdivision 4, paragraph (b), the batch from which
the sample was taken shall be subject to procedures established by the office for such batches,
including destruction, remediation, or retesting.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, deleted text begin medical cannabis cultivator, medical cannabis processor,deleted text end or
medical cannabis combination business must maintain the test results for cannabis flower,
cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or
hemp-derived consumer products grown, manufactured, or imported by that cannabis
business or hemp business for at least five years after the date of testing.

(c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, deleted text begin medical cannabis cultivator, medical cannabis processor,deleted text end or
medical cannabis combination business shall make test results maintained by that cannabis
business or hemp business available for review by any member of the public, upon request.
Test results made available to the public must be in plain language.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 112.

Minnesota Statutes 2023 Supplement, section 342.63, subdivision 2, is amended
to read:


Subd. 2.

Content of label; cannabis.

All cannabis flower and hemp-derived consumer
products that consist of hemp plant parts sold to customers or patients must have affixed
on the packaging or container of the cannabis flower or hemp-derived consumer product a
label that contains at least the following information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis cultivator, deleted text begin medical cannabis cultivator,deleted text end or industrial hemp grower where the
cannabis flower or hemp plant part was cultivated;

(2) the net weight or volume of cannabis flower or hemp plant parts in the package or
container;

(3) the batch number;

(4) the cannabinoid profile;

(5) a universal symbol established by the office indicating that the package or container
contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
hemp-derived consumer product;

(6) verification that the cannabis flower or hemp plant part was tested according to
section 342.61 and that the cannabis flower or hemp plant part complies with the applicable
standards;

deleted text begin (7) the maximum dose, quantity, or consumption that may be considered medically safe
within a 24-hour period;
 deleted text end

new text begin (7) information on the usage of the cannabis flower or hemp-derived consumer product;
 new text end

(8) the following statement: "Keep this product out of reach of children."; and

(9) any other statements or information required by the office.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 113.

Minnesota Statutes 2023 Supplement, section 342.63, subdivision 3, is amended
to read:


Subd. 3.

Content of label; cannabinoid products.

(a) All cannabis products,
lower-potency hemp edibles, hemp-derived consumer products other than products subject
to the requirements under subdivision 2, deleted text begin medicaldeleted text end cannabinoid products, and hemp-derived
topical products sold to customers or patients must have affixed to the packaging or container
of the cannabis product a label that contains at least the following information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis cultivator, deleted text begin medical cannabis cultivator,deleted text end or industrial hemp grower that cultivated
the cannabis flower or hemp plant parts used in the cannabis product, lower-potency hemp
edible, hemp-derived consumer product, or deleted text begin medicaldeleted text end cannabinoid product;

(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis manufacturer, lower-potency hemp edible manufacturer, deleted text begin medical cannabis
processor,deleted text end or industrial hemp grower that manufactured the cannabis concentrate, hemp
concentrate, or artificially derived cannabinoid and, if different, the name and license number
of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer, new text begin or
new text end lower-potency hemp edible manufacturerdeleted text begin , or medical cannabis processordeleted text end that manufactured
the product;

(3) the net weight or volume of the cannabis product, lower-potency hemp edible, or
hemp-derived consumer product in the package or container;

(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer
product;

(5) the batch number;

(6) the serving size;

(7) the cannabinoid profile per serving and in total;

(8) a list of ingredients;

(9) a universal symbol established by the office indicating that the package or container
contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
hemp-derived consumer product;

(10) a warning symbol developed by the office in consultation with the commissioner
of health and the Minnesota Poison Control System that:

(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;

(ii) is in a highly visible color;

(iii) includes a visual element that is commonly understood to mean a person should
stop;

(iv) indicates that the product is not for children; and

(v) includes the phone number of the Minnesota Poison Control System;

(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived
consumer product, or deleted text begin medicaldeleted text end cannabinoid product was tested according to section 342.61
and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product,
or deleted text begin medicaldeleted text end cannabinoid product complies with the applicable standards;

deleted text begin (12) the maximum dose, quantity, or consumption that may be considered medically
safe within a 24-hour period;
 deleted text end

new text begin (12) information on the usage of the product;
 new text end

(13) the following statement: "Keep this product out of reach of children."; and

(14) any other statements or information required by the office.

(b) The office may by rule establish alternative labeling requirements for lower-potency
hemp edibles that are imported into the state provided that those requirements provide
consumers with information that is substantially similar to the information described in
paragraph (a).

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 114.

Minnesota Statutes 2023 Supplement, section 342.63, subdivision 4, is amended
to read:


Subd. 4.

Additional content of label; deleted text begin medicaldeleted text end cannabis flower and deleted text begin medicaldeleted text end
cannabinoid products.

In addition to the applicable requirements for labeling under
subdivision 2 or 3, all deleted text begin medicaldeleted text end cannabis flower new text begin sold to patients new text end and deleted text begin medicaldeleted text end cannabinoid
products new text begin sold to patients new text end must include at least the following information on the label affixed
to the packaging or container of the deleted text begin medicaldeleted text end cannabis flower or deleted text begin medicaldeleted text end cannabinoid product:

(1) the patient's name and date of birth;

(2) the name and date of birth of the patient's registered designated caregiver or, if listed
on the registry verification, the name of the patient's parent, legal guardian, or spouse, if
applicable; and

(3) the patient's registry identification number.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 115.

Minnesota Statutes 2023 Supplement, section 342.63, subdivision 6, is amended
to read:


Subd. 6.

Additional information.

(a) A cannabis microbusiness, cannabis mezzobusiness,
cannabis retailer, deleted text begin medical cannabis retailer,deleted text end or medical cannabis combination business must
provide customers and patients with the following information:

(1) factual information about impairment effects and the expected timing of impairment
effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products;

(2) a statement that customers and patients must not operate a motor vehicle or heavy
machinery while under the influence of cannabis flower, cannabis products, lower-potency
hemp edibles, and hemp-derived consumer products;

(3) resources customers and patients may consult to answer questions about cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products, and any side effects and adverse effects;

(4) contact information for the poison control center and a safety hotline or website for
customers to report and obtain advice about side effects and adverse effects of cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products;

(5) substance use disorder treatment options; and

(6) any other information specified by the office.

(b) A cannabis microbusiness, cannabis mezzobusiness, new text begin or new text end cannabis retailerdeleted text begin , or medical
cannabis retailerdeleted text end may include the information described in paragraph (a) on the label affixed
to the packaging or container of cannabis flower, cannabis products, lower-potency hemp
edibles, and hemp-derived consumer products by:

(1) posting the information in the premises of the cannabis microbusiness, cannabis
mezzobusiness, cannabis retailer, deleted text begin medical cannabis retailer,deleted text end or medical cannabis combination
business; or

(2) providing the information on a separate document or pamphlet provided to customers
or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency
hemp edible, or a hemp-derived consumer product.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment.
 new text end

Sec. 116.

Laws 2023, chapter 63, article 1, section 2, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective July 1, 2023deleted text begin , except for subdivision 3,
which is effective March 1, 2025deleted text end .

Sec. 117.

Laws 2023, chapter 63, article 1, section 51, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective March 1, 2025new text begin , or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is laternew text end .

Sec. 118.

Laws 2023, chapter 63, article 1, section 52, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin March 1, 2025deleted text end new text begin the day following final
enactmentnew text end .

Sec. 119.

Laws 2023, chapter 63, article 1, section 53, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective March 1, 2025new text begin , or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is laternew text end .

Sec. 120.

Laws 2023, chapter 63, article 1, section 54, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective March 1, 2025new text begin , or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is laternew text end .

Sec. 121.

Laws 2023, chapter 63, article 1, section 55, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective March 1, 2025new text begin , or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is laternew text end .

Sec. 122.

Laws 2023, chapter 63, article 1, section 56, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective March 1, 2025new text begin , or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is laternew text end .

Sec. 123.

Laws 2023, chapter 63, article 1, section 57, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective March 1, 2025new text begin , or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is laternew text end .

Sec. 124.

Laws 2023, chapter 63, article 1, section 58, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective March 1, 2025new text begin , or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is laternew text end .

Sec. 125.

Laws 2023, chapter 63, article 1, section 59, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective March 1, 2025new text begin , or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is laternew text end .

Sec. 126.

Laws 2023, chapter 63, article 1, section 61, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective March 1, 2025new text begin , or upon the adoption of
initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever
is laternew text end .

Sec. 127.

Laws 2023, chapter 63, article 6, section 10, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin Marchdeleted text end new text begin Julynew text end 1, deleted text begin 2025deleted text end new text begin 2024new text end .

Sec. 128.

Laws 2023, chapter 63, article 6, section 73, the effective date, is amended to
read:


EFFECTIVE DATE.

Paragraph (a) is effective deleted text begin Marchdeleted text end new text begin Decembernew text end 1, 2025. Paragraph
(b) is effective August 1, 2023. Paragraph (c) is effective July 1, 2023.

Sec. 129. new text begin EMPLOYEE TRANSFER.
new text end

new text begin (a) The powers, duties, rights, obligations, and other authority imposed by law on the
Department of Health with respect to the sale of certain cannabinoid products under
Minnesota Statutes, section 151.72, are transferred to the Office of Cannabis Management
under Minnesota Statutes, section 15.039.
 new text end

new text begin (b) The following protections shall apply to employees who are transferred from the
Department of Health to the Office of Cannabis Management:
 new text end

new text begin (1) the employment status and job classification of a transferred employee shall not be
altered as a result of the transfer;
 new text end

new text begin (2) transferred employees who were represented by an exclusive representative prior to
the transfer shall continue to be represented by the same exclusive representative after the
transfer;
 new text end

new text begin (3) the applicable collective bargaining agreements with exclusive representatives shall
continue in full force and effect for such transferred employees after the transfer;
 new text end

new text begin (4) the state must meet and negotiate with the exclusive representatives of the transferred
employees about any proposed changes affecting or relating to the transferred employees'
terms and conditions of employment to the extent such changes are not addressed in the
applicable collective bargaining agreement; and
 new text end

new text begin (5) for an employee in a temporary unclassified position transferred to the Office of
Cannabis Management, the total length of time that the employee has served in the
appointment shall include all time served in the appointment at the transferring agency and
the time served in the appointment at the Office of Cannabis Management. An employee
in a temporary unclassified position who was hired by a transferring agency through an
open competitive selection process in accordance with a policy enacted by Minnesota
Management and Budget shall be considered to have been hired through such process after
the transfer.
 new text end

Sec. 130. new text begin TRANSFER OF ACTIVE AND INACTIVE COMPLAINTS.
new text end

new text begin The Department of Health shall transfer all data, including not public data as defined in
Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive
complaints involving alleged violations of Minnesota Statutes 2022, section 151.72, as well
as registration data collected under Minnesota Statutes 2022, section 151.72, subdivision
5b, to the Office of Cannabis Management. The Department of Health and the Office of
Cannabis Management shall ensure that the transfer takes place in a manner and on a schedule
that prioritizes public health.
 new text end

Sec. 131. new text begin TRANSFER OF MEDICAL PROGRAM.
new text end

new text begin (a) Notwithstanding the data's classification under Minnesota Statutes, chapter 13, the
Office of Cannabis Management may access data maintained by the commissioner of health
related to the responsibilities transferred under Minnesota Statutes, section 342.02,
subdivision 3. Data sharing authorized by this subdivision includes nonpublic data as defined
in Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive
complaints involving any alleged violation of Minnesota Statutes, sections 152.22 to 152.37,
by a medical cannabis manufacturer. Data sharing under this paragraph further includes
data in patient files maintained by the commissioner and the health care practitioner and
data submitted to or by a medical cannabis manufacturer classified as private data on
individuals, as defined in Minnesota Statutes, section 13.02, subdivision 12, or nonpublic
data, as defined in Minnesota Statutes, section 13.02, subdivision 9. Any data shared under
this section retain the data's classification from the agency holding the data.
 new text end

new text begin (b) All rules adopted by the commissioner of health pursuant to Minnesota Statutes,
sections 152.22 to 152.37, including but not limited to Minnesota Rules, chapter 4770,
remain effective and shall be enforced until amended or repealed consistent with Minnesota
Statutes, section 15.039, subdivision 3.
 new text end

new text begin (c) The director of the Office of Cannabis Management may use the good cause exempt
rulemaking process under Minnesota Statutes, section 14.388, subdivision 1, clauses (3)
and (4), to copy and adopt any portions of Minnesota Rules, parts 4770.0100 to 4770.4030,
that are necessary to effectuate the transfer of authority granted under Minnesota Statutes,
section 342.02, subdivision 3. The commissioner may make technical changes and any
changes necessary to conform with the transfer of authority. Any change to the rules that
is not authorized under this paragraph must be adopted according to Minnesota Statutes,
sections 14.001 to 14.366.
 new text end

new text begin (d) Unless otherwise specified in this section or Minnesota Statutes, section 342.02,
subdivision 3, transfer of the powers, duties, rights, obligations, and other authority imposed
by law on the Department of Health with respect to the medical cannabis program under
Minnesota Statutes 2022, sections 152.22 to 152.37, to the Office of Cannabis Management
is subject to Minnesota Statutes, section 15.039.
 new text end

Sec. 132. new text begin REPEALER.
new text end

new text begin (a) new text end new text begin Minnesota Statutes 2023 Supplement, sections 342.01, subdivisions 28, 52, 53, 54,
and 55; 342.18, subdivision 1; 342.27, subdivision 13; and 342.29, subdivision 9, new text end new text begin are
repealed.
 new text end

new text begin (b) new text end new text begin Minnesota Statutes 2023 Supplement, sections 342.47; 342.48; 342.49; 342.50; and
342.52, subdivision 8, new text end new text begin are repealed.
 new text end

new text begin (c) new text end new text begin Laws 2023, chapter 63, article 7, sections 4; and 6, new text end new text begin are repealed.
 new text end

new text begin (d) new text end new text begin Minnesota Statutes 2022, sections 152.22, subdivision 3; and 152.36, new text end new text begin are repealed.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin Paragraphs (a) and (c) are effective the day following final
enactment. Paragraph (b) is effective March 1, 2025, or upon the adoption of initial rules
pertaining to medical cannabis under section 342.02, subdivision 5, whichever is later.
Paragraph (d) is effective July 1, 2024.
 new text end

APPENDIX

Repealed Minnesota Statutes: S4782-4

152.22 DEFINITIONS.

Subd. 3.

Disqualifying felony offense.

"Disqualifying felony offense" means a violation of a state or federal controlled substance law that is a felony under Minnesota law, or would be a felony if committed in Minnesota, regardless of the sentence imposed, unless the commissioner determines that the person's conviction was for the medical use of cannabis or assisting with the medical use of cannabis.

152.36 IMPACT ASSESSMENT OF MEDICAL CANNABIS THERAPEUTIC RESEARCH.

Subdivision 1.

Task force on medical cannabis therapeutic research.

(a) A 23-member task force on medical cannabis therapeutic research is created to conduct an impact assessment of medical cannabis therapeutic research. The task force shall consist of the following members:

(1) two members of the house of representatives, one selected by the speaker of the house, the other selected by the minority leader;

(2) two members of the senate, one selected by the majority leader, the other selected by the minority leader;

(3) four members representing consumers or patients enrolled in the registry program, including at least two parents of patients under age 18;

(4) four members representing health care providers, including one licensed pharmacist;

(5) four members representing law enforcement, one from the Minnesota Chiefs of Police Association, one from the Minnesota Sheriff's Association, one from the Minnesota Police and Peace Officers Association, and one from the Minnesota County Attorneys Association;

(6) four members representing substance use disorder treatment providers; and

(7) the commissioners of health, human services, and public safety.

(b) Task force members listed under paragraph (a), clauses (3), (4), (5), and (6), shall be appointed by the governor under the appointment process in section 15.0597. Members shall serve on the task force at the pleasure of the appointing authority. All members must be appointed by July 15, 2014, and the commissioner of health shall convene the first meeting of the task force by August 1, 2014.

(c) There shall be two cochairs of the task force chosen from the members listed under paragraph (a). One cochair shall be selected by the speaker of the house and the other cochair shall be selected by the majority leader of the senate. The authority to convene meetings shall alternate between the cochairs.

(d) Members of the task force other than those in paragraph (a), clauses (1), (2), and (7), shall receive expenses as provided in section 15.059, subdivision 6.

Subd. 1a.

Administration.

The commissioner of health shall provide administrative and technical support to the task force.

Subd. 2.

Impact assessment.

The task force shall hold hearings to evaluate the impact of the use of medical cannabis and hemp and Minnesota's activities involving medical cannabis and hemp, including, but not limited to:

(1) program design and implementation;

(2) the impact on the health care provider community;

(3) patient experiences;

(4) the impact on the incidence of substance abuse;

(5) access to and quality of medical cannabis, hemp, and medical cannabis products;

(6) the impact on law enforcement and prosecutions;

(7) public awareness and perception; and

(8) any unintended consequences.

Subd. 3.

Cost assessment.

By January 15 of each year, beginning January 15, 2015, and ending January 15, 2019, the commissioners of state departments impacted by the medical cannabis therapeutic research study shall report to the cochairs of the task force on the costs incurred by each department on implementing sections 152.22 to 152.37. The reports must compare actual costs to the estimated costs of implementing these sections and must be submitted to the task force on medical cannabis therapeutic research.

Subd. 4.

Reports to the legislature.

(a) The cochairs of the task force shall submit the following reports to the chairs and ranking minority members of the legislative committees and divisions with jurisdiction over health and human services, public safety, judiciary, and civil law:

(1) by February 1, 2015, a report on the design and implementation of the registry program; and every two years thereafter, a complete impact assessment report; and

(2) upon receipt of a cost assessment from a commissioner of a state agency, the completed cost assessment.

(b) The task force may make recommendations to the legislature on whether to add or remove conditions from the list of qualifying medical conditions.

Subd. 5.

No expiration.

The task force on medical cannabis therapeutic research does not expire.

342.01 DEFINITIONS.

Subd. 28.

Division of Medical Cannabis.

"Division of Medical Cannabis" means a division housed in the Office of Cannabis Management that operates the medical cannabis program.

Subd. 52.

Medical cannabinoid product.

(a) "Medical cannabinoid product" means a product that:

(1) consists of or contains cannabis concentrate or hemp concentrate or is infused with cannabinoids, including but not limited to artificially derived cannabinoids; and

(2) is provided to a patient enrolled in the registry program; a registered designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a cannabis retailer or medical cannabis retailer to treat or alleviate the symptoms of a qualifying medical condition.

(b) A medical cannabinoid product must be in the form of:

(1) liquid, including but not limited to oil;

(2) pill;

(3) liquid or oil for use with a vaporized delivery method;

(4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles;

(5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and sublingual tablets;

(6) edible products in the form of gummies and chews;

(7) topical formulation; or

(8) any allowable form or delivery method approved by the office.

(c) Medical cannabinoid product does not include adult-use cannabis products or hemp-derived consumer products.

Subd. 53.

Medical cannabis business.

"Medical cannabis business" means an entity licensed under this chapter to engage in one or more of the following:

(1) the cultivation of cannabis plants for medical cannabis flower;

(2) the manufacture of medical cannabinoid products; and

(3) the retail sale of medical cannabis flower and medical cannabinoid products.

Subd. 54.

Medical cannabis flower.

"Medical cannabis flower" means cannabis flower provided to a patient enrolled in the registry program; a registered designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a cannabis retailer or medical cannabis business to treat or alleviate the symptoms of a qualifying medical condition. Medical cannabis flower does not include adult-use cannabis flower.

Subd. 55.

Medical cannabis paraphernalia.

"Medical cannabis paraphernalia" means a delivery device, related supply, or educational material used by a patient enrolled in the registry program to administer medical cannabis and medical cannabinoid products.

342.18 LICENSE SELECTION CRITERIA.

Subdivision 1.

Market stability.

The office shall issue the necessary number of licenses in order to ensure the sufficient supply of cannabis flower and cannabis products to meet demand, provide market stability, ensure a competitive market, and limit the sale of unregulated cannabis flower and cannabis products.

342.27 RETAIL SALE OF CANNABIS FLOWER AND PRODUCTS; GENERAL REQUIREMENTS.

Subd. 13.

Adult-use and medical cannabis; colocation.

(a) A cannabis business with a license or endorsement authorizing the retail sale of adult-use cannabis flower or adult-use cannabis products that is also a licensed medical cannabis retailer may sell medical cannabis flower and medical cannabinoid products on a portion of the business's premises.

(b) The premises must provide an appropriate space for a pharmacist employee of the medical cannabis retailer to consult with a patient to determine the proper type of medical cannabis flower and medical cannabinoid products and proper dosage for the patient.

342.29 CANNABIS MEZZOBUSINESS LICENSING AND OPERATIONS.

Subd. 9.

Medical cannabis endorsement.

A cannabis mezzobusiness that cultivates cannabis plants for use as medical cannabis flower or for use in medical cannabinoid products, processes medical cannabinoid products, or both, must comply with sections 342.49, paragraph (d); 342.50, paragraph (c), and any additional requirements established by the office.

342.47 MEDICAL CANNABIS BUSINESS LICENSES.

Subdivision 1.

License types.

(a) The office shall issue the following types of medical cannabis business licenses:

(1) medical cannabis cultivator;

(2) medical cannabis processor;

(3) medical cannabis retailer; and

(4) medical cannabis combination business license.

(b) The Division of Medical Cannabis may oversee the licensing and regulation of medical cannabis businesses.

Subd. 2.

Multiple licenses; limits.

(a) Except as provided in subdivision 3, a person, cooperative, or business holding:

(1) a medical cannabis cultivator license may also hold a medical cannabis processor license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses;

(2) a medical cannabis processor license may also hold a medical cannabis cultivator license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses; or

(3) a medical cannabis retailer license may also hold a cannabis mezzobusiness license, a cannabis retailer license, a cannabis delivery service license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses.

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a medical cannabis license may own or operate any other cannabis business or hemp business.

(c) The office by rule may limit the number of medical cannabis business licenses that a person or business may hold.

(d) For purposes of this subdivision, a restriction on the number of licenses or type of license that a business may hold applies to every cooperative member or every director, manager, and general partner of a medical cannabis business.

Subd. 3.

Medical cannabis combination business license.

(a) A person, cooperative, or business holding a medical cannabis combination license is prohibited from owning or operating any other cannabis business or hemp business.

(b) A person or business may only hold one medical cannabis combination license.

342.48 MEDICAL CANNABIS BUSINESS APPLICATIONS.

In addition to the information required to be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, a person, cooperative, or business seeking a medical cannabis business license must submit the following information in a form approved by the office:

(1) for medical cannabis cultivator license applicants:

(i) an operating plan demonstrating the proposed size and layout of the cultivation facility; plans for wastewater and waste disposal for the cultivation facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the cultivation facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements;

(ii) a cultivation plan demonstrating the proposed size and layout of the cultivation facility that will be used exclusively for cultivation for medical cannabis, including the total amount of plant canopy; and

(iii) evidence that the business will comply with the applicable operation requirements for the license being sought;

(2) for medical cannabis processor license applicants:

(i) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems; plans for wastewater and waste disposal for the manufacturing facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the manufacturing facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements;

(ii) all methods of extraction and concentration that the applicant intends to use and the volatile chemicals, if any, that are involved in extraction or concentration;

(iii) if the applicant is seeking an endorsement to manufacture products infused with cannabinoids for consumption by patients enrolled in the registry program, proof of an edible cannabinoid product handler endorsement from the office; and

(iv) evidence that the applicant will comply with the applicable operation requirements for the license being sought;

(3) for medical cannabis retailer license applicants:

(i) a list of every retail license held by the applicant and, if the applicant is a business, every retail license held, either as an individual or as part of another business, by each officer, director, manager, and general partner of the cannabis business;

(ii) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems, policies to avoid sales to individuals who are not authorized to receive the distribution of medical cannabis flower or medical cannabinoid products, identification of a restricted area for storage, and plans to prevent the visibility of cannabis flower and cannabinoid products; and

(iii) evidence that the applicant will comply with the applicable operation requirements for the license being sought; or

(4) for medical cannabis combination license applicants:

(i) the information required under clauses (1) to (3); and

(ii) any additional information required under sections 342.30, subdivision 3; 342.31, subdivision 3; and 342.32, subdivision 3.

342.49 MEDICAL CANNABIS CULTIVATORS.

(a) A medical cannabis cultivator license entitles the license holder to grow cannabis plants within the approved amount of space up to 60,000 square feet of plant canopy from seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package and label cannabis flower as medical cannabis flower, sell medical cannabis flower to medical cannabis processors and medical cannabis retailers, transport medical cannabis flower to a medical cannabis processor located on the same premises, and perform other actions approved by the office.

(b) A medical cannabis cultivator license holder must comply with all requirements of section 342.25.

(c) A medical cannabis cultivator license holder must verify that every batch of medical cannabis flower has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabis flower before the medical cannabis cultivator may package, label, or sell the medical cannabis flower to any other entity.

(d) A medical cannabis cultivator may exceed the limit of 60,000 square feet of plant canopy if it was legally cultivating medical cannabis with a greater plant canopy as of April 1, 2023.

342.50 MEDICAL CANNABIS PROCESSORS.

(a) A medical cannabis processor license, consistent with the specific license endorsement or endorsements, entitles the license holder to:

(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, and hemp concentrate from medical cannabis cultivators and other medical cannabis processors;

(2) purchase hemp plant parts from industrial hemp growers;

(3) make cannabis concentrate from medical cannabis flower;

(4) make hemp concentrate, including hemp concentrate with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

(5) manufacture medical cannabinoid products;

(6) package and label medical cannabinoid products for sale to other medical cannabis processors and to medical cannabis retailers; and

(7) perform other actions approved by the office.

(b) A medical cannabis processor license holder must comply with all requirements of section 342.26, including requirements to obtain specific license endorsements.

(c) A medical cannabis processor license holder must verify that every batch of medical cannabinoid product has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabinoid products before the medical cannabis processor may package, label, or sell the medical cannabinoid product to any other entity.

342.52 PATIENT REGISTRY PROGRAM.

Subd. 8.

Allowable delivery methods.

A patient in the registry program may receive medical cannabis flower and medical cannabinoid products. The office may approve additional delivery methods to expand the types of products that qualify as medical cannabinoid products.

Repealed Minnesota Session Laws: S4782-4

Laws 2023, chapter 63, article 7, section 4

Sec. 4. new text begin EDIBLE CANNABINOID PRODUCTS; ENFORCEMENT.new text end

new text begin (a) The Department of Health shall enforce the provisions of Minnesota Statutes, section 151.72, and all rules, orders, stipulation agreements, settlements, compliance agreements, and registrations related to that section adopted or issued by the Office of Medical Cannabis or the Department of Health pursuant to the Health Enforcement Consolidation Act of 1993 contained in Minnesota Statutes, sections 144.989 to 144.993, and the authority to embargo products described in paragraph (b). The commissioner of health may assign enforcement responsibilities to the Office of Medical Cannabis. new text end

new text begin (b) Whenever a duly authorized agent of the Department of Health finds or has probable cause to believe that any product is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the agent shall affix thereto an appropriate marking, giving notice that the article is, or is suspected of being in violation of Minnesota Statutes, section 151.72, has been embargoed, and warning that it is unlawful for any person to remove or dispose of the embargoed article by sale or otherwise without permission from the agent or the court. When an agent of the Department of Health has embargoed an article, the Department of Health shall, within 30 days, petition the district court in whose jurisdiction the article is embargoed for an order of condemnation. When an embargoed article is not so found by the agent, the agent shall remove the marking. If the court finds that an embargoed article is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the article shall be destroyed at the expense of the claimant thereof, who shall also pay all court costs and fees, storage, and other proper expenses. If the violation can be corrected by proper labeling or processing of the article, or by filing the proper documents with the court, the court, after the costs, fees, and expenses have been paid and a sufficient bond has been executed, may order that the article be delivered to the claimant for labeling, processing, or filing under supervision of an agent of the board. The expense of the supervision shall be paid by the claimant. The bond shall be returned to the claimant on the representation to the court by the board that the article is no longer in violation of this chapter and that the expenses of supervision have been paid. new text end

new text begin (c) The enforcement authority under paragraphs (a) and (b) shall transfer to the Office of Cannabis Management at any such time that the powers and duties of the Department of Health with respect to the medical cannabis program under Minnesota Statutes, sections 152.22 to 152.37, are transferred to the Office of Cannabis Management. The director of the Office of Cannabis Management may assign enforcement responsibilities to the Division of Medical Cannabis. new text end

new text begin (d) This section shall expire on March 1, 2025. new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment. new text end

Laws 2023, chapter 63, article 7, section 6

Sec. 6. new text begin REPEALER.new text end

new text begin Minnesota Statutes 2022, section 151.72, new text end new text begin is repealed. new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025. new text end